Rank;Sourceid;Title;Type;Issn;SJR;SJR Best Quartile;H index;Total Docs. (2017);Total Docs. (3years);Total Refs.;Total Cites (3years);Citable Docs. (3years);Cites / Doc. (2years);Ref. / Doc.;Country;Region;Publisher;Coverage;Categories
1;20425;Nature Reviews Drug Discovery;journal;14741784, 14741776;10.106;Q1;348;237;671;6857;7201;314;8.94;28.93;United Kingdom;Western Europe;Nature Publishing Group;2002-2021;"Drug Discovery (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q1)"
2;21191;Pharmacological Reviews;journal;15210081, 00316997;9.472;Q1;241;18;84;6360;1882;83;19.5;353.33;United States;Northern America;American Society for Pharmacology and Experimental Therapeutics;1949, 1951-2021;"Molecular Medicine (Q1); Pharmacology (Q1)"
3;4700152457;Nano Today;journal;17480132;7.191;Q1;155;46;184;6310;2530;134;13.45;137.17;Netherlands;Western Europe;Elsevier;1970, 2006-2021;"Bioengineering (Q1); Biomedical Engineering (Q1); Biotechnology (Q1); Materials Science (miscellaneous) (Q1); Medicine (miscellaneous) (Q1); Nanoscience and Nanotechnology (Q1); Pharmaceutical Science (Q1)"
4;19479;Annual Review of Pharmacology and Toxicology;journal;15454304, 03621642;6.718;Q1;210;28;91;3720;1255;90;13.88;132.86;United States;Northern America;Annual Reviews Inc.;1965-1973, 1975-2021;"Pharmacology (Q1); Toxicology (Q1)"
5;22321;Trends in Pharmacological Sciences;journal;18733735, 01656147;4.794;Q1;225;95;272;7600;2758;225;9.84;80;United Kingdom;Western Europe;Elsevier Ltd.;1979-2021;"Pharmacology (Q1); Toxicology (Q1)"
6;19409;Advanced Drug Delivery Reviews;journal;0169409X, 18728294;4.09;Q1;331;155;508;26594;6890;464;12.96;171.57;Netherlands;Western Europe;Elsevier;1987-2021;Pharmaceutical Science (Q1)
7;21195;Pharmacology and Therapeutics;journal;1879016X, 01637258;4.072;Q1;211;142;357;25171;3958;356;10.46;177.26;United States;Northern America;Elsevier Inc.;1975-1977, 1979-1985, 1987-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1)"
8;12611;Drug Resistance Updates;journal;13687646, 15322084;3.986;Q1;119;17;62;2472;752;62;12.32;145.41;United States;Northern America;Churchill Livingstone;1998-2021;"Cancer Research (Q1); Infectious Diseases (Q1); Oncology (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
9;26371;Natural Product Reports;journal;02650568, 14604752;3.918;Q1;188;60;246;11057;2544;239;10.23;184.28;United Kingdom;Western Europe;Royal Society of Chemistry;1984-2021;"Biochemistry (Q1); Drug Discovery (Q1); Organic Chemistry (Q1)"
10;13903;Cellular and Molecular Life Sciences;journal;1420682X, 14209071;3.388;Q1;233;280;923;33898;6315;909;6.9;121.06;Switzerland;Western Europe;Birkhauser Verlag Basel;1952, 1997-2021;"Cell Biology (Q1); Cellular and Molecular Neuroscience (Q1); Molecular Biology (Q1); Molecular Medicine (Q1); Pharmacology (Q1)"
11;18017;Neuropsychopharmacology;journal;0893133X, 1470634X;3.327;Q1;227;276;954;16185;5849;905;6.03;58.64;United Kingdom;Western Europe;Nature Publishing Group;1987-2021;"Pharmacology (Q1); Psychiatry and Mental Health (Q1)"
12;21100456838;Cell Chemical Biology;journal;24519448, 24519456;3.174;Q1;190;177;550;8050;2997;530;4.68;45.48;United States;Northern America;Elsevier Inc.;2016-2021;"Biochemistry (Q1); Clinical Biochemistry (Q1); Drug Discovery (Q1); Molecular Biology (Q1); Molecular Medicine (Q1); Pharmacology (Q1)"
13;12455;Molecular Therapy;journal;15250024, 15250016;3.141;Q1;185;258;687;11648;4004;562;5.73;45.15;United States;Northern America;Cell Press;2000-2021;"Drug Discovery (Q1); Genetics (Q1); Medicine (miscellaneous) (Q1); Molecular Biology (Q1); Molecular Medicine (Q1); Pharmacology (Q1)"
14;21100853576;Bulletin of Faculty of Pharmacy, Cairo University;journal;11100931;3.075;Q1;1;0;1;0;18;1;0;0;Egypt;Africa/Middle East;;;"Pharmaceutical Science (Q1); Pharmacy (Q1)"
15;19907;Medicinal Research Reviews;journal;01986325, 10981128;2.895;Q1;134;38;109;9057;1071;108;8.57;238.34;United States;Northern America;"John Wiley &amp; Sons Inc.";1981-2021;"Drug Discovery (Q1); Molecular Medicine (Q1); Pharmacology (Q1)"
16;21100466864;Journal for ImmunoTherapy of Cancer;journal;20511426;2.798;Q1;80;96;215;3910;1314;193;5.85;40.73;United Kingdom;Western Europe;BMJ Publishing Group;2013-2021;"Cancer Research (Q1); Immunology (Q1); Immunology and Allergy (Q1); Molecular Medicine (Q1); Oncology (Q1); Pharmacology (Q1)"
17;21100777378;Therapeutic Advances in Vaccines;journal;20510136;2.769;Q1;5;0;6;0;61;6;0;0;United Kingdom;Western Europe;;;"Drug Discovery (Q1); Immunology (Q1); Immunology and Allergy (Q1); Oncology (Q1); Pharmacology (medical) (Q1)"
18;19700178100;Nanotechnology, Science and Applications;journal;11778903;2.723;Q1;30;15;16;689;243;16;13.5;45.93;New Zealand;Pacific Region;Dove Medical Press Limited;2010-2012, 2014-2021;"Bioengineering (Q1); Biomedical Engineering (Q1); Nanoscience and Nanotechnology (Q1); Pharmaceutical Science (Q1)"
19;23010;Journal of Controlled Release;journal;18734995, 01683659;2.684;Q1;282;504;1565;34558;13151;1477;7.73;68.57;Netherlands;Western Europe;Elsevier;1984-2021;Pharmaceutical Science (Q1)
20;18148;Pain;journal;18726623, 03043959;2.671;Q1;269;324;1083;15671;5315;851;4.74;48.37;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1975-2021;"Anesthesiology and Pain Medicine (Q1); Neurology (Q1); Neurology (clinical) (Q1); Pharmacology (Q1)"
21;20084;British Journal of Pharmacology;journal;14765381, 00071188;2.603;Q1;223;348;1124;32427;6910;1101;6.57;93.18;United States;Northern America;Wiley-Blackwell;1965-2021;Pharmacology (Q1)
22;11900154404;PLoS Neglected Tropical Diseases;journal;19352727, 19352735;2.589;Q1;143;896;2463;43067;11876;2423;4.6;48.07;United States;Northern America;Public Library of Science;2007-2021;"Infectious Diseases (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Public Health, Environmental and Occupational Health (Q1)"
23;23041;Journal of Medicinal Chemistry;journal;00222623, 15204804;2.567;Q1;276;685;2207;36560;14523;2194;6.42;53.37;United States;Northern America;American Chemical Society;1959-1961, 1963-2021;"Drug Discovery (Q1); Molecular Medicine (Q1)"
24;5100155080;Neurotherapeutics;journal;19337213;2.53;Q1;122;97;234;8875;1410;216;5.54;91.49;United States;Northern America;Springer New York;2007-2021;"Neurology (clinical) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
25;21100218543;Molecular Therapy - Nucleic Acids;journal;21622531;2.523;Q1;71;160;247;8701;1444;236;5.28;54.38;United States;Northern America;Cell Press;2012-2021;"Drug Discovery (Q1); Molecular Medicine (Q1)"
26;21100207003;Theranostics;journal;18387640;2.515;Q1;115;360;394;20726;3675;388;8.85;57.57;Australia;Pacific Region;Ivyspring International Publisher;2012-2021;"Medicine (miscellaneous) (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1)"
27;20681;Current Opinion in Pharmacology;journal;14714973, 14714892;2.504;Q1;139;115;326;6188;1858;299;6.37;53.81;Netherlands;Western Europe;Elsevier BV;2001-2021;"Drug Discovery (Q1); Pharmacology (Q1)"
28;21100232818;Emerging Microbes and Infections;journal;22221751;2.433;Q1;68;113;184;3918;902;144;4.45;34.67;United Kingdom;Western Europe;Nature Publishing Group;2012-2021;"Drug Discovery (Q1); Epidemiology (Q1); Immunology (Q1); Infectious Diseases (Q1); Medicine (miscellaneous) (Q1); Microbiology (Q1); Parasitology (Q1); Virology (Q1)"
29;22418;Journal of Antimicrobial Chemotherapy;journal;03057453, 14602091;2.419;Q1;203;550;1672;16782;7865;1410;4.56;30.51;United Kingdom;Western Europe;Oxford University Press;1975-2021;"Infectious Diseases (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
30;144771;Clinical Trials;journal;17407753, 17407745;2.399;Q1;67;83;276;2327;583;221;2.2;28.04;United Kingdom;Western Europe;SAGE Publications Ltd;2004-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q1)"
31;19700174891;Perspectives in Medicinal Chemistry;journal;11773910, 1177391X;2.374;Q1;16;0;10;0;119;10;5;0;New Zealand;Pacific Region;Libertas Academica Ltd.;2008-2011, 2014-2016;"Drug Discovery (Q1); Pharmaceutical Science (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
32;19615;Antimicrobial Agents and Chemotherapy;journal;10986596, 00664804;2.291;Q1;269;931;3221;32159;14716;3049;4.34;34.54;United States;Northern America;American Society for Microbiology;1963-1970, 1972-2021;"Infectious Diseases (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
33;19600166320;Protein and Cell;journal;16748018, 1674800X;2.286;Q1;74;103;312;4608;1256;252;4;44.74;China;Asiatic Region;Higher Education Press;2010-2021;"Biochemistry (Q1); Biotechnology (Q1); Cell Biology (Q1); Drug Discovery (Q1); Medicine (miscellaneous) (Q1)"
34;21100850730;npj Vaccines;journal;20590105;2.269;Q1;30;34;16;1814;42;15;2.63;53.35;United Kingdom;Western Europe;Nature Publishing Group;2016-2021;"Immunology (Q1); Infectious Diseases (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
35;4400151524;Particle and Fibre Toxicology;journal;17438977;2.253;Q1;105;52;174;3213;1519;171;6.32;61.79;United Kingdom;Western Europe;BioMed Central Ltd.;2004-2021;"Health, Toxicology and Mutagenesis (Q1); Medicine (miscellaneous) (Q1); Toxicology (Q1)"
36;15984;Journal of Molecular Medicine;journal;09462716, 14321440;2.177;Q1;146;127;368;6943;1791;335;4.65;54.67;Germany;Western Europe;Springer Verlag;1976-1978, 1980-1981, 1995-2021;"Drug Discovery (Q1); Genetics (clinical) (Q1); Molecular Medicine (Q1)"
37;19963;Molecular Pharmacology;journal;15210111, 0026895X;2.076;Q1;202;127;492;6582;2067;492;4.03;51.83;United States;Northern America;American Society for Pharmacology and Experimental Therapeutics;1965-2021;"Molecular Medicine (Q1); Pharmacology (Q1)"
38;20435;Neuropharmacology;journal;00283908, 18737064;2.043;Q1;176;450;1228;35587;5949;1209;4.35;79.08;United Kingdom;Western Europe;Elsevier Ltd.;1962-2021;"Pharmacology (Q1); Cellular and Molecular Neuroscience (Q2)"
39;21196;Drug Discovery Today;journal;18785832, 13596446;2.008;Q1;185;191;636;14484;3883;594;6.56;75.83;United Kingdom;Western Europe;Elsevier Ltd.;1996-2021;"Drug Discovery (Q1); Pharmacology (Q1)"
40;21165;PharmacoEconomics;journal;11707690, 11792027;1.998;Q1;104;115;324;5257;1215;272;3.77;45.71;United Kingdom;Western Europe;Adis International Ltd;1992-2021;"Health Policy (Q1); Pharmacology (Q1); Public Health, Environmental and Occupational Health (Q1)"
41;21100225611;Advanced healthcare materials;journal;21922640, 21922659;1.989;Q1;105;301;812;22849;4640;774;5.58;75.91;United Kingdom;Western Europe;John Wiley and Sons Ltd;2012-2021;"Biomaterials (Q1); Biomedical Engineering (Q1); Pharmaceutical Science (Q1)"
42;24749;Addiction Biology;journal;13556215, 13691600;1.952;Q1;83;153;292;8489;1272;291;4.65;55.48;United States;Northern America;Wiley-Blackwell;1996-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q1); Psychiatry and Mental Health (Q1)"
43;23109;Journal of Psychopharmacology;journal;14617285, 02698811;1.939;Q1;121;158;402;10619;1681;374;4.51;67.21;United Kingdom;Western Europe;SAGE Publications Ltd;1987-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1)"
44;19617;Antiviral Research;journal;01663542, 18729096;1.925;Q1;134;247;598;11083;2726;582;4.6;44.87;Netherlands;Western Europe;Elsevier;1959, 1981-2021;"Pharmacology (Q1); Virology (Q1)"
45;15576;European Neuropsychopharmacology;journal;0924977X, 18737862;1.911;Q1;118;124;619;7137;2605;600;4.08;57.56;Netherlands;Western Europe;Elsevier;1990-2021;"Neurology (Q1); Neurology (clinical) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1); Biological Psychiatry (Q2)"
46;20063;Biochemical Pharmacology;journal;18732968, 00062952;1.832;Q1;206;282;837;20753;4064;755;4.22;73.59;United States;Northern America;Elsevier Inc.;1958-2021;"Biochemistry (Q1); Pharmacology (Q1)"
47;24661;Critical Reviews in Toxicology;journal;15476898, 10408444;1.828;Q1;117;36;124;4747;698;119;4.66;131.86;United Kingdom;Western Europe;Informa Healthcare;1971-2021;Toxicology (Q1)
48;25152;Journal of Toxicology and Environmental Health - Part B: Critical Reviews;journal;10937404, 15216950;1.816;Q1;89;23;46;3288;320;45;6.87;142.96;United Kingdom;Western Europe;Taylor and Francis Ltd.;1998-2021;"Health, Toxicology and Mutagenesis (Q1); Toxicology (Q1)"
49;21169;Pharmacological Research;journal;10436618, 10961186;1.811;Q1;147;296;717;24500;3622;675;4.91;82.77;United States;Northern America;Academic Press Inc.;1989-2021;Pharmacology (Q1)
50;22452;International Journal of Neuropsychopharmacology;journal;14611457, 14695111;1.808;Q1;113;111;515;6468;2273;503;4.48;58.27;United Kingdom;Western Europe;Oxford University Press;1998-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1)"
51;16876;Bioconjugate Chemistry;journal;15204812, 10431802;1.801;Q1;177;323;857;15783;3942;847;4.5;48.86;United States;Northern America;American Chemical Society;1990-2021;"Bioengineering (Q1); Biomedical Engineering (Q1); Biotechnology (Q1); Organic Chemistry (Q1); Pharmaceutical Science (Q1); Pharmacology (Q1)"
52;19900193739;Nucleic Acid Therapeutics;journal;21593345, 21593337;1.794;Q1;70;38;123;1457;353;119;2.45;38.34;United States;Northern America;Mary Ann Liebert Inc.;2011-2021;"Biochemistry (Q1); Drug Discovery (Q1); Genetics (Q1); Molecular Medicine (Q1); Molecular Biology (Q2)"
53;20700195026;Acta Pharmaceutica Sinica B;journal;22113843, 22113835;1.793;Q1;65;81;158;3905;940;144;6.17;48.21;Netherlands;Western Europe;Elsevier BV;2012, 2014-2021;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1)
54;4000148406;Clinical Toxicology;journal;15569519, 15563650;1.792;Q1;98;154;423;3061;1484;295;3.35;19.88;United Kingdom;Western Europe;Informa Healthcare;1968-1998, 2005-2021;"Medicine (miscellaneous) (Q1); Toxicology (Q1)"
55;4000149101;Nanomedicine: Nanotechnology, Biology, and Medicine;journal;15499634, 15499642;1.743;Q1;133;249;595;12173;3946;579;6.76;48.89;United States;Northern America;Elsevier Inc.;2005-2021;"Bioengineering (Q1); Biomedical Engineering (Q1); Materials Science (miscellaneous) (Q1); Medicine (miscellaneous) (Q1); Molecular Medicine (Q1); Nanoscience and Nanotechnology (Q1); Pharmaceutical Science (Q1)"
56;26380;Drug and Alcohol Dependence;journal;03768716;1.715;Q1;173;453;1270;22237;4665;1257;3.45;49.09;Ireland;Western Europe;Elsevier Ireland Ltd;1975-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1); Toxicology (Q1)"
57;21767;Progress in Neuro-Psychopharmacology and Biological Psychiatry;journal;18784216, 02785846;1.714;Q1;134;190;493;13395;2189;484;4.35;70.5;United States;Northern America;Elsevier Inc.;1982-2022;"Pharmacology (Q1); Biological Psychiatry (Q2)"
58;20626;Clinical Pharmacology and Therapeutics;journal;15326535, 00099236;1.699;Q1;195;239;556;7386;2582;502;4.57;30.9;United States;Northern America;Wiley-Blackwell;1960-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1)"
59;21100335701;Vaccines;journal;2076393X;1.691;Q1;50;51;141;3816;736;137;5.49;74.82;Switzerland;Western Europe;Multidisciplinary Digital Publishing Institute (MDPI);2013-2021;"Drug Discovery (Q1); Infectious Diseases (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1); Immunology (Q2)"
60;5400152706;Nanotoxicology;journal;17435390, 17435404;1.63;Q1;94;99;360;5671;2277;353;5.81;57.28;United Kingdom;Western Europe;Informa Healthcare;2007-2021;"Biomedical Engineering (Q1); Nanoscience and Nanotechnology (Q1); Toxicology (Q1)"
61;23916;Environmental Pollution;journal;02697491, 18736424;1.615;Q1;249;1097;1886;62123;9956;1850;4.7;56.63;United Kingdom;Western Europe;Elsevier Ltd.;1970-1980, 1986-2022;"Health, Toxicology and Mutagenesis (Q1); Medicine (miscellaneous) (Q1); Pollution (Q1); Toxicology (Q1)"
62;19700175015;Infection and Drug Resistance;journal;11786973;1.603;Q1;44;59;107;2241;516;105;4.11;37.98;New Zealand;Pacific Region;Dove Medical Press Ltd.;2009-2021;"Infectious Diseases (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
63;21354;Expert Opinion on Therapeutic Targets;journal;14728222, 17447631;1.597;Q1;94;109;366;10784;1587;356;4.26;98.94;United Kingdom;Western Europe;Taylor and Francis Ltd.;1997-2021;"Clinical Biochemistry (Q1); Drug Discovery (Q1); Molecular Medicine (Q1); Pharmacology (Q1)"
64;21100214102;Frontiers in Pharmacology;journal;16639812;1.587;Q1;104;943;1091;59185;4599;1026;3.83;62.76;Switzerland;Western Europe;Frontiers Media S.A.;2010-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1)"
65;23086;Journal of Pharmacology and Experimental Therapeutics;journal;15210103, 00223565;1.586;Q1;233;193;703;9271;2775;696;3.79;48.04;United States;Northern America;American Society for Pharmacology and Experimental Therapeutics;1945-2021;"Molecular Medicine (Q1); Pharmacology (Q1)"
66;22477;Investigational New Drugs;journal;01676997, 15730646;1.573;Q1;90;94;372;2891;1438;369;3.68;30.76;Netherlands;Western Europe;Kluwer Academic Publishers;1983-2021;"Oncology (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
67;130126;Molecular Pharmaceutics;journal;15438384, 15438392;1.572;Q1;138;437;1261;21011;6396;1252;4.77;48.08;United States;Northern America;American Chemical Society;2004-2021;"Drug Discovery (Q1); Molecular Medicine (Q1); Pharmaceutical Science (Q1)"
68;4000148203;Handbook of Experimental Pharmacology;journal;01712004;1.57;Q1;96;150;326;15468;1359;243;3.8;103.12;Germany;Western Europe;Springer Heidelberg;2004-2021;"Biochemistry (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1)"
69;21100197941;International Journal for Parasitology: Drugs and Drug Resistance;journal;22113207;1.556;Q1;40;44;106;2154;414;106;3.06;48.95;Netherlands;Western Europe;Elsevier BV;2011-2021;"Infectious Diseases (Q1); Parasitology (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
70;20783;Expert Review of Vaccines;journal;14760584, 17448395;1.551;Q1;91;110;415;9099;1463;392;3.56;82.72;United Kingdom;Western Europe;Taylor and Francis Ltd.;2002-2021;"Drug Discovery (Q1); Molecular Medicine (Q1); Pharmacology (Q1); Immunology (Q2)"
71;20082;British Journal of Clinical Pharmacology;journal;13652125, 03065251;1.543;Q1;153;298;841;11056;3163;731;3.59;37.1;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;1974-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1)"
72;24604;Archives of Toxicology;journal;14320738, 03405761;1.541;Q1;121;291;614;17479;3106;519;5.05;60.07;Germany;Western Europe;Springer Verlag;1930-1940, 1943-1944, 1972-2021;"Health, Toxicology and Mutagenesis (Q1); Medicine (miscellaneous) (Q1); Toxicology (Q1)"
73;25218;Toxicological Sciences;journal;10960929, 10966080;1.538;Q1;193;253;772;12869;3318;723;4.14;50.87;United Kingdom;Western Europe;Oxford University Press;1981-2021;Toxicology (Q1)
74;19427;Advances in Pharmacology;journal;15578925, 10543589;1.536;Q1;78;36;118;5802;433;0;3.44;161.17;United States;Northern America;Academic Press Inc.;1962-1964, 1966-1973, 1975, 1977-1982, 1984, 1990-2000, 2004-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q1)"
75;19700174913;Therapeutic Advances in Neurological Disorders;journal;17562864, 17562856;1.522;Q1;56;34;102;1851;474;97;4.91;54.44;United Kingdom;Western Europe;SAGE Publications Ltd;2008-2021;"Neurology (Q1); Neurology (clinical) (Q1); Pharmacology (Q1)"
76;145164;Human Genomics;journal;14739542, 14797364;1.501;Q1;59;34;89;1621;305;84;3.4;47.68;United Kingdom;Western Europe;BioMed Central Ltd.;2003-2006, 2008-2021;"Drug Discovery (Q1); Molecular Medicine (Q1); Genetics (Q2); Molecular Biology (Q2)"
77;21124;Pharmaceutical Statistics;journal;15391612, 15391604;1.494;Q1;39;39;158;1037;187;153;0.9;26.59;United Kingdom;Western Europe;John Wiley and Sons Ltd;2004-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1); Statistics and Probability (Q1)"
78;21782;Psychopharmacology;journal;00333158, 14322072;1.494;Q1;202;297;1167;18676;3836;1120;3.25;62.88;Germany;Western Europe;Springer Verlag;1959-2021;Pharmacology (Q1)
79;20624;Clinical Pharmacokinetics;journal;11791926, 03125963;1.482;Q1;169;122;301;6990;1361;272;4.13;57.3;United Kingdom;Western Europe;Adis International Ltd;1976-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1)"
80;24032;Reviews of Physiology Biochemistry and Pharmacology;journal;16175786, 03034240;1.463;Q1;66;3;25;524;108;17;3.65;174.67;Germany;Western Europe;Springer Verlag;1974-2008, 2012-2018;"Biochemistry (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q1); Physiology (Q1); Physiology (medical) (Q2)"
81;24791;Alcoholism: Clinical and Experimental Research;journal;01456008, 15300277;1.449;Q1;159;226;936;11521;2914;895;3.08;50.98;United States;Northern America;Wiley-Blackwell;1977-2021;"Medicine (miscellaneous) (Q1); Psychiatry and Mental Health (Q1); Toxicology (Q1)"
82;21237;Drug Safety;journal;01145916, 11791942;1.447;Q1;131;115;304;4725;1058;258;3.46;41.09;United Kingdom;Western Europe;Adis International Ltd;1990-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1); Toxicology (Q1)"
83;21226;Drug Metabolism and Disposition;journal;00909556, 1521009X;1.433;Q1;182;152;680;6122;2549;673;3.59;40.28;United States;Northern America;American Society for Pharmacology and Experimental Therapeutics;1973-2021;"Pharmaceutical Science (Q1); Pharmacology (Q1)"
84;84948;Expert Opinion on Drug Delivery;journal;17425247;1.432;Q1;116;118;425;10326;2260;410;5.26;87.51;United Kingdom;Western Europe;Taylor and Francis Ltd.;2004-2021;Pharmaceutical Science (Q1)
85;18403;Apoptosis : an international journal on programmed cell death;journal;13608185, 1573675X;1.424;Q1;115;124;387;6922;1606;384;4.05;55.82;Netherlands;Western Europe;Springer Netherlands;1996-2021;"Biochemistry (medical) (Q1); Clinical Biochemistry (Q1); Pharmaceutical Science (Q1); Pharmacology (Q1); Cancer Research (Q2); Cell Biology (Q2)"
86;4700152903;Forensic Toxicology;journal;18608965, 18608973;1.407;Q1;39;42;128;1300;407;121;3.8;30.95;Japan;Asiatic Region;Springer Japan;2006-2021;"Biochemistry (medical) (Q1); Pathology and Forensic Medicine (Q1); Toxicology (Q1)"
87;19700177127;ACS Medicinal Chemistry Letters;journal;19485875;1.388;Q1;73;236;671;5781;2412;661;3.73;24.5;United States;Northern America;American Chemical Society;2010-2021;"Drug Discovery (Q1); Organic Chemistry (Q1); Biochemistry (Q2)"
88;11700154316;CNS Neuroscience and Therapeutics;journal;17555949, 17555930;1.38;Q1;75;99;402;4502;1306;317;3.04;45.47;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;2008-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1); Physiology (medical) (Q2)"
89;16088;Journal of Nanobiotechnology;journal;14773155;1.38;Q1;84;91;228;5061;1364;227;5.56;55.62;United Kingdom;Western Europe;BioMed Central Ltd.;2003-2021;"Applied Microbiology and Biotechnology (Q1); Bioengineering (Q1); Biomedical Engineering (Q1); Medicine (miscellaneous) (Q1); Pharmaceutical Science (Q1); Molecular Medicine (Q2); Nanoscience and Nanotechnology (Q2)"
90;4700152872;Journal of NeuroImmune Pharmacology;journal;15571890, 15571904;1.379;Q1;77;59;186;4051;649;182;3.41;68.66;United States;Northern America;Springer New York;2006-2021;"Pharmacology (Q1); Immunology (Q2); Immunology and Allergy (Q2); Neuroscience (miscellaneous) (Q2)"
91;24786;Alcohol and Alcoholism;journal;07350414, 14643502;1.376;Q1;103;95;328;3352;894;300;2.14;35.28;United Kingdom;Western Europe;Oxford University Press;1965-2021;"Medicine (miscellaneous) (Q1); Psychiatry and Mental Health (Q1); Toxicology (Q1)"
92;110112;Journal of Immunotherapy;journal;15249557, 15374513;1.373;Q1;97;44;138;1337;525;138;4.21;30.39;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1991-2021;"Pharmacology (Q1); Cancer Research (Q2); Immunology (Q2); Immunology and Allergy (Q2)"
93;23053;Journal of Natural Products;journal;01633864, 15206025;1.368;Q1;147;423;1181;14937;4684;1171;4.01;35.31;United States;Northern America;American Chemical Society;1949, 1971, 1973, 1978-2021;"Analytical Chemistry (Q1); Complementary and Alternative Medicine (Q1); Drug Discovery (Q1); Organic Chemistry (Q1); Pharmaceutical Science (Q1); Pharmacology (Q1); Molecular Medicine (Q2)"
94;19700175029;Pharmacogenomics and Personalized Medicine;journal;11787066;1.353;Q1;31;31;66;1481;303;64;3.93;47.77;New Zealand;Pacific Region;Dove Medical Press Ltd.;2009-2021;"Pharmacology (Q1); Molecular Medicine (Q2)"
95;22378;Vascular Pharmacology;journal;18793649, 15371891;1.352;Q1;100;50;318;3195;1175;313;3.76;63.9;United States;Northern America;Elsevier Inc.;2002-2021;"Pharmacology (Q1); Molecular Medicine (Q2); Physiology (Q2)"
96;22552;Cardiovascular Drugs and Therapy;journal;15737241, 09203206;1.349;Q1;71;62;204;3322;533;172;2.65;53.58;Netherlands;Western Europe;Kluwer Academic Publishers;1987-2021;"Cardiology and Cardiovascular Medicine (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
97;4400151701;Journal of Exposure Science and Environmental Epidemiology;journal;1559064X, 15590631;1.346;Q1;96;82;247;3354;743;240;2.86;40.9;United Kingdom;Western Europe;Nature Publishing Group;2006-2021;"Pollution (Q1); Public Health, Environmental and Occupational Health (Q1); Toxicology (Q1); Epidemiology (Q2)"
98;19700174905;Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy;journal;11787007;1.342;Q1;50;52;163;2713;622;161;3.18;52.17;New Zealand;Pacific Region;Dove Medical Press Ltd.;2009-2021;"Internal Medicine (Q1); Pharmacology (Q1)"
99;21332;European Journal of Pharmaceutics and Biopharmaceutics;journal;18733441, 09396411;1.342;Q1;168;262;815;12588;4058;808;4.82;48.05;Netherlands;Western Europe;Elsevier;1991-2021;"Biotechnology (Q1); Medicine (miscellaneous) (Q1); Pharmaceutical Science (Q1)"
100;21168;Pharmacogenomics Journal;journal;1470269X, 14731150;1.32;Q1;90;81;229;3870;861;228;3.65;47.78;United Kingdom;Western Europe;Nature Publishing Group;2001-2021;"Pharmacology (Q1); Genetics (Q2); Molecular Medicine (Q2)"
101;6800153101;Expert Opinion on Drug Discovery;journal;1746045X, 17460441;1.309;Q1;68;104;308;10857;1181;294;4.29;104.39;United Kingdom;Western Europe;Informa Healthcare;2006-2021;Drug Discovery (Q1)
102;28792;Cancer Biology and Therapy;journal;15384047, 15558576;1.3;Q1;120;124;546;4724;1820;532;3.38;38.1;United States;Northern America;Landes Bioscience;2002-2021;"Pharmacology (Q1); Cancer Research (Q2); Molecular Medicine (Q2); Oncology (Q2)"
103;23035;Journal of Biopharmaceutical Statistics;journal;10543406, 15205711;1.294;Q1;52;86;249;1675;214;240;0.59;19.48;United States;Northern America;Taylor and Francis Ltd.;1991-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1); Statistics and Probability (Q2)"
104;17700156714;Pharmaceuticals;journal;14248247;1.293;Q1;69;95;177;6229;787;167;4.07;65.57;Switzerland;Western Europe;Multidisciplinary Digital Publishing Institute (MDPI);2009-2021;"Pharmaceutical Science (Q1); Molecular Medicine (Q2)"
105;24763;Addictive Behaviors;journal;03064603;1.29;Q1;135;321;886;13440;2824;878;2.76;41.87;United Kingdom;Western Europe;Elsevier Ltd.;1975-2022;"Clinical Psychology (Q1); Medicine (miscellaneous) (Q1); Psychiatry and Mental Health (Q1); Toxicology (Q1)"
106;25222;Toxicology and Applied Pharmacology;journal;10960333, 0041008X;1.275;Q1;175;280;861;14575;3445;858;3.88;52.05;United States;Northern America;Academic Press Inc.;1959-2021;"Pharmacology (Q1); Toxicology (Q1)"
107;22982;Journal of Cardiovascular Pharmacology and Therapeutics;journal;10742484, 19404034;1.272;Q1;52;64;175;3550;507;169;2.61;55.47;United Kingdom;Western Europe;SAGE Publications Ltd;1996-2021;"Cardiology and Cardiovascular Medicine (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
108;12584;Drug Metabolism Reviews;journal;10979883, 03602532;1.271;Q1;100;21;98;3158;488;97;4.07;150.38;United States;Northern America;Informa Healthcare;1972-2021;"Pharmacology (medical) (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1)"
109;17464;European Journal of Medicinal Chemistry;journal;02235234, 17683254;1.266;Q1;175;897;2386;47238;11579;2381;4.93;52.66;France;Western Europe;Elsevier Masson s.r.l.;1974-2021;"Drug Discovery (Q1); Medicine (miscellaneous) (Q1); Organic Chemistry (Q1); Pharmacology (Q1)"
110;7000153203;Journal of Studies on Alcohol and Drugs;journal;19371888, 19384114;1.266;Q1;129;124;360;4742;953;328;2.37;38.24;United States;Northern America;Alcohol Research Documentation, Inc.;2007-2021;"Health (social science) (Q1); Psychiatry and Mental Health (Q1); Toxicology (Q1)"
111;21455;Progress in Medicinal Chemistry;journal;00796468, 18757863;1.253;Q1;36;5;17;525;60;4;2.75;105;Netherlands;Western Europe;Elsevier;1961-1963, 1965, 1967, 1969-2021;"Pharmacology (Q1); Molecular Medicine (Q2)"
112;21100819608;Emerging Contaminants;journal;24056650, 24056642;1.233;Q1;24;16;35;992;113;33;3.23;62;China;Asiatic Region;KeAi Communications Co.;2015-2021;"Health, Toxicology and Mutagenesis (Q1); Public Health, Environmental and Occupational Health (Q1); Toxicology (Q1)"
113;7700153108;International Journal of Nanomedicine;journal;11782013, 11769114;1.225;Q1;145;625;1566;31259;7967;1544;4.62;50.01;New Zealand;Pacific Region;Dove Medical Press Ltd.;2006-2021;"Bioengineering (Q1); Biomaterials (Q1); Biophysics (Q1); Drug Discovery (Q1); Medicine (miscellaneous) (Q1); Organic Chemistry (Q1); Nanoscience and Nanotechnology (Q2)"
114;14990;Current Neuropharmacology;journal;18756190, 1570159X;1.21;Q1;82;82;241;9242;907;213;3.26;112.71;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2004-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1); Neurology (Q2); Neurology (clinical) (Q2)"
115;19900192174;International Journal of Applied Pharmaceutics;journal;09757058;1.209;Q1;20;162;49;3338;67;49;1.51;20.6;India;Asiatic Region;International Journal of Applied Pharmaceutics;2011-2021;Pharmaceutical Science (Q1)
116;4700152848;PPAR Research;journal;16874757, 16874765;1.204;Q1;52;25;85;1798;275;83;3.5;71.92;United States;Northern America;Hindawi Publishing Corporation;2006-2021;"Drug Discovery (Q1); Pharmacology (medical) (Q1)"
117;4700152278;Drugs in Context;journal;17404398, 17451981;1.194;Q1;26;12;38;359;123;36;2.94;29.92;United Kingdom;Western Europe;BioExcel Publishing Ltd.;2006-2008, 2012-2021;"Pharmacology (Q1); Molecular Medicine (Q2)"
118;110174;Prostaglandins and Other Lipid Mediators;journal;10988823;1.191;Q1;76;53;137;3215;403;132;2.86;60.66;United States;Northern America;Elsevier Inc.;1996, 1998-2021;"Pharmacology (Q1); Biochemistry (Q2); Physiology (Q2); Cell Biology (Q3)"
119;24649;Chemical Research in Toxicology;journal;15205010, 0893228X;1.187;Q1;163;194;664;14372;2522;649;3.55;74.08;United States;Northern America;American Chemical Society;1988-2021;"Medicine (miscellaneous) (Q1); Toxicology (Q1)"
120;21100209501;Statistics in Biopharmaceutical Research;journal;19466315;1.187;Q1;18;44;109;925;85;98;0.74;21.02;United Kingdom;Western Europe;Taylor and Francis Ltd.;2011-2021;"Pharmaceutical Science (Q1); Statistics and Probability (Q2)"
121;14144;Experimental and Clinical Psychopharmacology;journal;19362293, 10641297;1.176;Q1;95;57;162;3054;427;160;2.56;53.58;United States;Northern America;American Psychological Association;1993-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1)"
122;19403;Acta Pharmacologica Sinica;journal;16714083, 17457254;1.173;Q1;98;146;480;7403;1565;476;3.41;50.71;United Kingdom;Western Europe;Nature Publishing Group;1980-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
123;22454;International Journal of Pharmaceutics;journal;18733476, 03785173;1.172;Q1;229;871;2495;43782;10847;2467;4.11;50.27;Netherlands;Western Europe;Elsevier;1978-2021;Pharmaceutical Science (Q1)
124;19700173005;Cancer Nanotechnology;journal;18686958, 18686966;1.168;Q1;29;10;22;861;100;20;3.29;86.1;United States;Northern America;Springer Science + Business Media;2010-2021;"Biomedical Engineering (Q1); Pharmaceutical Science (Q1); Physical and Theoretical Chemistry (Q1); Oncology (Q2)"
125;21351;Expert Opinion on Investigational Drugs;journal;13543784, 17447658;1.166;Q1;109;137;398;10419;1354;387;3.56;76.05;United Kingdom;Western Europe;Taylor and Francis Ltd.;1994-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
126;21326;European Journal of Clinical Pharmacology;journal;00316970, 14321041;1.159;Q1;114;201;544;6387;1532;485;2.61;31.78;Germany;Western Europe;Springer Verlag;1968-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
127;24785;Alcohol;journal;07418329;1.153;Q1;83;82;243;4784;701;238;2.49;58.34;United States;Northern America;Elsevier Inc.;1984-2021;"Health (social science) (Q1); Medicine (miscellaneous) (Q1); Toxicology (Q1); Behavioral Neuroscience (Q2); Biochemistry (Q2); Neurology (Q2)"
128;29712;Clinical Therapeutics;journal;1879114X, 01492918;1.151;Q1;140;222;740;8674;2114;648;2.91;39.07;United States;Northern America;Elsevier Inc.;1977-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1)"
129;23015;Journal of Ethnopharmacology;journal;03788741, 18727573;1.15;Q1;205;448;2087;25925;7631;2073;3.37;57.87;Ireland;Western Europe;Elsevier Ireland Ltd;1979-2022;"Drug Discovery (Q1); Pharmacology (Q1)"
130;21197;Pharmacology Biochemistry and Behavior;journal;00913057, 18735177;1.15;Q1;139;122;592;8282;1881;586;2.74;67.89;United States;Northern America;Elsevier Inc.;1973-2021;"Clinical Biochemistry (Q1); Pharmacology (Q1); Toxicology (Q1); Behavioral Neuroscience (Q2); Biochemistry (Q2); Biological Psychiatry (Q3)"
131;29097;Cancer Chemotherapy and Pharmacology;journal;14320843, 03445704;1.147;Q1;114;260;842;8494;2574;825;2.94;32.67;Germany;Western Europe;Springer Verlag;1978-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1); Toxicology (Q1); Cancer Research (Q2); Oncology (Q2)"
132;25096;Food and Chemical Toxicology;journal;18736351, 02786915;1.144;Q1;183;589;1094;33248;4676;1058;4.05;56.45;United Kingdom;Western Europe;Elsevier Ltd.;1982-2021;"Food Science (Q1); Medicine (miscellaneous) (Q1); Toxicology (Q1)"
133;14500154702;Journal of Cardiovascular Translational Research;journal;19375395, 19375387;1.141;Q1;53;50;196;2229;453;188;2.15;44.58;United States;Northern America;Springer New York;2008-2021;"Cardiology and Cardiovascular Medicine (Q1); Pharmaceutical Science (Q1); Genetics (Q2); Genetics (clinical) (Q2); Molecular Medicine (Q2)"
134;4400151608;ChemMedChem;journal;18607187, 18607179;1.137;Q1;106;221;862;10416;2283;833;2.58;47.13;United Kingdom;Western Europe;John Wiley and Sons Ltd;2006-2021;"Organic Chemistry (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Molecular Medicine (Q2)"
135;16573;Phytotherapy Research;journal;10991573, 0951418X;1.136;Q1;140;199;721;10592;2805;716;3.65;53.23;United Kingdom;Western Europe;John Wiley and Sons Ltd;1987-2021;Pharmacology (Q1)
136;17700156705;Modern Trends in Pharmacopsychiatry;journal;16622685, 16624505;1.12;Q1;0;0;0;0;0;0;0;0;Switzerland;Western Europe;S. Karger AG;2009-2010, 2013, 2015, 2017;"Medicine (miscellaneous) (Q1); Pharmacology (Q1); Psychiatry and Mental Health (Q1)"
137;19700175143;Pharmacognosy Reviews (discontinued);journal;09737847, 09762787;1.12;Q1;54;22;63;2165;324;62;3.05;98.41;India;Asiatic Region;Wolters Kluwer Medknow Publications;2009-2018;"Complementary and Alternative Medicine (Q1); Drug Discovery (Q1); Plant Science (Q1); Pharmacology (Q2)"
138;4000148019;AAPS Journal;journal;15507416;1.118;Q1;118;171;411;9285;1652;401;3.84;54.3;United States;Northern America;Springer New York;1999-2021;Pharmaceutical Science (Q1)
139;13250;Expert Opinion on Biological Therapy;journal;14712598, 17447682;1.117;Q1;91;144;478;12513;1567;460;3.65;86.9;United Kingdom;Western Europe;Taylor and Francis Ltd.;2001-2021;"Clinical Biochemistry (Q1); Drug Discovery (Q1); Pharmacology (Q2)"
140;19700174974;Future Medicinal Chemistry;journal;17568919, 17568927;1.111;Q1;76;154;523;10039;1579;440;3.01;65.19;United Kingdom;Western Europe;Future Science;2009-2021;"Drug Discovery (Q1); Molecular Medicine (Q2); Pharmacology (Q2)"
141;21000196010;Topics in antiviral medicine;journal;21615861, 21615853;1.11;Q2;43;16;60;250;179;57;2.98;15.63;United States;Northern America;International Antiviral Society;2011-2021;"Pharmacology (medical) (Q1); Infectious Diseases (Q2); Pharmacology (Q2); Virology (Q2)"
142;21350;Expert Opinion on Emerging Drugs;journal;14728214, 17447623;1.109;Q2;51;28;129;3050;390;121;3.36;108.93;United Kingdom;Western Europe;Taylor and Francis Ltd.;2000-2021;"Pharmacology (medical) (Q1); Pharmacology (Q2)"
143;25240;Toxicology Letters;journal;03784274, 18793169;1.103;Q1;150;235;898;10606;3188;865;3.11;45.13;Netherlands;Western Europe;Elsevier BV;1977-2021;"Medicine (miscellaneous) (Q1); Toxicology (Q1)"
144;25219;Toxicology;journal;0300483X, 18793185;1.1;Q1;165;196;449;11776;1592;439;3.31;60.08;Ireland;Western Europe;Elsevier Ireland Ltd;1959, 1973-2021;Toxicology (Q1)
145;17067;Phytomedicine;journal;09447113, 1618095X;1.087;Q1;127;161;597;6118;2327;584;3.91;38;Germany;Western Europe;Urban und Fischer Verlag Jena;1994-2021;"Complementary and Alternative Medicine (Q1); Drug Discovery (Q1); Pharmaceutical Science (Q1); Molecular Medicine (Q2); Pharmacology (Q2)"
146;21123;Pharmaceutical Research;journal;07248741, 1573904X;1.077;Q1;213;244;835;11608;3062;828;3.67;47.57;United States;Northern America;Springer New York;1984-2021;"Biotechnology (Q1); Organic Chemistry (Q1); Pharmaceutical Science (Q1); Molecular Medicine (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
147;11900154314;Cardiovascular Therapeutics;journal;17555914, 17555922;1.075;Q2;48;71;154;2744;391;149;2.31;38.65;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;2008-2021;"Cardiology and Cardiovascular Medicine (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q2); Pharmacology (medical) (Q2)"
148;17595;Journal of Biomolecular Screening;journal;10870571, 1552454X;1.074;Q1;79;13;379;436;902;375;2.39;33.54;United States;Northern America;SAGE Publications Inc.;1996-2017;"Analytical Chemistry (Q1); Biotechnology (Q1); Drug Discovery (Q1); Biochemistry (Q2); Molecular Medicine (Q2); Pharmacology (Q2)"
149;20578;Journal of Food and Drug Analysis;journal;10219498;1.071;Q2;63;110;271;5060;1128;269;3.22;46;Taiwan;Asiatic Region;National Laboratories of Foods and Drugs;1994-2021;"Food Science (Q1); Pharmacology (Q2)"
150;20473;Life Sciences;journal;18790631, 00243205;1.071;Q1;174;338;1255;17883;4151;1243;3.39;52.91;United States;Northern America;Elsevier Inc.;1962-2021;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q1); Medicine (miscellaneous) (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1)"
151;25125;Journal of Analytical Toxicology;journal;19452403, 01464760;1.065;Q1;78;108;337;2629;863;313;2.5;24.34;United States;Northern America;Preston Publications;1977-2021;"Analytical Chemistry (Q1); Chemical Health and Safety (Q1); Health, Toxicology and Mutagenesis (Q1); Toxicology (Q1); Environmental Chemistry (Q2)"
152;21100469670;Antibiotics;journal;20796382;1.063;Q1;47;39;116;2276;350;112;2.76;58.36;Switzerland;Western Europe;Multidisciplinary Digital Publishing Institute (MDPI);2010, 2012-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Biochemistry (Q2); Infectious Diseases (Q2); Microbiology (Q2); Microbiology (medical) (Q2); Pharmacology (medical) (Q2)"
153;18071;Neurotoxicity Research;journal;14763524, 10298428;1.063;Q1;78;113;242;6810;765;242;3.24;60.27;United States;Northern America;Springer New York;1999, 2001-2021;"Toxicology (Q1); Neuroscience (miscellaneous) (Q2)"
154;22410;Inflammation Research;journal;1420908X, 10233830;1.062;Q2;94;101;308;5593;958;306;3.01;55.38;Switzerland;Western Europe;Birkhauser Verlag Basel;1995-2021;"Immunology (Q2); Pharmacology (Q2)"
155;21333;European Journal of Pharmacology;journal;00142999, 18790712;1.057;Q2;189;534;1974;27613;6544;1964;3.26;51.71;Netherlands;Western Europe;Elsevier;1967-2021;Pharmacology (Q2)
156;21100197929;Toxicological Research;journal;19768257, 22342753;1.052;Q1;35;39;121;1526;384;121;2.73;39.13;South Korea;Asiatic Region;Koreal Association of Medical Journal Editors;2008-2021;"Health, Toxicology and Mutagenesis (Q1); Toxicology (Q1)"
157;22432;International Immunopharmacology;journal;18781705, 15675769;1.051;Q2;119;352;1280;14737;4188;1271;3.21;41.87;Netherlands;Western Europe;Elsevier;2001-2021;"Immunology (Q2); Immunology and Allergy (Q2); Pharmacology (Q2)"
158;21100370879;"Journal of managed care &amp; specialty pharmacy";journal;23761032, 23760540;1.048;Q1;66;144;390;4017;849;358;1.85;27.9;United States;Northern America;Academy of Managed Care Pharmacy (AMCP);2014-2021;"Health Policy (Q1); Pharmaceutical Science (Q1); Pharmacy (Q1)"
159;17605;Journal of Enzyme Inhibition and Medicinal Chemistry;journal;14756374, 14756366;1.04;Q1;79;139;590;6429;2030;590;3.62;46.25;United Kingdom;Western Europe;Informa Healthcare;1985-2021;"Drug Discovery (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q2)"
160;20051;BioDrugs;journal;11738804, 1179190X;1.038;Q2;71;45;131;3062;504;125;4.34;68.04;United Kingdom;Western Europe;Adis International Ltd;1997-2021;"Biotechnology (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q2); Pharmacology (medical) (Q2)"
161;19984;Assay and Drug Development Technologies;journal;1540658X, 15578127;1.033;Q1;58;41;189;1221;419;138;1.61;29.78;United States;Northern America;Mary Ann Liebert Inc.;2002-2021;"Drug Discovery (Q1); Molecular Medicine (Q2)"
162;24652;Chemico-Biological Interactions;journal;00092797;1.033;Q2;128;281;900;13457;3210;886;3.42;47.89;Ireland;Western Europe;Elsevier Ireland Ltd;1969-2021;"Medicine (miscellaneous) (Q1); Toxicology (Q2)"
163;18073;NeuroToxicology;journal;18729711, 0161813X;1.017;Q2;122;184;436;9893;1505;416;3.14;53.77;Netherlands;Western Europe;Elsevier;1979-2021;"Neuroscience (miscellaneous) (Q2); Toxicology (Q2)"
164;21331;European Journal of Pharmaceutical Sciences;journal;18790720, 09280987;1.016;Q1;144;506;843;24359;3390;829;3.67;48.14;Netherlands;Western Europe;Elsevier;1993-2021;Pharmaceutical Science (Q1)
165;23488;Current Medicinal Chemistry;journal;09298673, 1875533X;1.015;Q2;183;284;873;35541;2840;815;3.29;125.14;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;1994-2021;"Molecular Medicine (Q2); Pharmacology (Q2)"
166;21100825823;Pharmacology Research and Perspectives;journal;20521707;1.005;Q1;32;86;229;3468;609;227;2.66;40.33;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;2013-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Neurology (Q2)"
167;26767;Altex;journal;1868596X, 18688551;1.001;Q2;57;41;128;2436;508;112;4;59.41;Germany;Western Europe;Springer International Publishing AG;2000-2021;"Medical Laboratory Technology (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q2)"
168;22983;Journal of Clinical Pharmacology;journal;15524604, 00912700;0.997;Q2;121;184;551;6257;1548;511;2.81;34.01;United States;Northern America;Wiley-Blackwell;1973-2021;"Pharmacology (Q2); Pharmacology (medical) (Q2)"
169;19600166302;Current Molecular Pharmacology;journal;18744702;0.996;Q1;42;27;90;2153;162;75;1.85;79.74;United Arab Emirates;Middle East;Bentham Science Publishers;2008-2021;"Drug Discovery (Q1); Molecular Medicine (Q2); Pharmacology (Q2)"
170;18075;Neurotoxicology and Teratology;journal;08920362, 18729738;0.987;Q2;103;67;224;4140;661;208;2.89;61.79;United States;Northern America;Elsevier Inc.;1987-2021;"Developmental Neuroscience (Q2); Toxicology (Q2); Cellular and Molecular Neuroscience (Q3)"
171;23085;Journal of Pharmacological Sciences;journal;13478648, 13478613;0.986;Q2;87;96;403;3169;1065;401;2.79;33.01;Japan;Asiatic Region;Japanese Pharmacological Society;1996-2021;"Molecular Medicine (Q2); Pharmacology (Q2)"
172;21100200427;Human Vaccines and Immunotherapeutics;journal;21645515, 2164554X;0.984;Q2;69;417;1364;16395;2870;1101;2.03;39.32;United States;Northern America;Landes Bioscience;2012-2021;"Medicine (miscellaneous) (Q1); Immunology and Allergy (Q2); Pharmacology (Q2); Immunology (Q3)"
173;23079;Journal of Pharmaceutical Sciences;journal;15206017, 00223549;0.984;Q1;186;412;1293;17889;4146;1236;3.23;43.42;United States;Northern America;"John Wiley &amp; Sons Inc.";1961-2021;Pharmaceutical Science (Q1)
174;21100781436;Journal of Experimental Pharmacology;journal;11791454;0.981;Q2;15;9;13;501;26;13;1.83;55.67;New Zealand;Pacific Region;Dove Medical Press Ltd.;2010, 2012-2021;"Molecular Medicine (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
175;144790;Marine Drugs;journal;16603397;0.978;Q1;128;392;954;22443;4622;951;4.87;57.25;Switzerland;Western Europe;Multidisciplinary Digital Publishing Institute (MDPI);2003-2021;Drug Discovery (Q1)
176;19700175230;Drug Design, Development and Therapy;journal;11778881;0.974;Q1;71;323;1125;15037;3498;1099;3.03;46.55;New Zealand;Pacific Region;Dove Medical Press Ltd.;2007-2021;"Drug Discovery (Q1); Pharmaceutical Science (Q1); Pharmacology (Q2)"
177;19300156901;Dose-Response;journal;15593258;0.959;Q2;41;42;104;1760;349;99;2.86;41.9;United States;Northern America;International Dose-Response Society;2008-2021;"Chemical Health and Safety (Q1); Health, Toxicology and Mutagenesis (Q1); Public Health, Environmental and Occupational Health (Q1); Toxicology (Q2)"
178;21790;Antiviral Therapy;journal;20402058, 13596535;0.958;Q2;89;90;310;2579;658;299;2.02;28.66;United Kingdom;Western Europe;International Medical Press Ltd;1996-2021;"Infectious Diseases (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
179;25126;Journal of Applied Toxicology;journal;10991263, 0260437X;0.958;Q2;91;151;467;8180;1586;465;3.14;54.17;United Kingdom;Western Europe;John Wiley and Sons Ltd;1981-2021;Toxicology (Q2)
180;19034;Microbial Drug Resistance;journal;10766294, 19318448;0.957;Q2;72;138;277;5253;665;275;2.29;38.07;United States;Northern America;Mary Ann Liebert Inc.;1995-2021;"Medicine (miscellaneous) (Q1); Microbiology (Q2); Microbiology (medical) (Q2); Pharmacology (Q2); Immunology (Q3)"
181;19700188352;Toxins;journal;20726651;0.955;Q2;91;408;900;24463;3172;871;3.35;59.96;Switzerland;Western Europe;Multidisciplinary Digital Publishing Institute (MDPI);2009-2021;"Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2)"
182;4700152856;Expert Opinion on Drug Metabolism and Toxicology;journal;17425255;0.954;Q2;88;119;413;9987;1326;399;3.12;83.92;United Kingdom;Western Europe;Taylor and Francis Ltd.;2005-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q2); Toxicology (Q2)"
183;23479;Journal of Physiology and Pharmacology;journal;08675910, 18991505;0.952;Q2;81;90;270;5110;760;270;2.96;56.78;Poland;Eastern Europe;Polish Physiological Society;1991-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q2); Physiology (Q2)"
184;28620;Biomedicine and Pharmacotherapy;journal;07533322;0.951;Q2;109;1616;1171;82145;4072;1168;3.54;50.83;France;Western Europe;Elsevier Masson s.r.l.;1982-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q2)"
185;29311;Current Cancer Drug Targets;journal;15680096, 18735576;0.951;Q1;96;69;223;6431;573;204;2.2;93.2;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2001-2021;"Drug Discovery (Q1); Pharmacology (Q2); Cancer Research (Q3)"
186;22072;Current Gene Therapy;journal;18755631, 15665232;0.951;Q1;75;44;140;4205;305;131;2.12;95.57;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2001-2021;"Drug Discovery (Q1); Genetics (Q2); Molecular Medicine (Q2); Genetics (clinical) (Q3); Molecular Biology (Q3)"
187;11700154735;Journal of Aerosol Medicine and Pulmonary Drug Delivery;journal;19412703, 19412711;0.95;Q1;73;44;161;1834;459;156;2.89;41.68;United States;Northern America;Mary Ann Liebert Inc.;2008-2021;"Pharmaceutical Science (Q1); Pharmacology (medical) (Q2); Pulmonary and Respiratory Medicine (Q2)"
188;19700188360;Pharmaceutics;journal;19994923;0.949;Q1;68;58;106;3212;418;101;3.65;55.38;Switzerland;Western Europe;Multidisciplinary Digital Publishing Institute (MDPI);2010-2021;Pharmaceutical Science (Q1)
189;18800156730;Biomolecules and Therapeutics;journal;19769148, 20054483;0.946;Q1;44;78;223;3841;664;222;2.77;49.24;South Korea;Asiatic Region;Korean Society of Applied Pharmacology;2008-2021;"Drug Discovery (Q1); Biochemistry (Q2); Molecular Medicine (Q2); Pharmacology (Q2)"
190;19700182043;Drug Delivery and Translational Research;journal;21903948, 2190393X;0.944;Q1;46;78;170;3852;575;162;3.56;49.38;United States;Northern America;Springer Publishing Company;2011-2021;Pharmaceutical Science (Q1)
191;24619;Journal of Computer-Aided Molecular Design;journal;15734951, 0920654X;0.941;Q1;104;87;275;4240;795;272;2.48;48.74;Netherlands;Western Europe;Springer Netherlands;1987-2021;"Computer Science Applications (Q1); Drug Discovery (Q1); Physical and Theoretical Chemistry (Q2)"
192;18077;Fitoterapia;journal;0367326X, 18736971;0.937;Q1;110;186;726;5934;2195;726;2.88;31.9;Netherlands;Western Europe;Elsevier;1948-1949, 1961, 1972-2021;"Drug Discovery (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q2)"
193;130044;Pharmacogenetics and Genomics;journal;17446880, 17446872;0.933;-;144;63;222;2470;582;216;2.53;39.21;United States;Northern America;Lippincott Williams and Wilkins Ltd.;2005-2021;"Genetics (Q2); Molecular Medicine (Q2); Genetics (clinical) (Q3); Molecular Biology (Q3)"
194;21100853016;Antibodies;journal;20734468;0.931;Q2;15;0;45;0;77;44;1.77;0;Switzerland;Western Europe;MDPI AG;2017-2021;"Drug Discovery (Q2); Immunology and Allergy (Q2); Immunology (Q3)"
195;25224;Toxicology in Vitro;journal;18793177, 08872333;0.931;Q2;112;250;663;12066;2311;655;3.44;48.26;United Kingdom;Western Europe;Elsevier Ltd.;1987-2021;"Medicine (miscellaneous) (Q1); Toxicology (Q2)"
196;21353;Expert Opinion on Therapeutic Patents;journal;13543776, 17447674;0.926;Q2;77;102;326;8792;997;323;2.79;86.2;United Kingdom;Western Europe;Taylor and Francis Ltd.;1991-2021;"Medicine (miscellaneous) (Q1); Drug Discovery (Q2); Pharmacology (Q2)"
197;21100258853;F1000Research;journal;20461402;0.926;Q1;72;721;1360;37921;2808;1272;2.17;52.6;United Kingdom;Western Europe;;2012-2021;"Medicine (miscellaneous) (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Immunology and Microbiology (miscellaneous)  (Q2)"
198;22411;Inflammopharmacology;journal;09254692, 15685608;0.925;Q2;55;59;111;3377;349;105;3.31;57.24;Switzerland;Western Europe;Birkhauser Verlag Basel;1991-2021;"Pharmacology (Q2); Pharmacology (medical) (Q2); Immunology (Q3)"
199;24626;Cell Biology and Toxicology;journal;15736822, 07422091;0.924;Q2;64;41;92;2890;444;85;5.35;70.49;Netherlands;Western Europe;Springer Netherlands;1984-2021;"Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2); Cell Biology (Q3)"
200;4200151509;Molecular Diagnosis and Therapy;journal;11771062;0.923;Q2;47;63;187;4214;493;181;2.7;66.89;United Kingdom;Western Europe;Adis International Ltd;2001, 2004, 2006-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q2); Genetics (Q3); Molecular Medicine (Q3)"
201;23061;Journal of Pharmaceutical and Biomedical Analysis;journal;07317085, 1873264X;0.919;Q1;133;602;1679;18734;5350;1669;3.03;31.12;Netherlands;Western Europe;Elsevier;1983-2022;"Analytical Chemistry (Q1); Pharmaceutical Science (Q1); Spectroscopy (Q1); Clinical Biochemistry (Q2); Drug Discovery (Q2)"
202;22981;Journal of Cardiovascular Pharmacology;journal;15334023, 01602446;0.917;Q2;104;101;423;5100;994;409;2.27;50.5;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1979-2021;"Cardiology and Cardiovascular Medicine (Q2); Pharmacology (Q2)"
203;20049;Behavioural Pharmacology;journal;14735849, 09558810;0.916;Q2;83;68;252;4155;538;246;1.87;61.1;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1992-2021;"Pharmacology (Q2); Psychiatry and Mental Health (Q2)"
204;18966;Mutagenesis;journal;02678357, 14643804;0.916;Q2;95;56;219;2086;591;217;2.74;37.25;United Kingdom;Western Europe;Oxford University Press;1986-2021;"Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2); Genetics (Q3); Genetics (clinical) (Q3)"
205;21352;Expert Opinion on Pharmacotherapy;journal;17447666, 14656566;0.909;Q2;83;207;733;14623;2143;708;3.08;70.64;United Kingdom;Western Europe;Taylor and Francis Ltd.;1999-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q2); Pharmacology (medical) (Q2)"
206;20664;Current Drug Targets;journal;18735592, 13894501;0.906;Q2;107;139;540;14135;1298;485;2.11;101.69;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2000-2021;"Clinical Biochemistry (Q2); Drug Discovery (Q2); Pharmacology (Q2); Molecular Medicine (Q3)"
207;19900192163;Results in Pharma Sciences;journal;22112863;0.904;Q1;16;0;10;0;38;10;5.25;0;Netherlands;Western Europe;Elsevier BV;2011-2016;Pharmaceutical Science (Q1)
208;14805;Steroids;journal;0039128X, 18785867;0.904;Q2;107;136;562;5197;1486;551;2.56;38.21;United States;Northern America;Elsevier Inc.;1963-2021;"Biochemistry (Q2); Clinical Biochemistry (Q2); Organic Chemistry (Q2); Pharmacology (Q2); Endocrinology (Q3); Molecular Biology (Q3)"
209;4700151922;Research in Social and Administrative Pharmacy;journal;15517411;0.897;Q1;54;143;279;4891;629;218;1.91;34.2;United States;Northern America;Elsevier Inc.;2005-2021;"Pharmaceutical Science (Q1); Pharmacy (Q1)"
210;21100225613;Human gene therapy methods;journal;19466536, 19466544;0.894;Q2;31;31;87;1386;202;85;2.29;44.71;United States;Northern America;Mary Ann Liebert Inc.;2012-2019;"Applied Microbiology and Biotechnology (Q2); Pharmacology (Q2); Genetics (Q3); Genetics (clinical) (Q3); Molecular Medicine (Q3)"
211;25151;Journal of Toxicology and Environmental Health - Part A: Current Issues;journal;10872620, 15287394;0.888;Q2;92;123;357;6243;1017;353;2.88;50.76;United Kingdom;Western Europe;Taylor and Francis Ltd.;1996-2021;"Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2)"
212;12331;Current Topics in Medicinal Chemistry;journal;15680266, 18734294;0.885;Q2;122;262;747;27685;2152;649;3.07;105.67;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2001-2021;"Drug Discovery (Q2); Medicine (miscellaneous) (Q2)"
213;19700174958;Drug Testing and Analysis;journal;19427611, 19427603;0.884;Q1;57;198;445;6864;1318;410;2.73;34.67;United Kingdom;Western Europe;John Wiley and Sons Ltd;2009-2021;"Analytical Chemistry (Q1); Pharmaceutical Science (Q1); Spectroscopy (Q1); Environmental Chemistry (Q2)"
214;20682;Current Pharmaceutical Design;journal;13816128, 18734286;0.883;Q2;166;620;1828;74679;5102;1667;2.64;120.45;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;1995-2021;"Drug Discovery (Q2); Pharmacology (Q2)"
215;25898;Journal of Peptide Science;journal;10752617, 10991387;0.883;Q2;68;101;314;4739;674;308;1.98;46.92;United Kingdom;Western Europe;John Wiley and Sons Ltd;1995-2021;"Biochemistry (Q2); Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Organic Chemistry (Q2); Pharmacology (Q2); Molecular Biology (Q3); Molecular Medicine (Q3); Structural Biology (Q3)"
216;21264;Drugs in R and D;journal;11796901, 11745886;0.881;Q2;47;64;111;2715;277;106;2.92;42.42;United Kingdom;Western Europe;Adis International Ltd;1999, 2002-2008, 2010-2021;Pharmacology (Q2)
217;25786;Bioorganic and Medicinal Chemistry;journal;14643391, 09680896;0.871;Q1;171;668;2099;27704;6390;2087;3;41.47;United Kingdom;Western Europe;Elsevier Ltd.;1993-2021;"Pharmaceutical Science (Q1); Biochemistry (Q2); Clinical Biochemistry (Q2); Drug Discovery (Q2); Organic Chemistry (Q2); Molecular Biology (Q3); Molecular Medicine (Q3)"
218;21100241624;International Journal of Genomics;journal;2314436X, 23144378;0.868;Q1;29;82;166;4472;441;160;1.75;54.54;Egypt;Africa/Middle East;Hindawi Limited;2013-2021;"Pharmaceutical Science (Q1); Biochemistry (Q2); Genetics (Q3); Molecular Biology (Q3)"
219;4500151409;CNS and Neurological Disorders - Drug Targets;journal;18715273;0.863;Q2;90;126;504;9916;1132;436;1.82;78.7;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Medicine (miscellaneous) (Q2); Pharmacology (Q2); Neuroscience (miscellaneous) (Q3)"
220;26370;Molecules;journal;14203049;0.855;Q1;171;2287;4411;115137;15261;4390;3.29;50.34;Switzerland;Western Europe;Multidisciplinary Digital Publishing Institute (MDPI);1992, 1996-2021;"Analytical Chemistry (Q1); Chemistry (miscellaneous) (Q1); Pharmaceutical Science (Q1); Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Organic Chemistry (Q2); Physical and Theoretical Chemistry (Q2); Molecular Medicine (Q3)"
221;23014;Journal of Drug Targeting;journal;10292330, 1061186X;0.851;Q1;95;90;273;5585;830;264;3.24;62.06;United Kingdom;Western Europe;Informa Healthcare;1986-1987, 1992-2021;Pharmaceutical Science (Q1)
222;25789;Bioorganic Chemistry;journal;00452068, 10902120;0.85;Q2;66;185;282;7914;1078;280;4.04;42.78;United States;Northern America;Academic Press Inc.;1971-2021;"Biochemistry (Q2); Drug Discovery (Q2); Organic Chemistry (Q2); Molecular Biology (Q3)"
223;19700174906;Molecular and Cellular Pharmacology;journal;19381247;0.846;Q1;26;3;10;33;20;8;1.29;11;United States;Northern America;Lumitext Publishing;2009-2017, 2020-2021;"Pharmaceutical Science (Q1); Molecular Biology (Q3)"
224;24028;Reproductive Toxicology;journal;08906238, 18731708;0.846;Q2;117;190;483;11609;1275;461;2.69;61.1;United States;Northern America;Elsevier Inc.;1987-2021;Toxicology (Q2)
225;21167;Pharmacogenomics;journal;14622416, 17448042;0.845;Q2;94;159;548;8151;1289;522;2.25;51.26;United Kingdom;Western Europe;Future Medicine Ltd.;2000-2021;"Pharmacology (Q2); Genetics (Q3); Molecular Medicine (Q3)"
226;21100793213;Current Pharmacology Reports;journal;2198641X;0.844;Q2;26;39;76;4191;236;76;3.11;107.46;Switzerland;Western Europe;Springer International Publishing AG;2015-2021;"Biochemistry (Q2); Drug Discovery (Q2); Pharmacology (Q2); Genetics (Q3)"
227;19700194010;MedChemComm;journal;20402503, 20402511;0.843;Q1;0;0;0;0;0;0;0;0;United Kingdom;Western Europe;Royal Society of Chemistry;2010-2019;"Pharmaceutical Science (Q1); Biochemistry (Q2)"
228;110172;Progress in Drug Research;book series;0071786X;0.843;Q1;44;24;64;1745;98;26;0.34;72.71;Switzerland;Western Europe;Birkhauser Verlag Basel;1959-1966, 1968-1969, 1972-2003, 2005, 2007-2008, 2011, 2014-2018;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Medicine (miscellaneous) (Q2); Molecular Medicine (Q3)"
229;16533;Phytochemical Analysis;journal;09580344, 10991565;0.841;Q2;76;65;164;2117;449;163;2.62;32.57;United Kingdom;Western Europe;John Wiley and Sons Ltd;1990-2021;"Analytical Chemistry (Q1); Complementary and Alternative Medicine (Q1); Food Science (Q1); Plant Science (Q1); Biochemistry (Q2); Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Molecular Medicine (Q3)"
230;22575;Cardiovascular Toxicology;journal;15307905, 15590259;0.836;Q2;56;58;125;2098;339;123;2.64;36.17;United States;Northern America;Humana Press;2001-2021;"Cardiology and Cardiovascular Medicine (Q2); Toxicology (Q2); Molecular Biology (Q3)"
231;20427;Naunyn-Schmiedeberg's Archives of Pharmacology;journal;00281298, 14321912;0.836;Q2;93;127;375;5808;880;359;2.37;45.73;Germany;Western Europe;Springer Verlag;1969-2021;"Medicine (miscellaneous) (Q2); Pharmacology (Q2)"
232;20663;Current Drug Metabolism;journal;18755453, 13892002;0.833;Q2;111;103;228;10789;719;214;2.72;104.75;Netherlands;Western Europe;Bentham Science Publishers B.V.;2000-2021;"Clinical Biochemistry (Q2); Pharmacology (Q2)"
233;10300153301;Expert Review of Clinical Pharmacology;journal;17512433, 17512441;0.833;Q1;46;127;314;10221;808;296;2.49;80.48;United Kingdom;Western Europe;Taylor and Francis Ltd.;2008-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Medicine (miscellaneous) (Q2); Pharmacology (medical) (Q2)"
234;11700154733;Journal of Biomedical Nanotechnology;journal;15507041, 15507033;0.828;Q1;80;148;602;8977;2977;601;5.32;60.66;United States;Northern America;American Scientific Publishers;2007-2020;"Materials Science (miscellaneous) (Q1); Pharmaceutical Science (Q1); Bioengineering (Q2); Biomedical Engineering (Q2); Medicine (miscellaneous) (Q2); Nanoscience and Nanotechnology (Q2)"
235;21207;Drug Discovery Today: Technologies;journal;17406749;0.822;Q2;53;29;106;1225;253;94;2.28;42.24;United Kingdom;Western Europe;Elsevier Ltd.;2004-2021;"Biotechnology (Q2); Drug Discovery (Q2); Molecular Medicine (Q3)"
236;19400157146;Food Additives and Contaminants: Part B Surveillance;journal;19393210, 19393229;0.82;Q2;32;41;145;1465;339;145;2.43;35.73;United Kingdom;Western Europe;Taylor and Francis Ltd.;2008-2021;"Food Science (Q1); Public Health, Environmental and Occupational Health (Q2); Toxicology (Q2)"
237;25109;Inhalation Toxicology;journal;08958378, 10917691;0.814;Q2;90;62;237;3001;464;233;1.82;48.4;United Kingdom;Western Europe;Informa Healthcare;1989-2021;"Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2)"
238;4000151703;Core Evidence (discontinued);journal;15551741, 1555175X;0.813;Q2;25;2;26;110;81;25;2.62;55;New Zealand;Pacific Region;Dove Medical Press Ltd.;2005-2018;"Reviews and References (medical) (Q1); Medicine (miscellaneous) (Q2); Pharmacology (Q2)"
239;25095;Environmental Toxicology and Pharmacology;journal;13826689;0.813;Q2;88;246;792;10803;2368;790;2.99;43.91;Netherlands;Western Europe;Elsevier;1996-2021;"Health, Toxicology and Mutagenesis (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q2); Toxicology (Q2)"
240;25176;Regulatory Toxicology and Pharmacology;journal;02732300, 10960295;0.812;Q2;112;248;757;11056;2370;673;3.29;44.58;United States;Northern America;Academic Press Inc.;1970, 1981-2021;"Medicine (miscellaneous) (Q2); Toxicology (Q2)"
241;10900153302;Biomarker Insights;journal;11772719;0.81;Q2;35;19;110;824;231;108;2.07;43.37;New Zealand;Pacific Region;Libertas Academica Ltd.;2008-2021;"Biochemistry (medical) (Q2); Pharmacology (Q2); Molecular Medicine (Q3)"
242;25788;Bioorganic and Medicinal Chemistry Letters;journal;14643405, 0960894X;0.81;Q1;154;997;3330;31564;8839;3328;2.56;31.66;United Kingdom;Western Europe;Elsevier Ltd.;1991-2021;"Pharmaceutical Science (Q1); Biochemistry (Q2); Clinical Biochemistry (Q2); Drug Discovery (Q2); Organic Chemistry (Q2); Molecular Biology (Q3); Molecular Medicine (Q3)"
243;19700201201;EPMA Journal;journal;18785077, 18785085;0.807;Q2;39;38;69;2928;280;68;4.1;77.05;United Kingdom;Western Europe;BioMed Central Ltd.;2010-2021;"Biochemistry (medical) (Q2); Drug Discovery (Q2); Health Policy (Q2)"
244;25214;Toxicologic Pathology;journal;15331601, 01926233;0.807;Q2;112;110;330;4219;692;325;2.01;38.35;United States;Northern America;SAGE Publications Inc.;1972-2021;"Pathology and Forensic Medicine (Q2); Toxicology (Q2); Cell Biology (Q3); Molecular Biology (Q3)"
245;14487;Journal of Ocular Pharmacology and Therapeutics;journal;15577732, 10807683;0.8;Q2;64;104;324;3869;612;296;1.88;37.2;United States;Northern America;Mary Ann Liebert Inc.;1987, 1991-1993, 1995-2021;"Ophthalmology (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
246;26512;Tetrahedron;journal;14645416, 00404020;0.8;Q2;226;841;3221;42446;7939;3202;2.41;50.47;United Kingdom;Western Europe;Elsevier Ltd.;1957-2021;"Biochemistry (Q2); Drug Discovery (Q2); Organic Chemistry (Q2)"
247;9000153111;Comparative Biochemistry and Physiology Part - C: Toxicology and Pharmacology;journal;15320456, 18781659;0.798;Q2;113;117;268;7449;748;266;2.51;63.67;United States;Northern America;Elsevier Inc.;1989, 2000-2022;"Biochemistry (Q2); Health, Toxicology and Mutagenesis (Q2); Medicine (miscellaneous) (Q2); Toxicology (Q2); Cell Biology (Q3); Physiology (Q3)"
248;25075;Ecotoxicology;journal;09639292, 15733017;0.797;Q2;97;129;578;7186;1374;574;2.17;55.71;Netherlands;Western Europe;Springer Netherlands;1992-2021;"Health, Toxicology and Mutagenesis (Q2); Management, Monitoring, Policy and Law (Q2); Medicine (miscellaneous) (Q2); Toxicology (Q2)"
249;19700188217;Bioanalysis;journal;17576180, 17576199;0.793;Q1;62;198;818;5841;1666;715;2.01;29.5;United Kingdom;Western Europe;Future Science;2009-2021;"Medical Laboratory Technology (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Analytical Chemistry (Q2); Clinical Biochemistry (Q2); Medicine (miscellaneous) (Q2)"
250;21100218055;"BMC pharmacology &amp; toxicology";journal;20506511;0.785;Q2;34;83;180;3011;432;177;1.94;36.28;United Kingdom;Western Europe;BioMed Central Ltd.;2012-2021;"Medicine (miscellaneous) (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
251;23081;Journal of Pharmacokinetics and Pharmacodynamics;journal;15738744, 1567567X;0.784;Q2;64;51;147;1818;270;144;1.91;35.65;United States;Northern America;Springer New York;1996-1999, 2001-2021;Pharmacology (Q2)
252;21100219314;Applied and Translational Genomics;journal;22120661;0.777;Q1;21;0;105;0;200;81;2.15;0;Netherlands;Western Europe;Elsevier BV;2012-2016;"Pharmaceutical Science (Q1); Biotechnology (Q2); Molecular Biology (Q3)"
253;24603;Archives of Environmental Contamination and Toxicology;journal;14320703, 00904341;0.773;Q2;115;110;331;5975;816;331;2.45;54.32;United States;Northern America;Springer New York;1973-2021;"Health, Toxicology and Mutagenesis (Q2); Medicine (miscellaneous) (Q2); Pollution (Q2); Toxicology (Q2)"
254;130063;Pharmacological Reports;journal;17341140;0.773;Q2;87;194;539;8805;1463;535;2.9;45.39;Netherlands;Western Europe;Elsevier BV;2005-2021;"Medicine (miscellaneous) (Q2); Pharmacology (Q2)"
255;15840;Journal of Antibiotics;journal;00218820, 18811469;0.762;Q2;84;189;426;6183;966;394;1.9;32.71;United Kingdom;Western Europe;Japan Antibiotics Research Association;1953-2021;"Drug Discovery (Q2); Pharmacology (Q2)"
256;5800173385;Recent Patents on Anti-Cancer Drug Discovery;journal;15748928;0.76;Q2;46;27;83;3115;215;78;2.41;115.37;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Pharmacology (medical) (Q2); Cancer Research (Q3); Oncology (Q3)"
257;23382;Clinical and Experimental Pharmacology and Physiology;journal;14401681, 03051870;0.759;Q2;107;164;444;7204;935;424;2.06;43.93;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;1974-2021;"Pharmacology (Q2); Physiology (Q3); Physiology (medical) (Q3)"
258;19374;AAPS PharmSciTech;journal;15309932;0.752;Q1;101;336;430;12825;1208;426;2.45;38.17;Switzerland;Western Europe;Springer International Publishing AG;2000-2021;"Agronomy and Crop Science (Q1); Pharmaceutical Science (Q1); Aquatic Science (Q2); Drug Discovery (Q2); Ecology (Q2); Ecology, Evolution, Behavior and Systematics (Q2); Medicine (miscellaneous) (Q2)"
259;11300153402;Biomarkers in Medicine;journal;17520363, 17520371;0.75;Q2;49;125;374;5499;777;337;2.1;43.99;United Kingdom;Western Europe;Future Medicine Ltd.;2008-2021;"Biochemistry (medical) (Q2); Clinical Biochemistry (Q2); Drug Discovery (Q2)"
260;25146;Journal of Pharmacological and Toxicological Methods;journal;10568719;0.75;Q2;75;77;242;3535;579;238;2.36;45.91;United States;Northern America;Elsevier Inc.;1992-2002, 2004-2021;"Pharmacology (Q2); Toxicology (Q2)"
261;19700175119;Asian Journal of Pharmaceutical Sciences;journal;18180876, 2221285X;0.748;Q1;48;65;282;2202;812;279;2.18;33.88;China;Asiatic Region;Shenyang Pharmaceutical University;2009-2021;"Pharmaceutical Science (Q1); Pharmacology (Q2)"
262;20770;Drug Delivery;journal;10717544, 15210464;0.748;Q1;72;197;551;10022;1706;551;3.15;50.87;United Kingdom;Western Europe;Informa Healthcare;1993, 1995-2021;"Pharmaceutical Science (Q1); Medicine (miscellaneous) (Q2)"
263;4700152233;Therapeutics and Clinical Risk Management;journal;11766336;0.748;Q1;59;189;532;6822;1256;515;2.17;36.1;New Zealand;Pacific Region;Dove Medical Press Ltd.;2006-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Safety Research (Q1); Chemical Health and Safety (Q2); Medicine (miscellaneous) (Q2); Pharmacology (medical) (Q2)"
264;18500157900;Food Additives and Contaminants - Part A Chemistry, Analysis, Control, Exposure and Risk Assessment;journal;19440057, 19440049;0.74;Q2;80;207;608;7579;1515;605;2.33;36.61;United Kingdom;Western Europe;Taylor and Francis Ltd.;2008-2021;"Food Science (Q1); Chemistry (miscellaneous) (Q2); Health, Toxicology and Mutagenesis (Q2); Medicine (miscellaneous) (Q2); Public Health, Environmental and Occupational Health (Q2); Toxicology (Q2)"
265;10300153342;Journal of Medical Toxicology;journal;15569039, 19376995;0.74;Q2;52;57;226;1491;446;187;1.86;26.16;United States;Northern America;Springer New York;2005-2021;"Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2)"
266;19900192116;Journal of Pharmaceutical Analysis;journal;20951779;0.734;Q1;38;58;150;2007;496;150;3.36;34.6;China;Asiatic Region;Xi'an Jiaotong University;2011-2021;"Pharmaceutical Science (Q1); Pharmacy (Q1); Analytical Chemistry (Q2); Drug Discovery (Q2); Electrochemistry (Q2); Spectroscopy (Q2)"
267;23173;Korean Journal of Physiology and Pharmacology;journal;20933827, 12264512;0.727;Q2;33;76;217;2953;467;217;1.61;38.86;South Korea;Asiatic Region;Korean Physiological Soc. and Korean Soc. of Pharmacology;1997-2021;"Pharmacology (Q2); Physiology (Q3)"
268;19700175819;Patient Preference and Adherence;journal;1177889X;0.727;Q1;54;209;613;7561;1294;599;1.87;36.18;New Zealand;Pacific Region;Dove Medical Press Ltd.;2007-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Social Sciences (miscellaneous) (Q1); Health Policy (Q2); Medicine (miscellaneous) (Q2)"
269;21100239606;Therapeutic Innovation and Regulatory Science;journal;21684790, 21684804;0.726;Q1;46;104;322;2088;268;298;0.94;20.08;United States;Northern America;SAGE Publications Inc.;1970, 1972, 1974-2006, 2008-2011, 2013-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Pharmacology (medical) (Q2); Public Health, Environmental and Occupational Health (Q2)"
270;23363;Canadian Journal of Physiology and Pharmacology;journal;00084212, 12057541;0.724;Q2;87;168;450;8480;937;426;2.18;50.48;Canada;Northern America;National Research Council of Canada;1964-2021;"Medicine (miscellaneous) (Q2); Pharmacology (Q2); Physiology (Q3); Physiology (medical) (Q3)"
271;23007;Journal of Clinical Pharmacy and Therapeutics;journal;13652710, 02694727;0.722;Q2;76;128;359;3863;723;352;1.88;30.18;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;1976-2021;"Pharmacology (Q2); Pharmacology (medical) (Q2)"
272;13845;Bulletin of Mathematical Biology;journal;00928240, 15229602;0.717;Q2;90;115;308;4815;516;301;1.65;41.87;United States;Northern America;Springer New York;1973-2021;"Agricultural and Biological Sciences (miscellaneous) (Q1); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Computational Theory and Mathematics (Q2); Environmental Science (miscellaneous) (Q2); Mathematics (miscellaneous) (Q2); Pharmacology (Q2); Immunology (Q3); Neuroscience (miscellaneous) (Q3)"
273;12328;Current Therapeutic Research;journal;0011393X, 18790313;0.717;Q2;42;26;69;824;173;64;1.64;31.69;United States;Northern America;Elsevier Inc.;1959-2021;"Pharmacology (Q2); Pharmacology (medical) (Q2)"
274;28727;Anti-Cancer Drugs;journal;09594973, 14735741;0.716;Q2;96;110;430;4425;874;425;1.77;40.23;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1990-2021;"Pharmacology (Q2); Pharmacology (medical) (Q2); Cancer Research (Q3); Oncology (Q3)"
275;23155;Current Vascular Pharmacology;journal;15701611, 18756212;0.715;Q2;63;68;292;5333;546;233;1.68;78.43;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2003-2021;"Cardiology and Cardiovascular Medicine (Q2); Pharmacology (Q2)"
276;22372;Immunopharmacology and Immunotoxicology;journal;15322513, 08923973;0.711;Q2;53;46;182;1702;398;180;2.11;37;United Kingdom;Western Europe;Informa Healthcare;1978-2021;"Medicine (miscellaneous) (Q2); Pharmacology (Q2); Toxicology (Q2); Immunology (Q3); Immunology and Allergy (Q3)"
277;21100198011;Current Protocols in Pharmacology;journal;19348282, 19348290;0.702;Q2;34;16;49;701;112;49;2.76;43.81;United States;Northern America;"John Wiley &amp; Sons Inc.";2001-2020;"Medicine (miscellaneous) (Q2); Pharmacology (Q2)"
278;19700182275;International Journal of Clinical Pharmacy;journal;22107711, 22107703;0.702;Q1;63;151;498;4373;825;468;1.48;28.96;Netherlands;Western Europe;Springer Netherlands;2011-2021;"Pharmaceutical Science (Q1); Pharmacy (Q1); Pharmacology (Q2); Pharmacology (medical) (Q2); Toxicology (Q2)"
279;23129;Journal of Veterinary Pharmacology and Therapeutics;journal;01407783, 13652885;0.7;Q2;62;95;258;3295;385;254;1.35;34.68;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;1978-2021;"Veterinary (miscellaneous) (Q1); Pharmacology (Q2)"
280;34645;Skin Pharmacology and Physiology;journal;16605527, 16605535;0.697;Q2;78;35;103;1530;274;102;2.39;43.71;Switzerland;Western Europe;S. Karger AG;1988-1997, 2004-2021;"Dermatology (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q2); Physiology (Q3)"
281;22319;Toxicon;journal;18793150, 00410101;0.692;Q2;133;239;761;10480;1903;748;2.41;43.85;United Kingdom;Western Europe;Elsevier Ltd.;1962-2021;Toxicology (Q2)
282;21865;Fundamental and Clinical Pharmacology;journal;07673981, 14728206;0.688;Q2;77;69;201;3327;451;200;2.25;48.22;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;1987-2021;"Pharmacology (Q2); Pharmacology (medical) (Q2)"
283;22205;Saudi Pharmaceutical Journal;journal;13190164;0.687;Q1;57;174;267;5323;900;257;3.33;30.59;Saudi Arabia;Middle East;King Saud University;1996-2021;"Pharmaceutical Science (Q1); Pharmacology (Q2)"
284;25171;Mycotoxin Research;journal;18671632, 01787888;0.684;Q2;40;34;76;1702;226;75;2.96;50.06;Germany;Western Europe;Springer-Verlag GmbH and Co. KG;1985-2021;"Biotechnology (Q2); Toxicology (Q2); Microbiology (Q3)"
285;26514;Tetrahedron Letters;journal;00404039, 18733581;0.683;Q2;173;1103;4579;43608;10061;4578;2.19;39.54;United Kingdom;Western Europe;Elsevier Ltd.;1959-2021;"Drug Discovery (Q2); Organic Chemistry (Q2); Biochemistry (Q3)"
286;21100455212;Biomedical Reports;journal;20499434, 20499442;0.675;Q1;29;131;298;4467;521;298;1.71;34.1;Greece;Western Europe;Spandidos Publications;2014-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Medicine (miscellaneous) (Q2); Neuroscience (miscellaneous) (Q3)"
287;29318;Anti-Cancer Agents in Medicinal Chemistry;journal;18715206, 18755992;0.674;Q2;100;174;488;9129;1077;454;2.02;52.47;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Pharmacology (Q2); Cancer Research (Q3); Molecular Medicine (Q3)"
288;19700174918;Clinical and Translational Science;journal;17528062, 17528054;0.669;Q1;48;66;246;2288;412;229;1.98;34.67;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;2008-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Medicine (miscellaneous) (Q2); Neuroscience (miscellaneous) (Q3)"
289;23102;Journal of Pharmacy and Pharmacology;journal;20427158, 00223573;0.657;Q1;124;176;500;7953;1230;496;2.46;45.19;United Kingdom;Western Europe;Oxford University Press;1949-2021;"Pharmaceutical Science (Q1); Pharmacology (Q2)"
290;22299;Therapeutic Drug Monitoring;journal;15363694, 01634356;0.656;Q2;96;97;378;3154;816;353;2.09;32.52;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1979-2021;"Pharmacology (Q2); Pharmacology (medical) (Q2)"
291;20047;Basic and Clinical Pharmacology and Toxicology;journal;17427843, 17427835;0.655;Q2;93;170;452;6506;1199;421;2.29;38.27;United States;Northern America;Wiley-Blackwell;2004-2021;"Medicine (miscellaneous) (Q2); Pharmacology (Q2); Toxicology (Q2)"
292;144956;Drug Metabolism and Pharmacokinetics;journal;13474367;0.652;Q1;69;44;207;1791;429;197;2.16;40.7;Japan;Asiatic Region;Japanese Society for the Study of Xenobiotics;2002-2021;"Pharmaceutical Science (Q1); Pharmacology (Q2); Pharmacology (medical) (Q2)"
293;25093;Environmental Toxicology;journal;15227278, 15204081;0.652;Q2;81;212;472;10465;1127;472;2.45;49.36;United States;Northern America;"John Wiley &amp; Sons Inc.";1980, 1999-2021;"Management, Monitoring, Policy and Law (Q2); Medicine (miscellaneous) (Q2); Toxicology (Q2); Health, Toxicology and Mutagenesis (Q3)"
294;21192;Drug Development Research;journal;02724391, 10982299;0.65;Q2;62;40;180;2217;398;174;2.54;55.43;United States;Northern America;"John Wiley &amp; Sons Inc.";1981-2021;Drug Discovery (Q2)
295;23039;Journal of Liposome Research;journal;08982104, 15322394;0.65;Q2;53;35;104;1529;260;103;2.25;43.69;United Kingdom;Western Europe;Informa Healthcare;1988-1990, 1992-2021;Pharmaceutical Science (Q2)
296;4100151708;Inflammation and Allergy - Drug Targets;journal;18715281;0.649;Q2;51;0;67;0;154;61;2.04;0;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2015;"Medicine (miscellaneous) (Q2); Pharmacology (Q2); Immunology (Q3); Immunology and Allergy (Q3)"
297;5800228222;Journal of Pharmaceutical Innovation;journal;18725120, 19398042;0.644;Q2;31;34;94;1106;193;93;2.1;32.53;United States;Northern America;Springer New York;2006-2021;"Drug Discovery (Q2); Pharmaceutical Science (Q2)"
298;19700185200;Journal of Natural Medicines;journal;13403443, 18610293;0.643;Q2;50;88;258;2725;529;256;2.05;30.97;Germany;Western Europe;Springer Verlag;2006-2021;"Complementary and Alternative Medicine (Q1); Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Organic Chemistry (Q2); Pharmaceutical Science (Q2)"
299;13671;Biologicals;journal;10958320, 10451056;0.636;Q2;60;101;198;3073;428;196;2.06;30.43;United States;Northern America;Academic Press Inc.;1990-2021;"Applied Microbiology and Biotechnology (Q2); Bioengineering (Q2); Biotechnology (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q2); Immunology and Microbiology (miscellaneous)  (Q3)"
300;16803;Antiviral Chemistry and Chemotherapy;journal;20402066, 09563202;0.635;Q2;54;10;32;444;60;32;1.65;44.4;United Kingdom;Western Europe;SAGE Publications Inc.;1991-2015, 2017-2021;"Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q2); Virology (Q3)"
301;21100232413;Advanced Pharmaceutical Bulletin;journal;22517308, 22285881;0.632;Q1;42;80;263;3298;699;260;2.5;41.23;Iran;Middle East;Tabriz University of Medical Sciences, Faculty of Pharmacy;2011-2021;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1)
302;21100238633;BioImpacts;journal;22285652, 22285660;0.629;Q2;37;32;91;1474;240;84;2.42;46.06;Iran;Middle East;Tabriz University of Medical Sciences;2011-2021;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2)"
303;19958;Archives of Pharmacal Research;journal;19763786, 02536269;0.626;Q2;93;137;595;6781;1413;588;2.42;49.5;South Korea;Asiatic Region;Pharmaceutical Society of Korea;1978-2021;"Drug Discovery (Q2); Organic Chemistry (Q2); Molecular Medicine (Q3)"
304;20064;Biological and Pharmaceutical Bulletin;journal;13475215, 09186158;0.626;Q2;122;315;861;10611;1545;850;1.76;33.69;Japan;Asiatic Region;Pharmaceutical Society of Japan;1993-2021;"Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Pharmacology (Q2)"
305;19700200821;Therapeutic Delivery;journal;20415990, 20416008;0.621;Q2;52;98;302;6153;609;267;2.22;62.79;United Kingdom;Western Europe;Future Science;2010-2021;Pharmaceutical Science (Q2)
306;11000153762;Journal of Immunotoxicology;journal;1547691X, 15476901;0.62;Q3;40;27;197;1286;358;196;1.57;47.63;United States;Northern America;Informa Healthcare;2004-2021;"Immunology (Q3); Toxicology (Q3)"
307;3500148011;Journal of Zhejiang University: Science B;journal;16731581;0.617;Q1;61;121;331;4778;650;318;1.97;39.49;China;Asiatic Region;Zhejiang University Press;2005-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Medicine (miscellaneous) (Q2); Veterinary (miscellaneous) (Q2)"
308;19444;American Journal of Pharmaceutical Education;journal;15536467, 00029459;0.616;Q1;69;190;582;4301;837;489;1.3;22.64;United States;Northern America;American Association of Colleges of Pharmacy;1945-1948, 1973-1989, 1991, 1996-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Education (Q2); Medicine (miscellaneous) (Q2)"
309;21907;Journal of Anaesthesiology Clinical Pharmacology;journal;09709185, 22312730;0.612;Q1;35;142;471;2337;476;270;0.95;16.46;India;Asiatic Region;Wolters Kluwer Medknow Publications;1996-1999, 2002-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Anesthesiology and Pain Medicine (Q2); Pharmacology (medical) (Q2)"
310;28675;Brazilian Journal of Medical and Biological Research;journal;0100879X, 1414431X;0.611;Q1;91;157;453;5057;814;453;1.62;32.21;Brazil;Latin America;Associacao Brasileira de Divulgacao Cientifica;1973-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Biophysics (Q2); Medicine (miscellaneous) (Q2); Biochemistry (Q3); Cell Biology (Q3); Immunology (Q3); Neuroscience (miscellaneous) (Q3); Physiology (Q3)"
311;19700170617;EXCLI Journal;journal;16112156;0.607;Q2;43;114;296;5128;678;244;2.23;44.98;Germany;Western Europe;Leibniz Research Centre for Working Environment and Human Factors;2009-2021;"Animal Science and Zoology (Q2); Drug Discovery (Q2); Molecular Medicine (Q3); Pharmacology (Q3)"
312;19443;American Journal of Health-System Pharmacy;journal;10792082, 15352900;0.595;Q3;99;372;1079;5178;1128;669;0.99;13.92;United States;Northern America;American Society of Health-Systems Pharmacy;1995-2021;"Health Policy (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q3)"
313;17700156777;Advances in Pharmacological Sciences;journal;16876342, 16876334;0.591;Q1;38;5;70;447;172;70;2.56;89.4;United States;Northern America;Hindawi Publishing Corporation;2009-2019;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Pharmacology (medical) (Q2); Molecular Medicine (Q3)"
314;15300154846;Journal of Occupational Medicine and Toxicology;journal;17456673;0.591;Q3;42;33;137;1185;284;137;2.02;35.91;United Kingdom;Western Europe;BioMed Central Ltd.;2006-2021;"Public Health, Environmental and Occupational Health (Q2); Safety Research (Q2); Toxicology (Q3)"
315;4000150314;Chemical Biology and Drug Design;journal;17470277;0.588;-;82;217;561;9942;1304;554;2.33;45.82;United Kingdom;Western Europe;Blackwell;2006-2021;"Biochemistry (Q3); Molecular Medicine (Q3)"
316;59665;Chinese Journal of Natural Medicines;journal;16723651;0.587;Q2;40;109;374;4104;779;371;2.12;37.65;China;Asiatic Region;China Pharmaceutical University;2004-2021;"Complementary and Alternative Medicine (Q1); Drug Discovery (Q2); Medicine (miscellaneous) (Q2)"
317;21744;Planta Medica;journal;14390221, 00320943;0.581;Q2;122;165;558;6215;1338;544;2.18;37.67;Germany;Western Europe;Georg Thieme Verlag;1961, 1965-2021;"Complementary and Alternative Medicine (Q1); Analytical Chemistry (Q2); Drug Discovery (Q2); Organic Chemistry (Q2); Pharmaceutical Science (Q2); Molecular Medicine (Q3); Pharmacology (Q3)"
318;19700177407;Interdisciplinary Toxicology;journal;13379569, 13376853;0.58;Q3;34;25;74;1070;183;73;0.83;42.8;Slovakia;Eastern Europe;Slovak Toxicology Society SETOX;2008-2020;"Health, Toxicology and Mutagenesis (Q3); Pharmacology (Q3); Toxicology (Q3)"
319;21100367469;Toxicology Reports;journal;22147500;0.58;Q3;46;82;396;3879;718;393;1.86;47.3;Ireland;Western Europe;Elsevier Scientific Publishers Ireland;2014-2021;"Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
320;15581;Current Pharmaceutical Biotechnology;journal;13892010, 18734316;0.574;Q2;88;133;415;7488;790;370;1.82;56.3;Netherlands;Western Europe;Bentham Science Publishers B.V.;2000-2021;"Biotechnology (Q2); Pharmaceutical Science (Q2)"
321;23089;Journal of Pharmacy and Pharmaceutical Sciences;journal;14821826;0.574;Q2;81;36;140;1251;298;139;2;34.75;Canada;Northern America;Canadian Society for Pharmaceutical Sciences;1998-2021;"Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Pharmacology (Q3)"
322;20659;Critical Reviews in Therapeutic Drug Carrier Systems;journal;07434863, 2162660X;0.573;Q2;76;16;44;2856;117;44;2.86;178.5;United States;Northern America;Begell House Inc.;1984-2021;"Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Pharmacology (Q3)"
323;4000152107;Journal of Venomous Animals and Toxins Including Tropical Diseases;journal;16789199;0.573;Q3;32;44;145;2161;294;138;1.8;49.11;United Kingdom;Western Europe;Centro de Estudos de Venenos e Animais Peconhentos;2006-2021;"Animal Science and Zoology (Q2); Infectious Diseases (Q3); Parasitology (Q3); Toxicology (Q3)"
324;19900192900;Molecular Informatics;journal;18681751, 18681743;0.573;Q2;70;71;208;3118;413;199;2.02;43.92;Germany;Western Europe;"Wiley - VCH Verlag GmbH &amp; CO. KGaA";2010-2021;"Computer Science Applications (Q2); Drug Discovery (Q2); Organic Chemistry (Q2); Molecular Medicine (Q3); Structural Biology (Q4)"
325;6400153120;Chinese Medicine;journal;17498546;0.57;Q3;45;36;113;1536;220;112;1.84;42.67;United Kingdom;Western Europe;BioMed Central Ltd.;2006-2021;"Complementary and Alternative Medicine (Q1); Pharmacology (Q3)"
326;28794;Cancer Biotherapy and Radiopharmaceuticals;journal;10849785, 15578852;0.567;Q3;63;46;168;1728;276;164;1.57;37.57;United States;Northern America;Mary Ann Liebert Inc.;1996-2021;"Medicine (miscellaneous) (Q2); Radiology, Nuclear Medicine and Imaging (Q2); Cancer Research (Q3); Oncology (Q3); Pharmacology (Q3)"
327;24797;Mini-Reviews in Medicinal Chemistry;journal;18755607, 13895575;0.567;Q2;95;113;400;11974;858;367;2.06;105.96;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2001-2021;"Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q3)"
328;16319;IEEE Transactions on Nanobioscience;journal;15361241, 15582639;0.566;Q2;65;96;270;3733;787;257;2.59;38.89;United States;Northern America;Institute of Electrical and Electronics Engineers Inc.;2002-2021;"Bioengineering (Q2); Biomedical Engineering (Q2); Biotechnology (Q2); Computer Science Applications (Q2); Electrical and Electronic Engineering (Q2); Medicine (miscellaneous) (Q2); Nanoscience and Nanotechnology (Q2); Pharmaceutical Science (Q2)"
329;29550;Journal of Biochemical and Molecular Toxicology;journal;10956670, 10990461;0.565;Q3;62;137;212;5265;422;210;1.78;38.43;United States;Northern America;"John Wiley &amp; Sons Inc.";1998-2021;"Medicine (miscellaneous) (Q2); Biochemistry (Q3); Health, Toxicology and Mutagenesis (Q3); Molecular Medicine (Q3); Toxicology (Q3); Molecular Biology (Q4)"
330;21082;Pharmaceutical Biology;journal;13880209, 17445116;0.563;Q2;72;289;857;11959;1731;857;2.02;41.38;United Kingdom;Western Europe;Taylor and Francis Ltd.;1961-1972, 1975-2021;"Complementary and Alternative Medicine (Q1); Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Molecular Medicine (Q3); Pharmacology (Q3)"
331;25241;Toxicology Mechanisms and Methods;journal;15376524, 15376516;0.562;Q3;46;78;247;3838;500;246;2.01;49.21;United Kingdom;Western Europe;Informa Healthcare;1991-2021;"Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
332;25149;Journal of Toxicological Sciences;journal;18803989, 03881350;0.56;Q3;53;81;275;2581;491;218;1.78;31.86;Japan;Asiatic Region;Japanese Society of Toxicological Sciences;1976-2021;"Medicine (miscellaneous) (Q2); Toxicology (Q3)"
333;25106;Human and Experimental Toxicology;journal;09603271;0.559;Q3;82;132;400;5401;727;390;1.82;40.92;United States;Northern America;SAGE Publications Inc.;1981-2021;"Medicine (miscellaneous) (Q2); Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
334;19600157763;Research in Pharmaceutical Sciences;journal;17355362, 17359414;0.557;Q1;33;62;172;2082;421;172;1.74;33.58;India;Asiatic Region;Wolters Kluwer Medknow Publications;2009-2021;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1)
335;20066;Biopharmaceutics and Drug Disposition;journal;1099081X, 01422782;0.551;Q2;61;51;148;1963;304;146;1.69;38.49;United Kingdom;Western Europe;John Wiley and Sons Ltd;1979-2021;"Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Pharmacology (medical) (Q2); Pharmacology (Q3)"
336;13248;Experimental and Toxicologic Pathology;journal;09402993, 16181433;0.551;Q3;70;83;190;3462;395;188;2.24;41.71;Germany;Western Europe;Urban und Fischer Verlag Jena;1992-2017;"Medicine (miscellaneous) (Q2); Pathology and Forensic Medicine (Q2); Toxicology (Q3); Cell Biology (Q4)"
337;5800173383;Current Clinical Pharmacology;journal;15748847, 22123938;0.55;Q1;0;0;0;0;0;0;0;0;United Arab Emirates;Middle East;Bentham Science Publishers;2006-2020;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Medicine (miscellaneous) (Q2); Pharmacology (medical) (Q2)"
338;26568;International Journal of Cosmetic Science;journal;01425463, 14682494;0.548;Q2;66;82;248;2585;488;243;1.97;31.52;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;1979-2021;"Chemistry (miscellaneous) (Q2); Dermatology (Q2); Drug Discovery (Q2); Pharmaceutical Science (Q2); Aging (Q3); Colloid and Surface Chemistry (Q3)"
339;21100325142;Journal of Pharmaceutical Policy and Practice;journal;20523211;0.545;Q1;21;36;133;1299;161;123;1.64;36.08;United Kingdom;Western Europe;BioMed Central Ltd.;2013-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Health Policy (Q2)"
340;19700174628;Iranian Journal of Basic Medical Sciences;journal;20083874, 20083866;0.538;Q2;44;183;522;7396;928;517;1.7;40.42;Iran;Middle East;Mashhad University of Medical Sciences;2007-2021;"Drug Discovery (Q2); Biochemistry (Q3); Biophysics (Q3); Clinical Biochemistry (Q3); Immunology and Microbiology (miscellaneous)  (Q3)"
341;21100241601;Toxicology Research;journal;2045452X, 20454538;0.537;Q3;37;88;352;4854;716;350;2.04;55.16;United Kingdom;Western Europe;Oxford University Press;2012-2021;"Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
342;145693;Canadian Pharmacists Journal;journal;17151635;0.536;Q2;24;66;172;1044;151;107;0.81;15.82;Canada;Northern America;Canadian Pharmacists Association;2005-2021;"Pharmacy (Q1); Pharmaceutical Science (Q2)"
343;16948;Chirality;journal;1520636X, 08990042;0.536;Q2;80;89;358;3413;655;353;1.84;38.35;United States;Northern America;Wiley-Liss Inc.;1989-2021;"Analytical Chemistry (Q2); Drug Discovery (Q2); Organic Chemistry (Q2); Spectroscopy (Q2); Catalysis (Q3); Pharmacology (Q3)"
344;24624;Bulletin of Environmental Contamination and Toxicology;journal;00074861, 14320800;0.533;Q3;76;257;808;7805;1298;790;1.54;30.37;United States;Northern America;Springer New York;1966-2021;"Medicine (miscellaneous) (Q2); Pollution (Q2); Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
345;21100389517;Drug Metabolism and Personalized Therapy;journal;23638907, 23638915;0.531;Q2;36;29;92;1075;151;82;1.39;37.07;Germany;Western Europe;Walter de Gruyter GmbH;2015-2021;"Pharmacology (medical) (Q2); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2)"
346;19700174889;Drug Target Insights;journal;11773928;0.529;Q2;13;3;20;117;46;19;2.23;39;Italy;Western Europe;AboutScience Srl;2008-2009, 2011-2020;"Medicine (miscellaneous) (Q2); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Clinical Biochemistry (Q3); Pharmacology (medical) (Q3)"
347;20710;DARU, Journal of Pharmaceutical Sciences;journal;15608115, 20082231;0.528;Q2;47;25;157;1134;412;149;2.62;45.36;United Kingdom;Western Europe;BioMed Central Ltd.;2000-2021;"Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q3)"
348;19700188399;Current protocols in toxicology / editorial board, Mahin D. Maines (editor-in-chief) ... [et al.];journal;19349254, 19349262;0.527;Q3;28;24;43;742;85;43;1.52;30.92;United States;Northern America;"John Wiley &amp; Sons Inc.";2001-2020;"Medicine (miscellaneous) (Q2); Toxicology (Q3)"
349;20570;Chemotherapy;journal;00093157, 14219794;0.524;Q2;58;45;156;1093;271;153;1.74;24.29;Switzerland;Western Europe;S. Karger AG;1960-2021;"Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Infectious Diseases (Q3); Oncology (Q3); Pharmacology (Q3); Pharmacology (medical) (Q3)"
350;23050;Journal of Microencapsulation;journal;02652048, 14645246;0.52;Q2;81;70;265;3140;520;265;1.89;44.86;United Kingdom;Western Europe;Informa Healthcare;1984-2021;"Bioengineering (Q2); Pharmaceutical Science (Q2); Colloid and Surface Chemistry (Q3); Organic Chemistry (Q3); Physical and Theoretical Chemistry (Q3)"
351;21190;Drug Development and Industrial Pharmacy;journal;03639045, 15205762;0.519;Q2;90;206;659;9376;1338;654;1.95;45.51;United States;Northern America;Informa Healthcare;1974, 1976-2021;"Drug Discovery (Q2); Organic Chemistry (Q3); Pharmacology (Q3)"
352;25129;Journal of Environmental Pathology, Toxicology and Oncology;journal;07318898;0.519;Q3;47;28;90;1844;147;90;1.27;65.86;United States;Northern America;Begell House Inc.;1984-1990, 1992-2021;"Medicine (miscellaneous) (Q2); Pathology and Forensic Medicine (Q2); Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
353;19200156706;Pharmacognosy Magazine (discontinued);journal;09731296, 09764062;0.519;Q2;42;262;365;8552;684;365;1.97;32.64;India;Asiatic Region;Wolters Kluwer Medknow Publications;2008-2018, 2020-2021;"Drug Discovery (Q2); Pharmaceutical Science (Q2)"
354;22204;Journal of Drug Delivery Science and Technology;journal;17732247, 25888943;0.517;Q2;52;203;364;9780;758;359;2.53;48.18;France;Western Europe;Editions de Sante;2004-2021;Pharmaceutical Science (Q2)
355;24578;Mathematical Medicine and Biology;journal;14778599;0.517;Q3;46;24;61;862;99;61;1.62;35.92;United Kingdom;Western Europe;Oxford University Press;1984-2021;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Environmental Science (miscellaneous) (Q2); Medicine (miscellaneous) (Q2); Modeling and Simulation (Q2); Applied Mathematics (Q3); Immunology and Microbiology (miscellaneous)  (Q3); Neuroscience (miscellaneous) (Q3); Pharmacology (Q3)"
356;17500155003;Records of Natural Products;journal;13076167;0.517;Q2;33;83;239;2522;362;238;1.51;30.39;Turkey;Middle East;ACG Publications;2009-2022;"Drug Discovery (Q2); Plant Science (Q2); Organic Chemistry (Q3); Pharmacology (Q3)"
357;28636;Birth Defects Research Part B - Developmental and Reproductive Toxicology;journal;15429733, 15429741;0.515;Q3;52;0;84;0;149;83;1.44;0;United States;Northern America;Wiley-Liss Inc.;2003-2016;"Embryology (Q3); Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3); Developmental Biology (Q4)"
358;19500157062;Current Cardiovascular Risk Reports;journal;19329563, 19329520;0.515;Q3;30;37;155;2124;149;155;0.95;57.41;United States;Northern America;Current Medicine Group;2007-2021;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
359;19700175023;Journal of Toxicology;journal;16878205, 16878191;0.515;Q3;39;15;71;663;163;71;2.05;44.2;Egypt;Africa/Middle East;Hindawi Limited;2010-2021;"Pharmacology (Q3); Toxicology (Q3)"
360;4600151526;Cardiovascular and Hematological Disorders - Drug Targets;journal;1871529X;0.513;Q3;42;28;71;1457;91;64;1.13;52.04;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Cardiology and Cardiovascular Medicine (Q2); Medicine (miscellaneous) (Q2); Hematology (Q3); Molecular Medicine (Q3); Pharmacology (Q3)"
361;20634;Journal of Texture Studies;journal;00224901, 17454603;0.511;Q2;57;67;146;2367;246;142;1.62;35.33;United States;Northern America;Wiley-Blackwell;1969-2021;"Food Science (Q2); Pharmaceutical Science (Q2)"
362;20602;Clinical Neuropharmacology;journal;1537162X, 03625664;0.506;Q3;80;65;182;1558;267;167;1.33;23.97;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1982-2021;"Neurology (clinical) (Q3); Pharmacology (Q3); Pharmacology (medical) (Q3)"
363;19700174941;Pharmacognosy Research (discontinued);journal;09748490;0.506;Q3;37;82;195;3096;369;193;1.8;37.76;India;Asiatic Region;Wolters Kluwer Medknow Publications;2010-2019, 2021;"Drug Discovery (Q3); Pharmacology (Q3)"
364;17700156313;Iranian Journal of Pharmaceutical Research;journal;17350328, 17266890;0.502;Q2;48;188;511;6882;841;497;1.48;36.61;Iran;Middle East;Iranian Journal of Pharmaceutical Research;2002-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Pharmacology (medical) (Q3)"
365;21194;Pharmacology;journal;00317012, 14230313;0.502;Q3;60;85;250;3059;387;250;1.44;35.99;Switzerland;Western Europe;S. Karger AG;1959-2021;"Medicine (miscellaneous) (Q2); Pharmacology (Q3)"
366;5800173387;Reviews on Recent Clinical Trials;journal;15748871;0.498;Q3;32;43;132;1860;194;117;0.93;43.26;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Medicine (miscellaneous) (Q2); Pharmacology (Q3)"
367;21100241807;Artificial Cells, Nanomedicine and Biotechnology;journal;2169141X, 21691401;0.495;Q2;57;208;366;8391;926;366;2.68;40.34;United States;Northern America;Informa Healthcare;2013-2021;"Biomedical Engineering (Q2); Biotechnology (Q2); Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2)"
368;29053;Molecular Diversity;journal;1573501X, 13811991;0.494;Q3;58;86;213;3391;491;213;2.33;39.43;Netherlands;Western Europe;Springer Netherlands;1995-1998, 2000, 2003-2021;"Information Systems (Q2); Medicine (miscellaneous) (Q2); Catalysis (Q3); Drug Discovery (Q3); Inorganic Chemistry (Q3); Organic Chemistry (Q3); Physical and Theoretical Chemistry (Q3); Molecular Biology (Q4)"
369;18922;Journal of Gene Medicine;journal;1099498X, 15212254;0.493;Q3;94;48;77;2155;137;77;1.45;44.9;United States;Northern America;John Wiley and Sons Ltd;1998-2021;"Drug Discovery (Q3); Molecular Medicine (Q3); Genetics (Q4); Genetics (clinical) (Q4); Molecular Biology (Q4)"
370;4900153304;Archives of Environmental and Occupational Health;journal;19338244;0.492;Q3;64;50;136;1662;153;117;1.15;33.24;United States;Northern America;Heldref Publications;2005-2021;"Environmental Science (miscellaneous) (Q2); Public Health, Environmental and Occupational Health (Q2); Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
371;23942;Biomedical Chromatography;journal;10990801, 02693879;0.49;Q3;68;238;746;7375;1287;734;1.75;30.99;United Kingdom;Western Europe;John Wiley and Sons Ltd;1986-2021;"Analytical Chemistry (Q2); Medicine (miscellaneous) (Q2); Biochemistry (Q3); Clinical Biochemistry (Q3); Drug Discovery (Q3); Pharmacology (Q3); Molecular Biology (Q4)"
372;25305;SAR and QSAR in Environmental Research;journal;1029046X, 1062936X;0.49;Q3;50;61;167;2990;339;167;2.23;49.02;United Kingdom;Western Europe;Taylor and Francis Ltd.;1993-2021;"Medicine (miscellaneous) (Q2); Bioengineering (Q3); Drug Discovery (Q3); Molecular Medicine (Q3)"
373;20627;Clinical Research and Regulatory Affairs;journal;15322521, 10601333;0.486;Q2;17;0;29;0;54;28;1.88;0;United States;Northern America;Informa Healthcare;1983-1990, 1992-2016;"Pharmaceutical Science (Q2); Pharmacology (Q3); Pharmacology (medical) (Q3)"
374;29947;Journal of Chemotherapy;journal;1120009X, 19739478;0.483;Q3;52;70;234;2058;295;214;1.27;29.4;United Kingdom;Western Europe;Maney Publishing;1989-2021;"Medicine (miscellaneous) (Q2); Infectious Diseases (Q3); Oncology (Q3); Pharmacology (Q3); Pharmacology (medical) (Q3)"
375;29634;Journal of Negative Results in BioMedicine;journal;14775751;0.483;Q2;23;15;61;483;59;59;1.02;32.2;United Kingdom;Western Europe;BioMed Central Ltd.;2002-2017;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Medicine (miscellaneous) (Q2); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2)"
376;21100788810;Chemotherapy Research and Practice;journal;20902107;0.481;Q2;5;0;4;0;10;4;2;0;United States;Northern America;;;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Oncology (Q3); Pharmacology (medical) (Q3)"
377;19700175086;Drug, Healthcare and Patient Safety;journal;11791365;0.481;Q3;25;11;54;470;100;54;1.03;42.73;New Zealand;Pacific Region;Dove Medical Press Limited;2009-2021;"Health Policy (Q2); Pharmacology (Q3)"
378;21099;Pharmaceutical Development and Technology;journal;10837450, 10979867;0.479;Q2;62;114;352;4324;590;352;1.63;37.93;United States;Northern America;Informa Healthcare;1996-2021;"Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2)"
379;21100220486;Journal of Pharmaceutical Investigation;journal;20935552, 20936214;0.478;Q2;31;50;173;2906;313;172;2.28;58.12;Netherlands;Western Europe;Springer Netherlands;2012-2021;"Pharmaceutical Science (Q2); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2)"
380;24043;Journal of Labelled Compounds and Radiopharmaceuticals;journal;03624803, 10991344;0.477;Q3;48;75;281;2259;399;275;1.25;30.12;United Kingdom;Western Europe;John Wiley and Sons Ltd;1976-2021;"Analytical Chemistry (Q2); Biochemistry (Q3); Drug Discovery (Q3); Organic Chemistry (Q3); Radiology, Nuclear Medicine and Imaging (Q3); Spectroscopy (Q3)"
381;21100209502;Journal of Pharmacology and Pharmacotherapeutics;journal;0976500X, 09765018;0.476;Q3;37;39;184;816;242;127;1.08;20.92;India;Asiatic Region;Wolters Kluwer Medknow Publications;2010-2021;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
382;21246;International Journal of Immunopathology and Pharmacology;journal;03946320;0.471;Q3;58;51;267;1427;534;237;2.04;27.98;Italy;Western Europe;SAGE Publications Inc.;1989-2021;"Immunology and Allergy (Q3); Pharmacology (Q3); Immunology (Q4)"
383;14822;Xenobiotica;journal;00498254, 13665928;0.47;Q3;82;120;364;4484;598;362;1.72;37.37;United Kingdom;Western Europe;Informa Healthcare;1971-2021;"Medicine (miscellaneous) (Q2); Biochemistry (Q3); Health, Toxicology and Mutagenesis (Q3); Pharmacology (Q3); Toxicology (Q3)"
384;21100212330;Drug Discoveries and Therapeutics;journal;1881784X, 18817831;0.468;Q2;27;29;126;0;230;123;1.83;0;Japan;Asiatic Region;"International Advancement Center for Medicine &amp; Health Research Co., Ltd. (IACMHR Co., Ltd.)";1997, 2010-2018, 2020;"Medicine (miscellaneous) (Q2); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Pharmacology (medical) (Q3)"
385;18200156711;Bangladesh Journal of Pharmacology;journal;1991007X, 19910088;0.466;Q3;26;75;415;1908;377;392;0.85;25.44;Bangladesh;Asiatic Region;Bangladesh Pharmacological Society;2009-2021;Pharmacology (Q3)
386;20766;Drug and Chemical Toxicology;journal;01480545, 15256014;0.46;Q3;46;62;195;2794;290;195;1.37;45.06;United States;Northern America;Informa Healthcare;1977-2021;"Medicine (miscellaneous) (Q2); Chemical Health and Safety (Q3); Health, Toxicology and Mutagenesis (Q3); Pharmacology (Q3); Public Health, Environmental and Occupational Health (Q3); Toxicology (Q3)"
387;23489;Chemical Speciation and Bioavailability;journal;09542299;0.457;Q3;0;0;0;0;0;0;0;0;United Kingdom;Western Europe;Taylor and Francis Ltd.;1989-2018;"Chemical Health and Safety (Q3); Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
388;130031;Journal of Toxicologic Pathology;journal;09149198;0.453;Q3;30;42;108;1103;154;107;1.32;26.26;Japan;Asiatic Region;Japanese Society of Toxicologic Pathology;1988-1990, 1992-2021;"Pathology and Forensic Medicine (Q3); Toxicology (Q3)"
389;18200156702;World Mycotoxin Journal;journal;18750710, 18750796;0.453;Q3;40;38;181;1690;329;176;1.85;44.47;Netherlands;Western Europe;Wageningen Academic Publishers;2009-2021;"Food Science (Q2); Public Health, Environmental and Occupational Health (Q3); Toxicology (Q3)"
390;4700152701;Pharmacy Practice;journal;1885642X, 18863655;0.451;Q2;28;50;114;1546;150;110;1.21;30.92;Spain;Western Europe;Centro de Investigaciones y Publicaciones Farmaceuticas;2006-2021;"Pharmaceutical Science (Q2); Pharmacy (Q2)"
391;130047;Current Drug Discovery Technologies;journal;15701638;0.449;Q3;44;23;75;1136;112;73;1.57;49.39;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2004-2021;Drug Discovery (Q3)
392;25111;International Journal of Toxicology;journal;10915818, 1092874X;0.449;Q3;62;74;198;3105;294;190;1.59;41.96;United States;Northern America;SAGE Publications Inc.;1982-2021;Toxicology (Q3)
393;130025;Current Drug Delivery;journal;15672018;0.443;Q2;65;96;325;5178;585;309;1.64;53.94;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2004-2021;Pharmaceutical Science (Q2)
394;22434;International Journal of Clinical Pharmacology and Therapeutics;journal;09461965;0.438;Q3;69;130;403;2885;488;396;1.18;22.19;Germany;Western Europe;Dustri-Verlag Dr. Karl Feistle;1994-2021;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
395;22392;Indian Journal of Pharmaceutical Sciences;journal;0250474X, 19983743;0.434;Q2;61;119;325;4310;336;322;0.87;36.22;India;Asiatic Region;Wolters Kluwer Medknow Publications;1978-2021;Pharmaceutical Science (Q2)
396;130072;International Journal of Medicinal Mushrooms;journal;15219437;0.433;Q3;33;103;283;3760;399;281;1.32;36.5;United States;Northern America;Begell House Inc.;2005-2021;"Applied Microbiology and Biotechnology (Q3); Drug Discovery (Q3); Pharmacology (Q3)"
397;5400152628;Revista Brasileira de Farmacognosia;journal;0102695X, 1981528X;0.433;Q2;50;115;301;4650;608;296;1.83;40.43;Brazil;Latin America;Springer Nature Switzerland AG;2007-2021;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2)
398;15462;Biotechnology and Applied Biochemistry;journal;14708744, 08854513;0.431;Q3;74;102;299;4204;446;298;1.51;41.22;United States;Northern America;Wiley-Blackwell;1986-2021;"Process Chemistry and Technology (Q2); Applied Microbiology and Biotechnology (Q3); Bioengineering (Q3); Biomedical Engineering (Q3); Biotechnology (Q3); Drug Discovery (Q3); Medicine (miscellaneous) (Q3); Molecular Medicine (Q4)"
399;21100262305;Clinical Pharmacology in Drug Development;journal;21607648, 2160763X;0.43;Q2;26;70;193;2064;242;178;1.32;29.49;United States;Northern America;Wiley-Blackwell;2012-2021;"Pharmaceutical Science (Q2); Pharmacology (medical) (Q3)"
400;19383;Fluoride - Quarterly Reports;journal;22534083, 00154725;0.429;Q3;48;44;130;1362;171;118;1.15;30.95;New Zealand;Pacific Region;International Society for Fluoride Research;1973-2021;"Agricultural and Biological Sciences (miscellaneous) (Q2); Chemistry (miscellaneous) (Q2); Dentistry (miscellaneous) (Q2); Biochemistry (Q3); Health, Toxicology and Mutagenesis (Q3); Public Health, Environmental and Occupational Health (Q3); Toxicology (Q3)"
401;16067;Reading Teacher;journal;00340561;0.429;Q3;53;98;265;2235;188;228;0.63;22.81;United States;Northern America;Wiley-Blackwell;1995-2021;"Linguistics and Language (Q1); Pharmacology (Q3); Pharmacology (medical) (Q3)"
402;23348;Journal of Environmental Biology;journal;23940379, 02548704;0.424;Q3;51;186;573;6017;510;571;0.79;32.35;India;Asiatic Region;Triveni Enterprises;1988-2021;"Environmental Engineering (Q3); Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
403;130089;Toxin Reviews;journal;15569543, 15569551;0.424;Q3;46;47;98;2295;151;89;1.64;48.83;United Kingdom;Western Europe;Informa Healthcare;1982-2021;Toxicology (Q3)
404;18384;Medicinal Chemistry Research;journal;10542523, 15548120;0.422;Q2;50;304;1085;11117;1840;1085;1.67;36.57;United States;Northern America;Birkhauser Boston;1994, 1996-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Organic Chemistry (Q3)"
405;19700188356;Journal of Excipients and Food Chemicals;journal;21502668;0.419;Q2;16;11;42;299;40;27;0.11;27.18;United States;Northern America;IPEC-Americas;2010-2021;"Food Science (Q2); Pharmaceutical Science (Q2)"
406;21100239265;PharmaNutrition;journal;22134344;0.418;Q3;23;18;64;1139;107;61;1.79;63.28;Netherlands;Western Europe;Elsevier BV;2013-2021;"Food Science (Q2); Pharmacology (Q3); Pharmacology (medical) (Q3)"
407;5900153312;Recent Patents on Cardiovascular Drug Discovery;journal;15748901;0.415;Q3;28;0;20;0;32;18;1.29;0;Netherlands;Western Europe;Bentham Science Publishers B.V.;2006-2015;"Cardiology and Cardiovascular Medicine (Q3); Drug Discovery (Q3); Pharmacology (medical) (Q3)"
408;20580;Journal of Food Biochemistry;journal;17454514, 01458884;0.414;Q3;50;149;225;6690;343;224;1.48;44.9;United States;Northern America;Wiley-Blackwell;1977-2021;"Food Science (Q2); Biophysics (Q3); Pharmacology (Q3); Cell Biology (Q4)"
409;19956;Archiv der Pharmazie;journal;15214184, 03656233;0.413;Q2;65;83;268;3453;605;267;2.37;41.6;Germany;Western Europe;Wiley-VCH Verlag;1822-1831, 1835-1933, 1937-1938, 1940, 1943-1944, 1950-2021;"Pharmaceutical Science (Q2); Drug Discovery (Q3)"
410;20545;PDA Journal of Pharmaceutical Science and Technology;journal;19482124, 10797440;0.413;Q2;40;50;186;914;125;165;0.61;18.28;United States;Northern America;Parenteral Drug Association Inc.;1994-2021;Pharmaceutical Science (Q2)
411;21100444313;Sustainable Chemistry and Pharmacy;journal;23525541;0.413;Q2;27;34;27;1819;64;23;2.37;53.5;Netherlands;Western Europe;Elsevier BV;2015-2021;"Pharmaceutical Science (Q2); Environmental Chemistry (Q3); Management, Monitoring, Policy and Law (Q3); Pollution (Q3)"
412;22393;Indian Journal of Pharmacology;journal;02537613, 19983751;0.412;Q3;62;79;486;1568;497;420;0.9;19.85;India;Asiatic Region;Wolters Kluwer Medknow Publications;1978-1980, 1982, 1984-1986, 1994-2021;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
413;27210;In Vivo;journal;17917549, 0258851X;0.409;Q3;64;178;410;5247;526;410;1.24;29.48;Greece;Western Europe;International Institute of Anticancer Research;1987-2021;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Medicine (miscellaneous) (Q3); Pharmacology (Q3)"
414;34545;Journal of Asian Natural Products Research;journal;10286020, 14772213;0.403;Q2;42;149;469;2989;578;455;1.08;20.06;United Kingdom;Western Europe;Taylor and Francis Ltd.;1998-2021;"Complementary and Alternative Medicine (Q2); Pharmaceutical Science (Q2); Analytical Chemistry (Q3); Drug Discovery (Q3); Medicine (miscellaneous) (Q3); Organic Chemistry (Q3); Pharmacology (Q3); Molecular Medicine (Q4)"
415;19447;Journal of the American Pharmacists Association : JAPhA;journal;15443191, 15443450;0.4;Q3;67;197;366;3894;376;318;0.9;19.77;United States;Northern America;American Pharmacists Association;2003-2021;"Pharmacology (nursing) (Q1); Pharmacy (Q2); Pharmacology (Q3)"
416;27087;American Journal of Therapeutics;journal;10752765, 15363686;0.399;Q3;63;142;585;2971;545;546;0.94;20.92;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1960-1961, 1996-2021;"Medicine (miscellaneous) (Q3); Pharmacology (Q3); Pharmacology (medical) (Q3)"
417;130016;Cutaneous and Ocular Toxicology;journal;15569527, 15569535;0.392;Q3;32;77;213;1972;242;211;0.9;25.61;United Kingdom;Western Europe;Informa Healthcare;1982-2000, 2005-2021;"Medicine (miscellaneous) (Q3); Toxicology (Q3)"
418;22456;International Journal of Pharmacy Practice;journal;09617671, 20427174;0.391;Q2;39;66;201;1758;218;169;1.06;26.64;United Kingdom;Western Europe;Oxford University Press;1991-2021;"Pharmaceutical Science (Q2); Pharmacy (Q2); Health Policy (Q3); Medicine (miscellaneous) (Q3); Public Health, Environmental and Occupational Health (Q3)"
419;19700175244;Current Radiopharmaceuticals;journal;18744710, 18744729;0.389;Q3;26;27;74;762;85;67;1.24;28.22;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2009-2021;"Pharmacology (Q3); Radiology, Nuclear Medicine and Imaging (Q3)"
420;4700152769;Pharmacopeial Forum (discontinued);journal;03634655;0.388;Q3;19;16;31;177;18;31;0.82;11.06;United States;Northern America;United States Pharmacopeial Convention Inc.;1996-1998, 2000-2018;"Drug Guides (Q2); Pharmacy (Q2); Pharmacology (Q3)"
421;21100446418;Contemporary Clinical Trials Communications;journal;24518654;0.387;Q3;17;115;79;4091;52;76;0.66;35.57;United States;Northern America;Elsevier Inc.;2015-2021;"Medicine (miscellaneous) (Q3); Pharmacology (Q3)"
422;5800173402;Recent Patents on CNS Drug Discovery;journal;15748898;0.383;Q3;34;0;45;0;63;39;1.15;0;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2016;"Drug Discovery (Q3); Pharmacology (medical) (Q3); Psychiatry and Mental Health (Q3)"
423;5000158117;Profiles of Drug Substances, Excipients and Related Methodology;journal;18715125;0.381;Q2;21;9;24;703;52;0;1.5;78.11;United States;Northern America;Academic Press Inc.;2001-2003, 2005, 2007-2021;"Pharmaceutical Science (Q2); Medicine (miscellaneous) (Q3); Pharmacology (Q3); Molecular Medicine (Q4)"
424;3200147837;Journal of Exercise Science and Fitness;journal;1728869X;0.378;Q2;25;16;45;550;46;45;0.77;34.38;Singapore;Asiatic Region;Elsevier;2005-2021;"Pharmaceutical Science (Q2); Pharmacology (nursing) (Q2); Sports Science (Q3)"
425;5800173403;Recent Patents on Anti-Infective Drug Discovery;journal;1574891X, 22124071;0.376;Q3;0;0;0;0;0;0;0;0;Netherlands;Western Europe;Bentham Science Publishers B.V.;2006-2020;"Drug Discovery (Q3); Infectious Diseases (Q3); Medicine (miscellaneous) (Q3); Pharmacology (medical) (Q3)"
426;21717;Die Pharmazie;journal;00317144;0.375;Q2;66;127;423;4270;506;422;1.1;33.62;Germany;Western Europe;Govi-Verlag Pharmazeutischer Verlag GmbH;1947-2021;Pharmaceutical Science (Q2)
427;13718;Pharmaceutical Engineering;journal;02738139;0.375;Q2;16;82;240;329;52;187;0.16;4.01;United States;Northern America;Int. Society for Pharmaceutical Engineering, Inc.;1996-2018;Pharmaceutical Science (Q2)
428;11500153306;Recent Patents on Drug Delivery and Formulation;journal;22124039, 18722113;0.373;Q2;36;23;70;1273;98;67;1.14;55.35;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2007-2020;"Pharmaceutical Science (Q2); Biomedical Engineering (Q3); Medicine (miscellaneous) (Q3)"
429;4700152603;Medicinal Chemistry;journal;15734064, 18756638;0.372;Q3;46;80;270;4278;404;261;1.69;53.48;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2005-2021;Drug Discovery (Q3)
430;25223;Toxicology and Industrial Health;journal;07482337, 14770393;0.371;Q3;62;87;473;4128;663;473;1.41;47.45;United Kingdom;Western Europe;SAGE Publications Ltd;1985-2021;"Health, Toxicology and Mutagenesis (Q3); Public Health, Environmental and Occupational Health (Q3); Toxicology (Q3)"
431;19700180522;Molecular and Cellular Toxicology;journal;20928467, 1738642X;0.369;Q2;23;50;149;2270;224;149;1.65;45.4;Germany;Western Europe;Springer Verlag;2010-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Health, Toxicology and Mutagenesis (Q3); Pathology and Forensic Medicine (Q3); Public Health, Environmental and Occupational Health (Q3); Toxicology (Q3)"
432;11400153330;Recent Patents on Endocrine, Metabolic and Immune Drug Discovery;journal;18722148, 22123334;0.369;Q3;25;8;58;478;79;54;1.09;59.75;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2008-2017;"Biochemistry (medical) (Q3); Drug Discovery (Q3); Endocrinology, Diabetes and Metabolism (Q3); Immunology and Allergy (Q3); Medicine (miscellaneous) (Q3)"
433;21100218529;Value in Health Regional Issues;journal;22121099, 22121102;0.366;Q2;21;54;172;1481;133;156;0.71;27.43;United States;Northern America;Elsevier USA;2012-2021;"Economics, Econometrics and Finance (miscellaneous) (Q2); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Health Policy (Q3)"
434;22769;Chemical and Pharmaceutical Bulletin;journal;00092363, 13475223;0.364;Q3;95;170;582;5761;791;580;1.34;33.89;Japan;Asiatic Region;Pharmaceutical Society of Japan;1958-2021;"Chemistry (miscellaneous) (Q2); Drug Discovery (Q3); Medicine (miscellaneous) (Q3)"
435;19398;Acta Pharmaceutica;journal;18469558, 13300075;0.362;Q2;60;40;124;1054;191;124;1.26;26.35;Croatia;Eastern Europe;Croatian Pharmaceutical Society;1986, 1992-2022;"Pharmaceutical Science (Q2); Medicine (miscellaneous) (Q3); Pharmacology (Q3)"
436;79053;Natural Product Sciences;journal;12263907;0.361;Q3;28;50;151;1253;139;150;0.92;25.06;South Korea;Asiatic Region;Korean Society of Pharmacognosy;1997-2021;"Drug Discovery (Q3); Organic Chemistry (Q3)"
437;24074;Helvetica Chimica Acta;journal;0018019X, 15222675;0.359;Q3;85;47;488;2976;568;486;1.14;63.32;United States;Northern America;Wiley-Blackwell;1918-2021;"Drug Discovery (Q3); Inorganic Chemistry (Q3); Organic Chemistry (Q3); Physical and Theoretical Chemistry (Q3); Biochemistry (Q4); Catalysis (Q4)"
438;4000148204;Pakistan Journal of Pharmaceutical Sciences;journal;1011601X;0.358;Q2;42;351;982;6767;941;982;0.88;19.28;Pakistan;Asiatic Region;Pakistan Journal of Pharmaceutical Sciences;1995, 2005-2021;Pharmaceutical Science (Q2)
439;21100318814;Pharmaceutical patent analyst;journal;20468954, 20468962;0.358;Q2;17;30;130;0;103;102;0.78;0;United Kingdom;Western Europe;Future Science;2012-2018, 2021;"Pharmaceutical Science (Q2); Drug Discovery (Q3); Medicine (miscellaneous) (Q3)"
440;21256;Drugs of Today;journal;00257656, 16993993, 16994019;0.357;Q3;53;53;186;1518;225;181;1.45;28.64;Spain;Western Europe;Prous Science;1968, 1978-2021;"Medicine (miscellaneous) (Q3); Pharmacology (Q3); Pharmacology (medical) (Q3)"
441;21100366771;Journal of Applied Research on Medicinal and Aromatic Plants;journal;22147861;0.355;Q3;24;60;80;2284;152;79;2.13;38.07;Germany;Western Europe;Elsevier GmbH;2014-2021;"Drug Discovery (Q3); Plant Science (Q3)"
442;25864;Heterocycles;journal;03855414;0.354;Q3;66;240;712;9028;706;712;1.01;37.62;Japan;Asiatic Region;Japan Institute of Heterocyclic Chemistry;1983-2021;"Analytical Chemistry (Q3); Organic Chemistry (Q3); Pharmacology (Q3)"
443;21100241608;Journal of Nanomedicine and Nanotechnology (discontinued);journal;21577439;0.351;Q2;24;0;18;0;35;18;0;0;United States;Northern America;OMICS Publishing Group;2010-2014;"Pharmaceutical Science (Q2); Bioengineering (Q3); Biomedical Engineering (Q3); Medicine (miscellaneous) (Q3)"
444;17700155034;Natural Product Communications;journal;15559475, 1934578X;0.351;Q3;50;470;1459;12848;1288;1421;0.83;27.34;United States;Northern America;SAGE Publications Inc.;2006-2022;"Complementary and Alternative Medicine (Q2); Drug Discovery (Q3); Medicine (miscellaneous) (Q3); Pharmacology (Q3); Plant Science (Q3)"
445;21100804457;Current Opinion in Toxicology;journal;24682020;0.349;Q4;27;67;18;3631;32;16;1.78;54.19;Netherlands;Western Europe;Elsevier BV;2016-2021;Toxicology (Q4)
446;5800173386;Current Drug Safety;journal;15748863;0.348;Q3;37;32;134;959;141;123;1.09;29.97;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Pharmacology (Q3); Pharmacology (medical) (Q3); Toxicology (Q4)"
447;130045;Journal of Applied Biomedicine;journal;12140287, 1214021X;0.348;Q2;33;39;105;1897;205;103;1.94;48.64;Spain;Western Europe;Elsevier Espana;2005-2021;"Agricultural and Biological Sciences (miscellaneous) (Q2); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q3); Medicine (miscellaneous) (Q3); Neuroscience (miscellaneous) (Q3)"
448;4500151530;Personalized Medicine;journal;17410541;0.348;Q3;33;59;207;2366;189;180;0.77;40.1;United Kingdom;Western Europe;Future Medicine Ltd.;2006-2021;"Medicine (miscellaneous) (Q3); Pharmacology (Q3); Molecular Medicine (Q4)"
449;23453;Combinatorial Chemistry and High Throughput Screening;journal;13862073, 18755402;0.346;Q3;66;95;288;4560;303;253;1.09;48;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;1998-2021;"Computer Science Applications (Q3); Drug Discovery (Q3); Medicine (miscellaneous) (Q3); Organic Chemistry (Q3)"
450;22980;Journal of Basic and Clinical Physiology and Pharmacology;journal;21910286, 07926855;0.342;Q3;36;72;207;3022;271;205;1.44;41.97;Germany;Western Europe;Walter de Gruyter GmbH;1985-1988, 1990-2021;"Drug Discovery (Q3); Medicine (miscellaneous) (Q3); Pharmacology (Q3); Physiology (Q4)"
451;24605;Arhiv za Higijenu Rada i Toksikologiju;journal;18486312, 00041254;0.341;Q4;37;39;127;1734;167;117;1.16;44.46;Croatia;Eastern Europe;Institute for Medical Research and Occupational Health;1953-2021;"Public Health, Environmental and Occupational Health (Q3); Toxicology (Q4)"
452;21328;European Journal of Drug Metabolism and Pharmacokinetics;journal;21070180, 03787966;0.338;Q3;39;97;180;3541;231;179;1.33;36.51;France;Western Europe;Springer Paris;1976-2021;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
453;19700201141;Journal of Ayurveda and Integrative Medicine;journal;09759476, 09762809;0.338;Q3;29;51;143;1362;132;113;0.96;26.71;Netherlands;Western Europe;Wolters Kluwer Medknow Publications;2010-2021;"Complementary and Alternative Medicine (Q2); Drug Discovery (Q3)"
454;19700201144;Journal of Pharmacy and Bioallied Sciences;journal;09764879, 09757406;0.338;Q2;42;105;462;2429;533;442;0.93;23.13;India;Asiatic Region;Wolters Kluwer Medknow Publications;2011-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q3); Bioengineering (Q3)"
455;4400151415;Cardiovascular and Hematological Agents in Medicinal Chemistry;journal;18715257;0.336;Q3;40;8;79;502;68;67;0.81;62.75;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Cardiology and Cardiovascular Medicine (Q3); Hematology (Q3); Medicine (miscellaneous) (Q3); Pharmacology (Q3)"
456;21100470510;Drug Research;journal;21949379, 21949387;0.334;Q3;65;115;371;3605;388;361;1.02;31.35;Germany;Western Europe;Thieme;1972, 2013-2021;"Drug Discovery (Q3); Medicine (miscellaneous) (Q3)"
457;145580;International Journal of Peptide Research and Therapeutics;journal;15733149, 15733904;0.333;Q3;38;50;168;2000;195;167;1.2;40;Netherlands;Western Europe;Springer Netherlands;1996-2002, 2005-2021;"Analytical Chemistry (Q3); Bioengineering (Q3); Drug Discovery (Q3); Biochemistry (Q4); Molecular Medicine (Q4)"
458;19888;Medical Letter on Drugs and Therapeutics;journal;0025732X, 15232859;0.328;Q3;20;110;364;1040;149;161;0.43;9.45;United States;Northern America;Medical Letter Inc.;1965-2021;"Medicine (miscellaneous) (Q3); Pharmacology (Q3); Pharmacology (medical) (Q3)"
459;19700200860;International Journal of Current Pharmaceutical Review and Research (discontinued);journal;0976822X;0.325;Q2;14;2;169;72;60;169;0.35;36;India;Asiatic Region;Publishers, In-IJCPR;2010-2017;Pharmaceutical Science (Q2)
460;23412;Journal of AOAC International;journal;10603271;0.324;Q3;90;257;667;5389;698;652;1.03;20.97;United States;Northern America;AOAC International;1993-2021;"Agronomy and Crop Science (Q3); Analytical Chemistry (Q3); Food Science (Q3); Pharmacology (Q3); Environmental Chemistry (Q4)"
461;144879;Toxicology International;journal;09716580;0.324;Q4;28;33;188;735;124;181;0.27;22.27;India;Asiatic Region;Society of Toxicology India;2005-2021;"Health, Toxicology and Mutagenesis (Q4); Toxicology (Q4)"
462;4600151527;Infectious Disorders - Drug Targets;journal;18715265;0.323;Q3;55;28;88;886;81;76;0.93;31.64;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Medicine (miscellaneous) (Q3); Microbiology (medical) (Q3); Pharmacology (Q3); Molecular Medicine (Q4)"
463;18800156720;Dissolution Technologies;journal;1521298X;0.321;Q2;34;27;88;620;57;68;0.41;22.96;United States;Northern America;Dissolution Technologies Inc;1996-2021;Pharmaceutical Science (Q2)
464;21100815317;Journal of Pharmacopuncture;journal;20936966, 22346856;0.321;Q3;18;34;38;1267;37;38;0.97;37.26;South Korea;Asiatic Region;Korean Pharmacopuncture Institute;2016-2021;"Complementary and Alternative Medicine (Q2); Pharmacology (Q3)"
465;11200153563;Drug Metabolism Letters;journal;18740758, 18723128;0.314;Q2;28;19;72;820;60;65;0.78;43.16;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2007-2019, 2021;"Pharmaceutical Science (Q2); Biochemistry (medical) (Q3); Clinical Biochemistry (Q3); Pharmacology (medical) (Q3)"
466;11400153335;Recent Patents on Inflammation and Allergy Drug Discovery;journal;1872213X, 22122710;0.314;Q3;29;13;61;1038;77;57;1.24;79.85;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2007-2020;"Drug Discovery (Q3); Medicine (miscellaneous) (Q3); Immunology and Allergy (Q4)"
467;21100788832;International Journal of Medicinal Chemistry;journal;20902069, 20902077;0.31;Q3;4;0;6;0;7;6;0.75;0;United States;Northern America;Hindawi Publishing Corporation;2014-2016;"Drug Discovery (Q3); Biochemistry (Q4); Molecular Medicine (Q4)"
468;19700201137;Journal of Advanced Pharmaceutical Technology and Research;journal;01105558, 09762094;0.309;Q2;38;31;107;678;131;93;1.15;21.87;India;Asiatic Region;Wolters Kluwer Medknow Publications;2010-2021;Pharmaceutical Science (Q2)
469;19700177128;Journal of Young Pharmacists (discontinued);journal;09751505, 09751483;0.306;Q2;30;139;198;3324;157;187;0.78;23.91;India;Asiatic Region;EManuscript Services;2010-2018, 2021;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2)
470;21810;Farmacia;journal;00148237;0.304;Q2;27;149;399;4114;460;399;1.38;27.61;Romania;Eastern Europe;Romanian Society for Pharmaceutical Sciences;1945-1946, 1973-1987, 2003, 2008-2021;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2)
471;19500157042;Currents in Pharmacy Teaching and Learning;journal;18771297;0.3;Q2;23;164;365;3685;255;353;0.63;22.47;United States;Northern America;Elsevier Inc.;2009-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Pharmacy (Q2)"
472;3900148201;International Journal of Pharmacology (discontinued);journal;18125700, 18117775;0.3;Q3;39;115;266;5928;246;266;0.9;51.55;Pakistan;Asiatic Region;Asian Network for Scientific Information;2006-2018, 2020-2021;Pharmacology (Q3)
473;15240;Iranian Journal of Medical Sciences;journal;17353688, 02530716;0.3;-;31;91;258;2338;268;238;0.91;25.69;Iran;Middle East;Shiraz University of Medical Sciences;1979-1981, 1989-2021;Medicine (miscellaneous) (Q3)
474;26766;ATLA Alternatives to Laboratory Animals;journal;02611929;0.297;Q4;61;33;167;934;149;134;1.12;28.3;United Kingdom;Western Europe;FRAME;1982, 1985-1986, 1988-1989, 1994-2021;"Medical Laboratory Technology (Q2); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q3); Medicine (miscellaneous) (Q3); Toxicology (Q4)"
475;24640;Journal of Liquid Chromatography and Related Technologies;journal;1520572X, 10826076;0.297;Q2;51;120;572;4358;492;569;0.93;36.32;United States;Northern America;Taylor and Francis Ltd.;1996-2021;"Pharmaceutical Science (Q2); Analytical Chemistry (Q3); Clinical Biochemistry (Q3); Biochemistry (Q4)"
476;19700189400;Pharmaceutical Sciences;journal;23832886, 1735403X;0.295;Q2;19;48;112;1585;153;107;1.49;33.02;Iran;Middle East;Tabriz University of Medical Sciences;2009-2021;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2)
477;19405;Acta Poloniae Pharmaceutica;journal;00016837;0.293;Q2;45;207;459;6614;389;458;0.65;31.95;Poland;Eastern Europe;Polish Pharmaceutical Society;1951-1955, 1961-2021;"Pharmaceutical Science (Q2); Pharmacology (Q3)"
478;4700152612;Current Nanoscience;journal;15734137;0.292;Q2;47;75;346;3601;385;322;1.2;48.01;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Pharmaceutical Science (Q2); Bioengineering (Q3); Biomedical Engineering (Q3); Biotechnology (Q3); Medicine (miscellaneous) (Q3); Nanoscience and Nanotechnology (Q3)"
479;21100248874;Dilemas;journal;19835922, 21782792;0.288;-;9;33;99;1136;19;96;0.16;34.42;Brazil;Latin America;Universidade Federal do Rio de Janeiro - UFRJ;2013-2021;"Law (Q2); Sociology and Political Science (Q2)"
480;21100798510;Journal of Intercultural Ethnopharmacology (discontinued);journal;21468397;0.285;Q3;18;57;65;2724;74;62;1.14;47.79;Turkey;Middle East;Ejmanager LLC;2016-2017;"Complementary and Alternative Medicine (Q2); Pharmacology (Q3); Pharmacology (medical) (Q3); Toxicology (Q4)"
481;19700175004;Open Medicinal Chemistry Journal;journal;18741045;0.281;Q2;18;15;11;649;10;11;0.71;43.27;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2009-2020;"Pharmaceutical Science (Q2); Drug Discovery (Q3); Pharmacology (Q3); Molecular Medicine (Q4)"
482;21496;Revista de Chimie (discontinued);journal;00347752;0.28;-;31;599;1268;16279;1478;1268;1.24;27.18;Romania;Eastern Europe;Syscom 18 SRL;1973, 1996-2021;Chemistry (miscellaneous) (Q3)
483;21100285419;Expert Opinion on Orphan Drugs;journal;21678707;0.279;Q2;22;97;383;8193;247;371;0.74;84.46;United Kingdom;Western Europe;Taylor and Francis Ltd.;2013-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Health Policy (Q3); Pharmacology (medical) (Q3)"
484;21100833039;Journal of HerbMed Pharmacology;journal;23455004;0.272;Q3;13;33;63;926;79;63;1.25;28.06;Iran;Middle East;Nickan Research Institute;2015-2021;Drug Discovery (Q3)
485;19700180781;Strategies and Tactics in Organic Synthesis;book series;18746004;0.272;Q3;10;9;36;719;12;0;0.52;79.89;United States;Northern America;Academic Press Inc.;2004-2005, 2008, 2012-2017, 2019;"Drug Discovery (Q3); Organic Chemistry (Q4)"
486;22212;Scientia Pharmaceutica;journal;22180532, 00368709;0.268;Q2;46;37;165;1220;146;164;0.81;32.97;Switzerland;Western Europe;MDPI AG;1949, 1960-1961, 1973-2021;Pharmaceutical Science (Q2)
487;4700152609;Current Computer-Aided Drug Design;journal;15734099;0.259;Q3;31;34;116;1286;100;100;0.75;37.82;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Drug Discovery (Q3); Medicine (miscellaneous) (Q3); Molecular Medicine (Q4)"
488;18800156708;Tropical Journal of Pharmaceutical Research;journal;15965996, 15969827;0.256;Q3;39;374;955;8852;667;955;0.53;23.67;Nigeria;Africa;Pharmacotherapy Group;2009-2021;"Pharmaceutical Science (Q3); Pharmacology (medical) (Q3)"
489;35190;Revista Espanola de Quimioterapia;journal;02143429;0.254;Q3;26;103;217;2244;126;196;0.52;21.79;Spain;Western Europe;Sociedad Espanola de Quiminoterapia;1989-2021;"Medicine (miscellaneous) (Q3); Microbiology (medical) (Q3); Pharmacology (Q3)"
490;21758;Prescrire International;journal;11677422;0.252;Q3;13;58;535;723;105;474;0.17;12.47;France;Western Europe;Association Mieux Prescrire;1996-2021;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
491;19700174961;BioProcess International;trade journal;15426319;0.248;Q3;23;39;374;234;95;371;0.28;6;United States;Northern America;PJB Publications Ltd.;2009-2017;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q3); Drug Discovery (Q3)"
492;130038;Letters in Drug Design and Discovery;journal;15701808;0.247;Q3;35;149;371;5398;361;368;0.88;36.23;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2005-2021;"Drug Discovery (Q3); Pharmaceutical Science (Q3); Molecular Medicine (Q4)"
493;21100236605;Journal of Applied Pharmaceutical Science;journal;22313354;0.244;Q2;41;391;941;13251;696;936;0.69;33.89;India;Asiatic Region;MediPoeia;2011-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Medicine (miscellaneous) (Q3); Pharmacology (medical) (Q3)"
494;19700175099;Topics in Medicinal Chemistry;book series;1862247X, 18622461;0.244;Q3;12;22;75;2886;40;70;0.41;131.18;Germany;Western Europe;Springer Verlag;2009-2012, 2014-2021;"Drug Discovery (Q3); Molecular Medicine (Q4)"
495;4700152608;African Journal of Traditional, Complementary and Alternative Medicines (discontinued);journal;25050044, 01896016;0.242;Q3;48;134;457;284;323;456;0.42;2.12;Nigeria;Africa;African Ethnomedicines Network;2006-2017;"Complementary and Alternative Medicine (Q2); Drug Discovery (Q3); Medicine (miscellaneous) (Q3)"
496;21100853500;Clinical Cancer Drugs;journal;22126988, 2212697X;0.242;Q2;4;0;6;0;8;6;1.33;0;United Arab Emirates;Middle East;Bentham Science Publishers;2015-2016;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Oncology (Q3); Cancer Research (Q4)"
497;21100199816;Jundishapur Journal of Natural Pharmaceutical Products;journal;22287876, 17357780;0.236;Q2;24;63;129;2119;134;124;0.75;33.63;Netherlands;Western Europe;Kowsar Publishing Company;2011-2021;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2)
498;15600154705;EnvironmentAsia;journal;19061714;0.233;Q4;19;33;95;1013;61;95;0.63;30.7;Thailand;Asiatic Region;Thai Society of Higher Eduation Institutes on Environment;2009-2021;"Environmental Science (miscellaneous) (Q3); Toxicology (Q4)"
499;19461;Annales Pharmaceutiques Francaises;journal;00034509;0.232;Q3;27;49;146;1567;101;141;0.82;31.98;France;Western Europe;Elsevier Masson s.r.l.;1945, 1947-2021;"Pharmaceutical Science (Q3); Pharmacology (Q3)"
500;19600161802;International Journal of Computational Biology and Drug Design;journal;17560764, 17560756;0.231;Q3;14;24;68;782;33;66;0.27;32.58;United Kingdom;Western Europe;Inderscience Enterprises Ltd;2008-2021;"Computer Science Applications (Q3); Drug Discovery (Q3)"
501;4700152426;Current Pharmaceutical Analysis;journal;15734129;0.224;Q3;25;70;143;1998;106;134;0.75;28.54;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Pharmaceutical Science (Q3); Biochemistry (Q4); Biophysics (Q4); Molecular Medicine (Q4)"
502;19700174810;International Journal of Pharmacy and Pharmaceutical Sciences (discontinued);journal;09751491;0.224;Q3;49;7;3368;414;2729;3349;0.78;59.14;India;Asiatic Region;IJPPS;2009-2017, 2020-2021;"Pharmaceutical Science (Q3); Pharmacology (Q3)"
503;19700174904;Asian Journal of Pharmaceutical and Clinical Research (discontinued);journal;09742441, 24553891;0.223;Q3;41;1279;1502;34301;774;1499;0.49;26.82;India;Asiatic Region;Asian Journal of Pharmaceutical and Clinical Research;2009-2018, 2020-2021;"Pharmaceutical Science (Q3); Pharmacology (Q3); Pharmacology (medical) (Q3)"
504;19200156945;Boletin Latinoamericano y del Caribe de Plantas Medicinales y Aromaticas;journal;07177917;0.222;Q3;22;41;139;2250;94;139;0.65;54.88;Chile;Latin America;MS-Editions;2008-2021;"Complementary and Alternative Medicine (Q3); Drug Discovery (Q3); Pharmacology (Q3); Plant Science (Q3)"
505;144963;Drug Discovery Today: Disease Models;journal;17406757;0.218;Q3;28;26;80;1421;51;71;0.33;54.65;United Kingdom;Western Europe;Elsevier Ltd.;2004-2020;"Drug Discovery (Q3); Molecular Medicine (Q4)"
506;19400157518;Rasayan Journal of Chemistry;journal;09760083, 09741496;0.218;Q2;24;200;256;5177;181;256;0.82;25.89;India;Asiatic Region;Rasayan Journal;2008-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Chemical Engineering (miscellaneous) (Q3); Chemistry (miscellaneous) (Q3); Energy (miscellaneous) (Q3); Biochemistry (Q4)"
507;21100304895;Archives of Clinical Infectious Diseases;journal;23452641;0.217;Q4;17;54;116;1367;70;105;0.62;25.31;Iran;Middle East;Shahid Beheshti University of Medical Sciences;2012-2021;"Cardiology and Cardiovascular Medicine (Q3); Critical Care and Intensive Care Medicine (Q3); Infectious Diseases (Q4); Public Health, Environmental and Occupational Health (Q4); Toxicology (Q4)"
508;21811;Farmacia Hospitalaria;journal;21718695, 11306343;0.215;Q3;24;93;212;1455;111;163;0.56;15.65;Spain;Western Europe;Grupo Aula Medica S.A.;1990-2021;"Medicine (miscellaneous) (Q3); Pharmacology (Q3)"
509;37697;Autonomic and Autacoid Pharmacology;journal;14748673, 14748665;0.214;Q3;21;8;16;283;17;14;1.21;35.38;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;2002-2017;Pharmacology (Q3)
510;19700182901;Brazilian Journal of Pharmaceutical Sciences;journal;19848250, 21759790;0.214;Q2;43;115;281;4128;205;275;0.53;35.9;Brazil;Latin America;Faculdade de Ciencias Farmaceuticas (Biblioteca-;2009-2020;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2)
511;21100463829;Chinese Journal of Population Resources and Environment;journal;23254262, 10042857;0.212;Q4;14;42;81;1070;52;81;0.64;25.48;United Kingdom;Western Europe;Taylor and Francis Ltd.;1992, 2004-2013, 2015-2019;"Demography (Q3); Environmental Science (miscellaneous) (Q3); Toxicology (Q4)"
512;29845;IARC monographs on the evaluation of carcinogenic risks to humans / World Health Organization, International Agency for Research on Cancer;book series;10171606;0.211;Q4;48;6;29;2272;29;22;0.7;378.67;France;Western Europe;International Agency for Research on Cancer;1988-1997, 1999-2002, 2004, 2006-2008, 2010-2020;"Cancer Research (Q4); Toxicology (Q4)"
513;21100201517;RSC Drug Discovery Series;book series;20413203, 20413211;0.21;Q3;10;52;243;6187;95;127;0.41;118.98;United Kingdom;Western Europe;Royal Society of Chemistry;2010, 2014-2021;Drug Discovery (Q3)
514;22338;Hospital Pharmacy;journal;19451253, 00185787;0.207;Q3;24;125;458;2025;187;407;0.37;16.2;United States;Northern America;Thomas Land Publishers Inc.;1973-2021;"Pharmacy (Q2); Pharmacology (Q3); Pharmacology (medical) (Q3)"
515;21100256959;Biomarkers and Genomic Medicine;journal;22140247;0.206;Q3;12;0;51;0;41;51;1;0;United States;Northern America;Elsevier BV;2013-2015;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q3); Drug Discovery (Q3); Medicine (miscellaneous) (Q3); Biomedical Engineering (Q4)"
516;19700180785;Studies in Natural Products Chemistry;book series;15725995;0.206;Q4;41;45;147;6577;142;27;0.79;146.16;Netherlands;Western Europe;Elsevier;1995-1997, 2000-2003, 2005-2006, 2008, 2012-2021;"Drug Discovery (Q4); Organic Chemistry (Q4)"
517;23440;Indian Journal of Physiology and Pharmacology;journal;00195499;0.205;Q3;53;64;192;1709;94;171;0.38;26.7;India;Asiatic Region;Association of Physiologists and Pharmacologists of India;1959-2021;"Pharmacology (Q3); Physiology (Q4); Physiology (medical) (Q4)"
518;145096;Neuropsychopharmacologia Hungarica;journal;14198711;0.205;Q2;17;22;72;994;24;63;0.29;45.18;Hungary;Eastern Europe;Hungarian Association of Psychopharmacology;2004-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Neurology (clinical) (Q3); Neuropsychology and Physiological Psychology (Q4); Neuroscience (miscellaneous) (Q4)"
519;11900154394;Oriental Journal of Chemistry (discontinued);journal;0970020X, 22315039;0.205;Q4;27;396;984;10871;654;984;0.69;27.45;India;Asiatic Region;Bhopal, S.A. Iqbal;1989, 2008-2018, 2021;"Chemistry (miscellaneous) (Q3); Biochemistry (Q4); Drug Discovery (Q4); Environmental Chemistry (Q4)"
520;19700174658;Regulatory Rapporteur;trade journal;17428955;0.205;Q2;6;65;202;570;19;137;0.11;8.77;United Kingdom;Western Europe;TOPRA;2010-2020;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Pharmacy (Q2)"
521;21100853513;Pharmaceutical Nanotechnology;journal;22117385, 22117393;0.202;Q3;13;15;11;843;5;11;0.33;56.2;Netherlands;Western Europe;Bentham Science Publishers B.V.;2014-2021;"Pharmaceutical Science (Q3); Biomedical Engineering (Q4)"
522;29953;Journal of Experimental Therapeutics and Oncology;journal;13594117, 1533869X;0.201;Q3;38;25;65;566;35;65;0.44;22.64;United States;Northern America;Old City Publishing;1996, 2002-2020;"Pharmacology (Q3); Cancer Research (Q4); Drug Discovery (Q4)"
523;21100426011;Nano LIFE;journal;17939844;0.201;Q3;1;0;1;0;0;1;0;0;Singapore;Asiatic Region;;;"Medicine (miscellaneous) (Q3); Pharmaceutical Science (Q3); Bioengineering (Q4); Biomedical Engineering (Q4)"
524;19700174978;American Journal of Pharmacy Benefits;journal;21642494, 19454481;0.2;Q2;15;26;139;446;37;115;0.28;17.15;United States;Northern America;Managed Care and Healthcare Communications;2010-2018;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Business and International Management (Q3); Decision Sciences (miscellaneous) (Q4)"
525;21100440523;Interaction Design and Architecture(s);journal;18269745, 22832998;0.199;Q3;14;46;119;1703;99;110;0.7;37.02;Italy;Western Europe;ASLERD;2012-2021;"Architecture (Q2); Media Technology (Q2); Human-Computer Interaction (Q3); Pharmacology (Q3); Social Sciences (miscellaneous) (Q3); Computer Science Applications (Q4)"
526;16698;Revista Brasileira de Plantas Medicinais;journal;1983084X, 15160572;0.199;Q3;29;0;362;0;199;350;0.4;0;Brazil;Latin America;Instituto de Biociencias;1999-2016;"Complementary and Alternative Medicine (Q3); Pharmacology (Q3)"
527;21100853564;AAPS Advances in the Pharmaceutical Sciences Series;book series;22107371, 2210738X;0.198;Q3;13;34;321;1862;95;264;0.22;54.76;Germany;Western Europe;Springer Verlag;2011, 2014-2021;Pharmaceutical Science (Q3)
528;20564;Ceska a Slovenska Farmacie;journal;12107816;0.197;Q3;17;31;94;1205;41;91;0.55;38.87;Czech Republic;Eastern Europe;Czech Medical Association J.E. Purkyne;1994-2021;Pharmaceutical Science (Q3)
529;4700152607;Current Enzyme Inhibition;journal;15734080;0.197;Q4;18;21;56;1234;36;50;0.65;58.76;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Biochemistry (Q4); Drug Discovery (Q4); Molecular Medicine (Q4)"
530;21086;Pharmaceutical Chemistry Journal;journal;15739031, 0091150X;0.197;Q3;34;196;498;3979;221;498;0.4;20.3;United States;Northern America;Springer New York;1967-2021;"Pharmacology (Q3); Drug Discovery (Q4)"
531;110097;Food and Drug Law Journal;journal;1064590X;0.194;Q3;22;24;75;1738;41;73;0.52;72.42;United States;Northern America;Food and Drug Law Institute;1992-2018, 2021;"Law (Q3); Medicine (miscellaneous) (Q3); Pharmacology (Q3); Public Health, Environmental and Occupational Health (Q4)"
532;5700165173;Journal of Medical Marketing;journal;17457912, 17457904;0.194;Q3;19;3;41;83;13;31;0;27.67;United States;Northern America;SAGE Publications Inc.;2000-2015, 2017-2018;"Marketing (Q3); Medicine (miscellaneous) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Strategy and Management (Q3)"
533;21100455613;International Conference on Environmental Pollution and Public Health, EPPH 2015;conference and proceedings;-;0.193;-;5;0;15;0;11;14;0.73;0;China;Asiatic Region;;;Software
534;19800188074;Medicinal Plants - International Journal of Phytomedicines and Related Industries;journal;09754261, 09756892;0.193;Q4;10;48;133;1119;24;129;0.24;23.31;Netherlands;Western Europe;IOS Press BV;2010-2021;"Drug Discovery (Q4); Organic Chemistry (Q4); Plant Science (Q4)"
535;25425;Journal of Herbs, Spices and Medicinal Plants;journal;15403580, 10496475;0.192;Q3;29;32;99;1142;59;99;0.63;35.69;United States;Northern America;Taylor and Francis Ltd.;1992-2021;"Complementary and Alternative Medicine (Q3); Pharmacology (Q3)"
536;19700175785;Open Access Journal of Clinical Trials;journal;11791519;0.192;Q3;12;8;19;278;14;19;0.83;34.75;New Zealand;Pacific Region;Dove Medical Press Ltd.;2009-2021;"Pharmacology (medical) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)"
537;21100788744;OpenNano;journal;23529520;0.192;Q3;14;8;4;408;2;4;0.5;51;United States;Northern America;Elsevier Inc.;2016-2019;"Internal Medicine (Q3); Pharmaceutical Science (Q3); Pharmacology (medical) (Q3); Biotechnology (Q4)"
538;21715;Pharmazeutische Industrie;journal;16167074, 0031711X;0.192;Q3;19;272;815;1470;43;780;0.06;5.4;Germany;Western Europe;Editio Cantor Verlag GmbH;1960-1961, 1973-2019;Pharmaceutical Science (Q3)
539;21100218041;Anti-Infective Agents;journal;22113533, 22113525;0.191;Q3;24;18;63;626;41;56;0.55;34.78;United Arab Emirates;Middle East;Bentham Science Publishers;2012-2021;"Pharmacology (Q3); Infectious Diseases (Q4)"
540;19408;Actualites Pharmaceutiques;journal;05153700;0.19;Q4;5;178;512;1195;19;404;0.04;6.71;Netherlands;Western Europe;Elsevier;1961, 1963, 1996-2021;"Pharmacology (medical) (Q3); Pharmacology (Q4)"
541;4600151507;Anti-Inflammatory and Anti-Allergy Agents in Medicinal Chemistry;journal;18715230;0.189;Q4;24;15;72;675;50;65;0.48;45;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Medicine (miscellaneous) (Q3); Immunology (Q4); Immunology and Allergy (Q4); Pharmacology (Q4)"
542;19700201423;Journal of Pharmaceutical Health Services Research;journal;17598885, 17598893;0.189;Q3;16;39;103;1108;39;92;0.45;28.41;United Kingdom;Western Europe;Oxford University Press;2010-2021;"Economics, Econometrics and Finance (miscellaneous) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)"
543;19400157142;Chiang Mai University Journal of Natural Sciences;journal;16851994;0.188;-;12;25;115;647;43;115;0.31;25.88;Thailand;Asiatic Region;Chiang Mai University;2003, 2006, 2009-2021;Multidisciplinary (Q3)
544;58808;Pharmaceutical Care and Research;journal;16712838;0.188;Q3;8;137;434;1609;29;431;0.08;11.74;China;Asiatic Region;Publishing House of Pharmaceutical Care and Research;2004-2021;"Pharmaceutical Science (Q3); Drug Discovery (Q4); Pharmacology (Q4)"
545;21100226424;Toxicology and Environmental Health Sciences;journal;20059752, 22337784;0.188;Q4;17;42;112;1754;62;112;0.55;41.76;South Korea;Asiatic Region;Korean Society of Environmental Risk Assessment and Health Science;2009-2021;"Health, Toxicology and Mutagenesis (Q4); Toxicology (Q4)"
546;19700189100;Pharmaceutical Medicine;journal;11782595, 11791993;0.187;Q4;19;34;75;1474;44;63;0.52;43.35;United Kingdom;Western Europe;Adis International Ltd;2000-2001, 2008-2021;"Pharmacology (medical) (Q3); Pharmacology (Q4)"
547;17700156303;Neuromethods;book series;19406045, 08932336;0.185;Q3;21;170;653;9450;176;398;0.25;55.59;United States;Northern America;Humana Press;2009-2022;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Neuroscience (miscellaneous) (Q4); Psychiatry and Mental Health (Q4)"
548;21100376682;Toxicologie Analytique et Clinique;journal;23520078;0.185;Q4;9;52;122;1906;41;106;0.34;36.65;France;Western Europe;Elsevier Masson s.r.l.;2014-2021;"Health, Toxicology and Mutagenesis (Q4); Toxicology (Q4)"
549;5800173401;Current Bioactive Compounds;journal;15734072;0.183;Q3;27;39;113;1610;70;101;0.62;41.28;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2007-2021;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)
550;19700174893;Dhaka University Journal of Pharmaceutical Sciences (discontinued);journal;18161839, 18161820;0.183;Q3;13;30;97;892;38;94;0.38;29.73;Bangladesh;Asiatic Region;University of Dhaka;2007-2018, 2020;"Pharmaceutical Science (Q3); Pharmacology (medical) (Q3)"
551;19600162009;Advances in Molecular Toxicology;book series;18720854, 22122044;0.182;Q4;15;7;24;1294;12;0;0.29;184.86;Netherlands;Western Europe;Elsevier;2006, 2008-2018, 2020;"Health, Toxicology and Mutagenesis (Q4); Pharmacology (Q4); Toxicology (Q4)"
552;21100228007;Archives of Razi Institute;journal;20089872, 03653439;0.182;Q4;10;32;93;775;29;93;0.34;24.22;Iran;Middle East;Razi Vaccine and Serum Research Institute;2012-2021;"Veterinary (miscellaneous) (Q3); Immunology and Microbiology (miscellaneous)  (Q4); Toxicology (Q4)"
553;22881;Yaoxue Xuebao;journal;05134870;0.182;Q3;34;260;785;7946;383;785;0.52;30.56;China;Asiatic Region;Chinese Pharmaceutical Association;1960, 1962-1966, 1979-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Molecular Medicine (Q4)"
554;21100208082;VacciMonitor;journal;10250298, 1025028X;0.177;Q4;5;13;33;236;14;31;0.14;18.15;Cuba;Latin America;Instituto Finlay, Centro de Investigacion-Produccion de Vacunas y Sueros;2012-2021;"Drug Discovery (Q4); Immunology (Q4); Immunology and Allergy (Q4); Molecular Medicine (Q4)"
555;19700175096;Pharmacognosy Journal;journal;09753575;0.176;Q4;25;135;259;4189;124;256;0.67;31.03;India;Asiatic Region;EManuscript Technologies;2009-2021;"Drug Discovery (Q4); Pharmacology (Q4)"
556;20065;BioPharm International;trade journal;1542166X, 19391862;0.172;Q3;29;136;369;794;69;216;0.21;5.84;United States;Northern America;Advanstar Communications Inc.;2002-2020;"Pharmaceutical Science (Q3); Biotechnology (Q4)"
557;19700174609;Clinical Medicine Insights: Therapeutics;journal;1179559X;0.172;Q3;10;24;21;1253;8;21;0.41;52.21;New Zealand;Pacific Region;Libertas Academica Ltd.;2010-2018;"Medicine (miscellaneous) (Q3); Pharmaceutical Science (Q3); Pharmacology (Q4)"
558;19700181241;Physiology and Pharmacology;journal;17350581;0.172;Q4;12;38;123;1831;57;122;0.51;48.18;Iran;Middle East;Neuroscience Research Center;2009-2021;"Pharmacology (Q4); Physiology (Q4)"
559;19700188326;American Journal of Drug Discovery and Development (discontinued);journal;2150427X, 21504296;0.171;Q4;12;0;25;0;18;25;0.33;0;United States;Northern America;Academic Journals Inc.;2011-2015;Drug Discovery (Q4)
560;5400152620;American Journal of Pharmacology and Toxicology (discontinued);journal;15574970, 15574962;0.17;Q3;21;0;34;0;20;31;0.38;0;United States;Northern America;Science Publications;2007-2016;"Pharmacology (medical) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)"
561;21100201958;Journal of Chinese Pharmaceutical Sciences;journal;10031057;0.168;Q3;13;99;327;2743;98;320;0.27;27.71;China;Asiatic Region;Editorial Office of Journal of Chinese Pharmaceutical Sciences;2011-2021;Pharmaceutical Science (Q3)
562;21211;Pharmacy Education;journal;14772701, 15602214;0.168;Q3;18;34;98;841;29;98;0.26;24.74;Netherlands;Western Europe;;1973-1978, 2002-2021;"Pharmaceutical Science (Q3); Pharmacy (Q3); Education (Q4)"
563;19446;American Pharmaceutical Review;journal;10998012;0.167;Q3;24;93;265;1322;52;241;0.15;14.22;United States;Northern America;Russell Publishing LLC;2002-2020;Pharmaceutical Science (Q3)
564;4600151506;Immunology, Endocrine and Metabolic Agents in Medicinal Chemistry;journal;18715222;0.167;Q4;14;15;62;690;16;53;0.16;46;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2018;"Endocrinology, Diabetes and Metabolism (Q4); Immunology and Allergy (Q4); Pharmacology (Q4)"
565;21100301603;National Journal of Physiology, Pharmacy and Pharmacology (discontinued);journal;23204672, 22313206;0.166;Q3;13;278;283;6167;93;277;0.35;22.18;India;Asiatic Region;Mrs Dipika Charan for MedScience Publishers;2011-2017;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Physiology (Q4)"
566;22937;Zhongguo Zhongyao Zazhi;journal;10015302;0.165;Q3;32;764;2527;3822;771;2527;0.25;5;China;Asiatic Region;Zhongguo Zhongyi Yanjiuyuan;1989-2021;"Complementary and Alternative Medicine (Q3); Pharmacology (medical) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)"
567;19200156925;Cancer Therapy;journal;15439143, 15439135;0.164;Q4;8;0;4;0;5;4;0;0;United States;Northern America;Gene Therapy Press;2009-2014;"Cancer Research (Q4); Oncology (Q4); Pharmacology (Q4)"
568;17700155411;Research Journal of Environmental Toxicology (discontinued);journal;18193420;0.164;Q4;18;0;66;0;39;66;0.56;0;United States;Northern America;Academic Journals Inc.;2009-2016;"Health, Toxicology and Mutagenesis (Q4); Pollution (Q4); Toxicology (Q4)"
569;19700173109;Contract Pharma;trade journal;15443469, 23806559;0.163;Q3;4;102;363;150;15;355;0.05;1.47;United States;Northern America;Contract Pharma;2009-2018;"Industrial Relations (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)"
570;5800179590;Pharmacologyonline (discontinued);journal;18278620;0.163;Q4;27;57;220;2079;62;218;0.22;36.47;Italy;Western Europe;SILAE - Societa Italo-Latinoamericana di Etnomedicina;2007-2021;"Drug Discovery (Q4); Pharmacology (Q4)"
571;21412;Zeitschrift fur Phytotherapie : offizielles Organ der Ges. f. Phytotherapie e.V;journal;0722348X;0.163;Q4;13;53;161;658;13;113;0.06;12.42;Germany;Western Europe;Hippokrates Verlag GmbH;1982, 1985-2021;"Complementary and Alternative Medicine (Q3); Pharmacology (Q4)"
572;24111;Indian Journal of Chemistry - Section B Organic and Medicinal Chemistry;journal;03764699, 09750983;0.162;Q3;48;6;310;167;132;309;0.44;27.83;India;Asiatic Region;Scientific Publishers of India;1970, 1973-1978, 1981, 1989-1991, 1996-2018, 2020-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Organic Chemistry (Q4)"
573;19200156909;Indian Journal of Pharmaceutical Education and Research;journal;00195464;0.162;Q3;22;196;223;4842;101;220;0.43;24.7;India;Asiatic Region;Association of Pharmaceutical Teachers of India;2008-2021;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)
574;5800173394;Current Drug Therapy;journal;15748855;0.161;Q3;17;16;63;556;30;56;0.68;34.75;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2007-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Pharmacology (medical) (Q4)"
575;21100195303;Eurasian Journal of Analytical Chemistry (discontinued);journal;13063057;0.16;Q3;16;153;47;4616;19;47;0.47;30.17;Turkey;Middle East;Moment Publications;2010-2018, 2020;"Pharmaceutical Science (Q3); Analytical Chemistry (Q4); Electrochemistry (Q4); Spectroscopy (Q4)"
576;19700174971;Indian Journal of Forensic Medicine and Toxicology (discontinued);journal;09739122, 09739130;0.16;Q4;12;116;323;1816;17;323;0.05;15.66;India;Asiatic Region;Institute of Medico-legal Publications;2008-2021;"Law (Q3); Health, Toxicology and Mutagenesis (Q4); Pathology and Forensic Medicine (Q4); Toxicology (Q4)"
577;21100399725;Journal of Reports in Pharmaceutical Sciences;journal;23225106, 23221232;0.16;Q3;9;19;57;583;26;57;0.4;30.68;Iran;Middle East;Wolters Kluwer Medknow Publications;2012-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Biomedical Engineering (Q4); Pharmacology (medical) (Q4)"
578;22908;Chinese Pharmacological Bulletin;journal;10011978;0.158;Q4;17;344;1090;6250;464;1089;0.5;18.17;China;Asiatic Region;Institute of Clinical Pharmacology;1993-2020;Pharmacology (Q4)
579;19900191564;Journal of International Peacekeeping;journal;18754104, 18754112;0.158;Q4;10;10;51;682;7;49;0.09;68.2;Netherlands;Western Europe;Brill Academic Publishers;1995, 1997, 2001, 2004-2006, 2008-2011, 2013-2021;"Infectious Diseases (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4); Virology (Q4)"
580;21100456601;Journal of Pharmacy and Pharmacognosy Research;journal;07194250;0.158;Q3;10;37;66;1126;34;65;0.3;30.43;Chile;Latin America;Asociacion Academica de Ciencias Farmaceuticas de Antofagasta (ASOCIFA);2013-2021;"Pharmaceutical Science (Q3); Drug Discovery (Q4); Pharmacology (Q4)"
581;19700181240;Global Journal of Pharmacology (discontinued);journal;19920075;0.157;Q3;18;0;26;0;24;26;0;0;Pakistan;Asiatic Region;International Digital Organization for Scientific Information;2010-2014;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)
582;19700175758;International Journal of Drug Development and Research (discontinued);journal;09759344;0.157;Q3;24;0;124;0;51;124;0.14;0;India;Asiatic Region;International Journal of Drug Development and Research;2010-2015;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)
583;21100789875;Proceedings of the 3rd ACM Conference on Systems for Energy-Efficient Built Environments, BuildSys 2016;conference and proceedings;-;0.157;-;13;0;51;0;74;49;1.45;0;United States;Northern America;;;"Health, Toxicology and Mutagenesis; Toxicology"
584;19700183012;Iranian Journal of Pharmaceutical Sciences;journal;17352444;0.156;Q3;13;16;71;566;25;71;0.28;35.38;Iran;Middle East;Iranian Association of Pharmaceutical Scientists;2010-2014, 2016-2021;"Pharmaceutical Science (Q3); Bioengineering (Q4)"
585;21100265336;International Arabic Journal of Antimicrobial Agents (discontinued);journal;21749094;0.155;Q4;8;0;14;0;7;14;1;0;Spain;Western Europe;Internet Medical Publishing;2011-2015;"Microbiology (medical) (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4)"
586;19700188422;Research Journal of Pharmaceutical, Biological and Chemical Sciences (discontinued);journal;09758585;0.155;Q3;31;1;5073;13;926;5073;0.18;13;India;Asiatic Region;RJPBCS;2010-2017, 2020-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q4)"
587;21100795043;Journal of Natural Remedies;journal;23203358, 09725547;0.154;Q4;22;18;60;632;30;60;0.36;35.11;India;Asiatic Region;Informatics Publishing Limited;2002-2021;Pharmacology (Q4)
588;22854;Yakugaku Zasshi;journal;13475231, 00316903;0.154;Q3;43;202;594;3879;155;491;0.27;19.2;Japan;Asiatic Region;Pharmaceutical Society of Japan;1961-2021;"Pharmaceutical Science (Q3); Pharmacology (Q4)"
589;19700174933;Journal of Pharmaceutical Sciences and Research (discontinued);journal;09751459;0.153;Q3;30;534;637;13173;212;632;0.28;24.67;India;Asiatic Region;;2009-2018, 2020-2021;Pharmaceutical Science (Q3)
590;19381;Acta Farmaceutica Bonaerense;journal;03262383;0.152;Q3;0;0;0;0;0;0;0;0;Argentina;Latin America;Colegio de Farmaceuticos de la Provincia de Buenos Aires;1989-2006;"Pharmaceutical Science (Q3); Drug Discovery (Q4)"
591;15500154707;International Journal of Biological Chemistry (discontinued);journal;21522561, 1819155X;0.152;Q4;16;0;37;0;21;37;0.6;0;Pakistan;Asiatic Region;Asian Network for Scientific Information;2009-2016;"Biochemistry (Q4); Pharmacology (Q4)"
592;23171;Korean Journal of Pharmacognosy;journal;02533073;0.152;Q3;17;55;151;1204;38;151;0.26;21.89;South Korea;Asiatic Region;Korean Society of Pharmacognosy;1990-2011, 2013-2021;"Pharmaceutical Science (Q3); Drug Discovery (Q4); Pharmacology (Q4)"
593;19700174925;European Pharmaceutical Review;trade journal;13608606;0.151;Q3;8;63;184;334;27;180;0.15;5.3;United Kingdom;Western Europe;Russell Publishing LLC;2009-2019;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Biochemistry (Q4); Biophysics (Q4); Biotechnology (Q4); Molecular Medicine (Q4)"
594;80593;Journal of Medicinal Plants;journal;16840240;0.151;Q4;23;68;162;2657;53;161;0.27;39.07;Iran;Middle East;;2004-2021;"Complementary and Alternative Medicine (Q3); Pharmacology (Q4)"
595;21100216519;Journal of Pharmaceutical Negative Results;journal;09769234, 22297723;0.151;Q3;6;13;34;212;10;32;0.24;16.31;India;Asiatic Region;Wolters Kluwer Medknow Publications;2010-2011, 2013-2021;"Pharmaceutical Science (Q3); Drug Discovery (Q4); Pharmacology (Q4)"
596;21100451405;Natural Products Journal;journal;22103163, 22103155;0.151;Q4;13;39;109;1541;34;102;0.32;39.51;Netherlands;Western Europe;Bentham Science Publishers B.V.;2011-2021;"Complementary and Alternative Medicine (Q3); Drug Discovery (Q4)"
597;19700188319;International Journal of Pharmaceutical Sciences Review and Research (discontinued);journal;0976044X;0.149;Q3;33;0;1866;0;500;1866;0.21;0;India;Asiatic Region;Global Research Online;2010-2016, 2020-2021;Pharmaceutical Science (Q3)
598;19700201333;International Journal of Drug Delivery (discontinued);journal;09750215;0.148;Q3;15;0;49;0;28;49;0.78;0;United States;Northern America;Advanced Research Journals;2011-2015;Pharmaceutical Science (Q3)
599;19700201516;Journal of Chemical and Pharmaceutical Sciences (discontinued);journal;09742115;0.148;Q3;25;0;1588;0;257;1588;0.16;0;India;Asiatic Region;SPB Pharma Society;2010-2016;"Pharmaceutical Science (Q3); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q4); Pharmacology (Q4)"
600;22934;Chinese Pharmaceutical Journal;journal;10012494;0.146;Q3;21;392;1266;7968;250;1266;0.19;20.33;China;Asiatic Region;Chinese Pharmaceutical Association;1993-2021;"Pharmaceutical Science (Q3); Pharmacology (Q4)"
601;130170;Phytotherapie;journal;17652847, 16248597;0.146;Q4;18;77;218;1600;61;192;0.27;20.78;France;Western Europe;Springer Paris;2005-2020;"Complementary and Alternative Medicine (Q4); Pharmacology (Q4)"
602;19700175149;African Journal Biomedical Research;journal;11195096;0.145;Q3;17;47;90;1465;18;90;0.16;31.17;Nigeria;Africa;Ibadan Biomedical Communications Group;2008, 2010-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Medicine (miscellaneous) (Q4)"
603;19700175060;International Journal of PharmTech Research (discontinued);journal;09744304;0.145;Q3;48;0;1109;0;769;1109;0.74;0;India;Asiatic Region;Sphinx Knowledge House;2009-2016;"Pharmaceutical Science (Q3); Pharmacology (Q4)"
604;22977;Journal de Pharmacie de Belgique;journal;00472166;0.145;Q3;12;0;54;0;20;53;0.48;0;Belgium;Western Europe;APB Algemene Pharmaceutische Bond;1946-2015;"Pharmaceutical Science (Q3); Medicine (miscellaneous) (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4)"
605;19700174931;Asian Journal of Pharmaceutics (discontinued);journal;1998409X, 09738398;0.144;Q3;23;122;223;3271;64;222;0.27;26.81;India;Asiatic Region;Wolters Kluwer Medknow Publications;2009-2018, 2020-2021;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)
606;21798;Farmaceutski Glasnik;journal;00148202;0.144;Q3;6;84;220;828;5;179;0.03;9.86;Croatia;Eastern Europe;Hrvatsko Farmaceutsko Drustvo;1950-1951, 1962, 1990-2021;"Pharmaceutical Science (Q3); Pharmacology (Q4)"
607;21100782803;Current Psychopharmacology;journal;22115560, 22115579;0.143;Q4;4;0;20;0;6;19;0.3;0;Netherlands;Western Europe;Bentham Science Publishers B.V.;2012, 2015-2016;"Pharmacology (Q4); Pharmacology (medical) (Q4); Psychiatry and Mental Health (Q4)"
608;19700175137;Trends in Medical Research (discontinued);journal;18193587, 21516065;0.143;Q3;10;0;39;0;12;39;0.2;0;United States;Northern America;Academic Journals Inc.;2008-2016, 2020-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q4); Medicine (miscellaneous) (Q4)"
609;19700174900;International Journal of Green Pharmacy (discontinued);journal;19984103, 09738258;0.142;Q3;26;180;176;5999;56;176;0.21;33.33;India;Asiatic Region;Wolters Kluwer Medknow Publications;2009-2018, 2020-2021;"Pharmaceutical Science (Q3); Pharmacology (Q4)"
610;19700188437;Open Access Journal of Medicinal and Aromatic Plants;journal;09747877;0.142;Q4;7;3;12;76;1;12;0.11;25.33;India;Asiatic Region;Medicinal and Aromatic Plants Association of India;2010-2019;"Complementary and Alternative Medicine (Q4); Drug Discovery (Q4)"
611;21100237602;Journal of Pharmacy and Nutrition Sciences (discontinued);journal;19275951, 22233806;0.141;Q3;12;23;77;761;22;76;0.21;33.09;Canada;Northern America;;2011-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Health (social science) (Q4); Medicine (miscellaneous) (Q4); Nutrition and Dietetics (Q4)"
612;19700201140;Systematic Reviews in Pharmacy (discontinued);journal;09758453, 09762779;0.141;Q3;28;2;30;98;17;30;0.59;49;India;Asiatic Region;EManuscript Technologies;2010-2021;Pharmaceutical Science (Q3)
613;5100152606;Biosciences Biotechnology Research Asia (discontinued);journal;09731245;0.139;Q4;18;0;1110;0;370;1110;0.34;0;India;Asiatic Region;Oriental Scientific Publishing Company;2005-2016;"Agronomy and Crop Science (Q4); Biotechnology (Q4); Drug Discovery (Q4)"
614;19700200724;Der Pharmacia Lettre (discontinued);journal;09755071;0.139;Q3;28;0;1611;0;446;1611;0.27;0;India;Asiatic Region;Scholars Research Library;2011-2016;Pharmaceutical Science (Q3)
615;19900194914;Journal of Punjab Academy of Forensic Medicine and Toxicology;journal;0974083X, 09725687;0.139;Q4;7;37;81;581;8;74;0.11;15.7;India;Asiatic Region;Punjab Academy of Forensic Medicine and Toxicology;2011-2020;"Pathology and Forensic Medicine (Q4); Toxicology (Q4)"
616;19700174997;ONdrugDelivery;trade journal;2049145X, 20491468;0.139;Q3;6;98;230;409;26;142;0.11;4.17;United Kingdom;Western Europe;Frederick Furness Publishing;2009-2020;Pharmaceutical Science (Q3)
617;23107;Journal of Pharmacy Technology;journal;15494810, 87551225;0.138;Q3;13;32;120;711;23;118;0.21;22.22;United States;Northern America;SAGE Publications Inc.;1989-2021;Pharmaceutical Science (Q3)
618;19700175006;Thai Journal of Pharmaceutical Sciences;journal;01254685, 19054637;0.138;Q3;12;27;126;752;29;126;0.19;27.85;Thailand;Asiatic Region;Thai Journal of Pharmaceutical Sciences;2009-2021;"Pharmaceutical Science (Q3); Pharmacology (Q4)"
619;21100242405;Marmara Pharmaceutical Journal;journal;13090801;0.137;Q3;0;0;0;0;0;0;0;0;Turkey;Middle East;Marmara University;2010-2019;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Pharmacology (medical) (Q4)"
620;19700188484;Journal of Bioequivalence and Bioavailability (discontinued);journal;09750851;0.136;Q3;12;0;30;0;9;22;0;0;United States;Northern America;OMICS Publishing Group;2011-2014;Pharmaceutical Science (Q3)
621;19700174632;Journal of Receptor, Ligand and Channel Research;journal;1178699X;0.136;Q4;10;0;15;0;11;15;0.67;0;New Zealand;Pacific Region;Dove Medical Press Ltd.;2010-2016, 2018;"Biochemistry (Q4); Biophysics (Q4); Cell Biology (Q4); Pharmacology (Q4)"
622;19900192173;International Journal of Pharmaceutical and Clinical Research (discontinued);journal;09751556;0.135;Q3;13;0;379;0;148;379;0.4;0;Australia;Pacific Region;International Journal of Pharmaceutical and Clinical Research;2011-2016;"Pharmaceutical Science (Q3); Drug Discovery (Q4); Pharmacology (medical) (Q4)"
623;4000148308;Chinese Traditional and Herbal Drugs;journal;02532670;0.134;Q3;17;787;2016;14434;387;1994;0.17;18.34;China;Asiatic Region;Editorial Office of Chinese Traditional and Herbal Drugs;2006-2021;"Pharmaceutical Science (Q3); Complementary and Alternative Medicine (Q4); Drug Discovery (Q4); Pharmacology (medical) (Q4)"
624;19700174924;Biomedical and Pharmacology Journal;journal;09746242;0.132;Q4;22;266;654;7008;139;654;0.15;26.35;India;Asiatic Region;Oriental Scientific Publishing Company;2009-2021;Pharmacology (Q4)
625;73076;Drug Discovery World;journal;14694344;0.132;Q4;13;27;102;337;25;90;0.17;12.48;United Kingdom;Western Europe;RJ Communications and Media Ltd.;2004-2018;Drug Discovery (Q4)
626;19700175858;Journal of Pharmacognosy and Phytotherapy (discontinued);journal;21412502;0.132;Q4;22;1;51;26;204;51;4.7;26;United States;Northern America;Academic Journals Inc.;2010-2017;Drug Discovery (Q4)
627;21100239829;Current Issues in Pharmacy and Medical Sciences;journal;2084980X;0.131;Q4;10;40;158;1018;35;158;0.25;25.45;Poland;Eastern Europe;Uniwersytet Medyczny w Lublinie;2012-2021;"Biochemistry (Q4); Medicine (miscellaneous) (Q4); Molecular Biology (Q4); Pharmacology (Q4)"
628;4700152283;Revista de Ciencias Farmaceuticas Basica e Aplicada;journal;18084532;0.131;Q3;18;143;137;95;35;137;0.06;0.66;Brazil;Latin America;Universidade Estadual Paulista - UNESP;2005-2021;Pharmaceutical Science (Q3)
629;6400153143;Turkish Journal of Pharmaceutical Sciences;journal;1304530X;0.131;Q3;16;46;112;1826;38;112;0.26;39.7;Turkey;Middle East;Turkish Pharmacists  Association;2006-2021;"Pharmaceutical Science (Q3); Molecular Medicine (Q4)"
630;110141;Sangyo eiseigaku zasshi = Journal of occupational health;journal;13410725;0.13;Q4;14;16;72;0;14;72;0.15;0;Japan;Asiatic Region;Nihon Sangyo Eisei Gakkai;1995-2021;"Medicine (miscellaneous) (Q4); Public Health, Environmental and Occupational Health (Q4); Toxicology (Q4)"
631;9100153105;Current Topics in Pharmacology;journal;09724559;0.129;Q4;6;12;25;476;5;25;0.21;39.67;India;Asiatic Region;Research Trends;2006-2021;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
632;21100804474;European Pharmaceutical Journal;journal;24536725;0.129;Q3;8;15;57;339;16;53;0.24;22.6;Germany;Western Europe;de Gruyter;2016-2021;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)
633;22375;Indian Drugs;journal;0019462X;0.129;Q3;31;118;273;2634;27;273;0.1;22.32;India;Asiatic Region;Indian Drug Manufacturers' Association;1989-2021;"Pharmaceutical Science (Q3); Drug Discovery (Q4); Pharmacology (Q4)"
634;21100244805;Journal of Vaccines and Vaccination (discontinued);journal;21577560;0.129;Q4;12;0;31;0;7;29;0;0;United States;Northern America;OMICS Publishing Group;2010-2014;"Drug Discovery (Q4); Immunology (Q4); Immunology and Allergy (Q4); Virology (Q4)"
635;144613;Journal of Generic Medicines (discontinued);journal;17411343;0.128;Q3;15;30;47;447;6;39;0.11;14.9;United Kingdom;Western Europe;SAGE Publications Inc.;2003-2015, 2017, 2021;Pharmaceutical Science (Q3)
636;25197;Revista de Toxicologia (discontinued);journal;02127113;0.128;Q4;11;32;57;637;14;52;0.23;19.91;Spain;Western Europe;Asociacion Espanola de Toxicologia;1989-2017, 2020;Toxicology (Q4)
637;21265;Drugs of the Future;journal;03778282;0.127;Q4;45;85;308;1715;35;301;0.14;20.18;Spain;Western Europe;Prous Science;1978-2021;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
638;73430;Pharmaceutical Technology;journal;15432521;0.127;Q3;38;239;516;1080;59;312;0.14;4.52;United States;Northern America;Advanstar Communications Inc.;1979-1985, 1987, 1996-2021;"Pharmaceutical Science (Q3); Biophysics (Q4)"
639;5100152903;Revista Cubana de Plantas Medicinales;journal;10284796;0.127;Q4;14;32;133;879;32;129;0.2;27.47;Cuba;Latin America;Editorial Ciencias Medicas;1996-1997, 1999-2002, 2005-2020;"Drug Discovery (Q4); Pharmacology (Q4); Plant Science (Q4)"
640;19700200880;Botulinum Journal;journal;17547326, 17547318;0.126;Q3;6;0;6;0;4;6;0.67;0;Switzerland;Western Europe;Inderscience Publishers;2009-2013, 2016;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Biochemistry (Q4); Cellular and Molecular Neuroscience (Q4)"
641;21100197160;Research Journal of Pharmacy and Technology;journal;09743618, 0974360X;0.126;Q3;47;627;973;14250;140;971;0.16;22.73;India;Asiatic Region;A and V Publication;1997, 2005, 2011-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Pharmacology (medical) (Q4)"
642;21100781409;International Conference on Environmental Pollution and Public Health, EPPH 2016;conference and proceedings;-;0.124;-;2;0;11;0;4;10;0.36;0;China;Asiatic Region;;;"Computer Networks and Communications; Computer Vision and Pattern Recognition; Human-Computer Interaction; Software"
643;21100784631;AIAA Modeling and Simulation Technologies Conference, 2015;conference and proceedings;-;0.123;-;0;0;1;0;0;1;0;0;United States;Northern America;;;"Bioengineering; Drug Discovery"
644;25253;Blutalkohol (discontinued);journal;00065250;0.123;Q4;13;23;100;216;6;85;0.07;9.39;Germany;Western Europe;Steintor-Verlag GmbH;1974-2017, 2020-2021;"Medicine (miscellaneous) (Q4); Toxicology (Q4)"
645;17700156434;Current Pharmacogenomics and Personalized Medicine;journal;18756913, 18756921;0.123;Q4;19;16;56;1195;7;52;0.05;74.69;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2008-2018, 2020;"Genetics (Q4); Genetics (clinical) (Q4); Molecular Biology (Q4); Molecular Medicine (Q4); Pharmacology (Q4)"
646;17300154738;Current Trends in Biotechnology and Pharmacy;journal;22307303, 09738916;0.123;Q4;14;37;123;1250;25;123;0.22;33.78;India;Asiatic Region;Association of Biotechnology and Pharmacy;2009-2021;"Biotechnology (Q4); Drug Discovery (Q4); Pharmaceutical Science (Q4)"
647;20500195212;International Journal of Drug Delivery Technology;journal;09754415;0.123;Q3;10;40;42;1065;12;42;0.23;26.63;India;Asiatic Region;Dr. Yashwant Research Labs Pvt. Ltd.;2011-2012, 2014-2021;Pharmaceutical Science (Q3)
648;21100241763;International Journal of Green Nanotechnology;journal;19430906, 19430892;0.123;Q4;4;0;1;0;0;1;0;0;United Kingdom;Western Europe;Taylor and Francis Ltd.;2011-2014;"Biomedical Engineering (Q4); Chemistry (miscellaneous) (Q4); Electrical and Electronic Engineering (Q4); Materials Science (miscellaneous) (Q4); Medicine (miscellaneous) (Q4); Pharmaceutical Science (Q4)"
649;19700175049;Internet Journal of Toxicology;journal;15593916;0.123;Q4;7;0;1;0;0;1;0;0;United States;Northern America;Internet Scientific Publications, LLC;2009-2011, 2013, 2015;Toxicology (Q4)
650;22906;Journal of China Pharmaceutical University;journal;10005048;0.123;Q4;14;90;365;2254;50;365;0.13;25.04;China;Asiatic Region;China Pharmaceutical University;1989-1991, 2002-2021;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
651;19700175105;Open Drug Delivery Journal;journal;18741266;0.123;Q3;5;0;1;0;0;1;0;0;Netherlands;Western Europe;;;Pharmaceutical Science (Q3)
652;21100205919;Open Drug Discovery Journal;journal;18773818;0.123;Q4;9;0;1;0;0;1;0;0;United Arab Emirates;Middle East;Bentham open;2010, 2014;Drug Discovery (Q4)
653;19700201609;Open Natural Products Journal;journal;18748481;0.123;Q4;3;0;1;0;0;1;0;0;Netherlands;Western Europe;;;"Complementary and Alternative Medicine (Q4); Drug Discovery (Q4)"
654;21100853008;Pharmacie Globale;journal;09768157;0.123;Q3;0;0;1;0;0;1;0;0;India;Asiatic Region;;;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Pharmacology (medical) (Q4)"
655;70864;Anales de la Real Academia Nacional de Farmacia (discontinued);journal;1697428X, 16974271;0.122;Q4;10;50;122;2083;18;109;0.17;41.66;Spain;Western Europe;Real Academia Nacional de Farmacia;1988-2018;"Cell Biology (Q4); Molecular Biology (Q4); Pharmaceutical Science (Q4); Pharmacology (medical) (Q4)"
656;13000154717;Current Topics in Toxicology;journal;09728228;0.122;Q4;7;12;31;449;6;31;0.25;37.42;India;Asiatic Region;Research Trends;2007-2009, 2011-2021;"Health, Toxicology and Mutagenesis (Q4); Toxicology (Q4)"
657;21100293201;International Journal of Research in Ayurveda and Pharmacy (discontinued);journal;22774343, 22293566;0.122;Q4;13;0;149;0;43;149;0.45;0;India;Asiatic Region;Moksha Publishing House;2012-2016;"Drug Discovery (Q4); Pharmaceutical Science (Q4)"
658;19700175098;Klinicka Farmakologie a Farmacie;journal;12127973, 18035353;0.122;Q4;5;29;129;591;9;112;0.06;20.38;Czech Republic;Eastern Europe;SOLEN S.R.O.;2009-2021;"Pharmacy (Q3); Pharmaceutical Science (Q4); Pharmacology (Q4)"
659;21127;Pharmaceutical Technology Europe;journal;01646826;0.122;Q4;18;135;446;595;15;378;0.02;4.41;United States;Northern America;Advanstar Communications Inc.;1998-2020;Pharmaceutical Science (Q4)
660;21279;Eksperimental'naya i Klinicheskaya Farmakologiya;journal;08692092;0.121;Q4;15;101;301;1505;50;301;0.18;14.9;Russian Federation;Eastern Europe;Izdatelstvo Meditsina;1992-2021;"Medicine (miscellaneous) (Q4); Pharmacology (Q4); Toxicology (Q4)"
661;19430;Adverse Drug Reaction Bulletin;journal;21597774, 00446394;0.12;Q4;7;8;17;214;5;17;0.17;26.75;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1970, 1973-2021;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
662;19700182629;Methods in Pharmacology and Toxicology;book series;15572153, 19406053;0.12;Q4;10;13;191;615;46;120;0.24;47.31;United States;Northern America;Humana Press;2008, 2012, 2014-2021;"Molecular Medicine (Q4); Pharmacology (medical) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
663;19700175031;Research Journal of Pharmacology (discontinued);journal;19936019, 18159362;0.12;Q4;9;0;10;0;2;10;0;0;Pakistan;Asiatic Region;Medwell Publishing;2008-2014, 2016;"Pharmacology (medical) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
664;17600155051;Drug Development and Delivery;trade journal;1944818X, 15372898;0.119;Q4;11;69;243;399;14;116;0.06;5.78;United States;Northern America;Drug Delivery Technology;2009-2021;Pharmaceutical Science (Q4)
665;19700201471;International Journal of Pharmacy and Technology (discontinued);journal;0975766X;0.119;Q4;23;0;2271;0;416;2268;0.19;0;India;Asiatic Region;International Journal of Pharmacy and Technology(IJPT);2011-2016;"Biomedical Engineering (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
666;19700201521;Journal of Chemical and Pharmaceutical Research (discontinued);journal;09757384;0.119;Q4;39;0;2372;0;536;2371;0.25;0;India;Asiatic Region;JOCPR;2004, 2011-2016;Pharmaceutical Science (Q4)
667;19700175778;International Journal of Research in Pharmaceutical Sciences (discontinued);journal;09757538;0.117;Q4;21;109;143;2834;19;143;0.1;26;India;Asiatic Region;"JK Welfare &amp; Pharmascope Foundation";2010-2021;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)
668;22514;Japanese Journal of Chemotherapy;journal;13407007;0.117;Q4;12;28;60;785;7;60;0.1;28.04;Japan;Asiatic Region;Japan Society of Chemotherapy;1995-2021;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
669;22858;Japanese Pharmacology and Therapeutics;journal;03863603;0.117;Q4;16;138;323;2185;25;321;0.07;15.83;Japan;Asiatic Region;Life Science Publishing Co. Ltd;1981-2020;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
670;25247;Chinese Journal of Pharmacology and Toxicology;journal;10003002;0.116;Q4;12;143;447;5170;51;394;0.09;36.15;China;Asiatic Region;Chinese Journal of Pharmacology and Toxicology;1986-2020;"Pharmacology (Q4); Toxicology (Q4)"
671;20400195018;International Journal of Pharmacognosy and Phytochemical Research (discontinued);journal;09754873;0.116;Q4;19;0;716;0;318;716;0.5;0;India;Asiatic Region;International Journal of Pharmacognosy and Phytochemical Research;2011-2016, 2020;Drug Discovery (Q4)
672;19700188355;International Journal of Phytomedicine (discontinued);journal;09750185;0.116;Q4;20;0;162;0;22;162;0.13;0;United States;Northern America;Advanced Research Journals;2010-2016;"Complementary and Alternative Medicine (Q4); Drug Discovery (Q4)"
673;78698;Japanese Journal of Clinical Pharmacology and Therapeutics;journal;18828272, 03881601;0.116;Q4;7;35;102;300;4;97;0.06;8.57;Japan;Asiatic Region;Japanese Society of Clinical Pharmacology and Therapeutics;1970-2021;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
674;4700151603;Journal of Pharmacy of Istanbul University;journal;03677524;0.115;Q4;9;0;29;0;8;28;0.28;0;Turkey;Middle East;University of Istanbul;2005, 2007-2008, 2010, 2012, 2015-2016;"Pharmacy (Q3); Pharmaceutical Science (Q4)"
675;19700174940;SA Pharmaceutical Journal;journal;10151362;0.115;Q4;7;76;293;846;24;215;0.09;11.13;South Africa;Africa;Medpharm Publications;2009-2021;Pharmaceutical Science (Q4)
676;21100291830;Selenium in the Environment and Human Health - Proceedings of the 3rd International Conference on Selenium in the Environment and Human Health;conference and proceedings;-;0.115;-;5;0;92;0;10;90;0;0;Netherlands;Western Europe;;;"Health, Toxicology and Mutagenesis; Toxicology"
677;21000195625;Asian Journal of Pharmaceutical Research and Health Care (discontinued);journal;22501444, 22501460;0.114;Q4;6;0;44;0;16;44;0.28;0;India;Asiatic Region;;2011-2016;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)
678;4000148821;International Journal of Pharmaceutical Compounding;journal;10924221;0.114;Q4;11;69;223;0;46;213;0.19;0;United States;Northern America;International Journal of Pharmaceutical Compounding;2006-2021;"Pharmacology (nursing) (Q3); Pharmacy (Q3); Medicine (miscellaneous) (Q4); Pharmaceutical Science (Q4); Pharmacology (medical) (Q4)"
679;5900153315;Pharmacoeconomics - Spanish Research Articles;journal;1695405X;0.114;Q4;6;12;47;367;5;47;0.06;30.58;Switzerland;Western Europe;Springer Science + Business Media;2007-2018;"Health Policy (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
680;19700194018;Russian Journal of Biopharmaceuticals (discontinued);journal;20738099;0.114;Q4;6;45;135;690;18;134;0.13;15.33;Russian Federation;Eastern Europe;Folium Publishing Company;2011-2021;"Bioengineering (Q4); Drug Discovery (Q4)"
681;21840;Folia Pharmacologica Japonica;journal;00155691, 13478397;0.113;Q4;19;99;349;1788;29;252;0.09;18.06;Japan;Asiatic Region;Japanese Pharmacological Society;1944, 1947-1948, 1951-1956, 1958-2021;Pharmacology (Q4)
682;21100455612;2015 4th International Conference on Future Generation Communication Technology, FGCT 2015;conference and proceedings;-;0.112;-;5;0;29;0;22;27;0.76;0;United States;Northern America;;;"Health, Toxicology and Mutagenesis; Pollution; Toxicology"
683;21374;Fabad Journal of Pharmaceutical Sciences;journal;13004182;0.112;Q4;18;22;12;1286;1;12;0;58.45;Turkey;Middle East;Society of Pharmaceutical Sciences of Ankara;1999-2001, 2003-2021;Pharmaceutical Science (Q4)
684;21100853531;Indian Journal of Novel Drug Delivery;journal;09755500;0.111;Q4;0;0;2;0;0;2;0;0;India;Asiatic Region;Karnataka Education and Scientific Society;2015-2016;Pharmaceutical Science (Q4)
685;21100790356;International Journal of Life Sciences Biotechnology and Pharma Research;journal;22503137;0.111;Q4;1;0;2;0;0;2;0;0;India;Asiatic Region;;2012, 2014, 2016;"Applied Microbiology and Biotechnology (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
686;21100785532;International Journal of Pharma Medicine and Biological Sciences;journal;22785221;0.111;Q4;1;0;3;0;0;3;0;0;India;Asiatic Region;;2012, 2016;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q4); Medicine (miscellaneous) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
687;19700175056;Jordan Journal of Pharmaceutical Sciences;journal;19957157;0.111;Q4;10;7;52;257;7;52;0.12;36.71;Jordan;Middle East;The University of Jordan;2009-2021;Pharmaceutical Science (Q4)
688;19700188309;Journal of Bioanalysis and Biomedicine (discontinued);journal;1948593X;0.111;Q4;11;0;3;0;0;2;0;0;United States;Northern America;OMICS Publishing Group;2010-2014;Pharmaceutical Science (Q4)
689;19700177006;Psychopharm Review;trade journal;19369255;0.111;Q4;4;0;2;0;0;2;0;0;United States;Northern America;Lippincott Williams and Wilkins Ltd.;2009-2014;"Pharmacology (Q4); Pharmacology (medical) (Q4); Psychiatry and Mental Health (Q4)"
690;20628;Circular Farmaceutica;journal;00097314;0.11;Q4;3;24;90;189;1;76;0;7.88;Spain;Western Europe;Col-legi de Farmaceutics de la Provincia de Barcelona;1961, 1973-2020;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
691;19700174645;International Journal of Pharmaceutical Research (discontinued);journal;09752366;0.11;Q4;24;38;156;1004;14;156;0.05;26.42;India;Asiatic Region;Advanced Scientific Research;2010-2021;"Pharmaceutical Science (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
692;21100301409;Issues in Toxicology;book series;17577179, 17577187;0.11;Q4;16;35;169;3257;31;85;0.23;93.06;United Kingdom;Western Europe;Royal Society of Chemistry;2007-2021;"Health, Toxicology and Mutagenesis (Q4); Pharmacology (Q4); Toxicology (Q4)"
693;21823;Pharmacia;journal;04280296;0.11;Q4;16;22;75;592;11;75;0.04;26.91;Bulgaria;Eastern Europe;Pensoft Publishers;1945, 1954-1955, 1987-1991, 1997-2021;"Pharmacy (Q3); Pharmaceutical Science (Q4); Pharmacology (medical) (Q4)"
694;21716;Pharmazeutische Zeitung;journal;00317136;0.11;Q4;7;791;2233;890;6;1488;0;1.13;Germany;Western Europe;Govi-Verlag Pharmazeutischer Verlag GmbH;1947-1948, 1985-2021;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
695;19399;Acta Pharmaceutica Hungarica (discontinued);journal;00016659;0.109;Q4;14;9;48;306;6;48;0.13;34;Hungary;Eastern Europe;Magyar Gyogyszereszeti Tarsasag;1965-2018;"Medicine (miscellaneous) (Q4); Pharmaceutical Science (Q4)"
696;21100199794;Industrial Pharmacy;trade journal;17414911;0.109;Q4;4;0;31;0;2;31;0.13;0;United Kingdom;Western Europe;Euromed Communications;2011-2016;Pharmaceutical Science (Q4)
697;19700201509;Pharma Research (discontinued);journal;09758216;0.109;Q4;5;0;27;0;3;27;0.3;0;India;Asiatic Region;Sudarshan Publications;2011-2016;"Pharmacology (medical) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
698;22358;U.S. Pharmacist;trade journal;01484818;0.109;Q4;9;112;497;1973;33;362;0.06;17.62;United States;Northern America;Jobson Publishing Corporation;1979, 1990-1996, 2007-2021;"Pharmaceutical Science (Q4); Pharmacology (Q4); Pharmacy (Q4)"
699;19700174922;Chinese Journal of New Drugs;journal;10033734;0.108;Q4;12;519;1614;7174;107;1614;0.06;13.82;China;Asiatic Region;Chinese Journal of New Drugs Co. Ltd.;2008-2021;"Pharmacology (medical) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
700;21100202909;Drug Invention Today (discontinued);journal;09757619;0.108;Q4;20;29;6;749;1;6;0;25.83;India;Asiatic Region;Association of Pharmaceutical Innovators;2012-2021;Drug Discovery (Q4)
701;19700174987;Research Journal of Toxins (discontinued);journal;18193560, 21517258;0.108;Q4;3;0;3;0;0;3;0;0;United States;Northern America;Academic Journals Inc.;2009, 2014, 2016;"Agronomy and Crop Science (Q4); Food Science (Q4); Toxicology (Q4)"
702;21836;Revista Mexicana de Ciencias Farmaceuticas;journal;10273956;0.108;Q4;9;0;63;0;6;51;0.1;0;Mexico;Latin America;Asociacion Farmaceutica Mexicana A.C.;1997-2015;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
703;19700170837;Vitae;journal;21452660, 01214004;0.108;Q4;15;18;352;596;20;257;0.03;33.11;Colombia;Latin America;Universidad de Antioquia;2009-2021;"Applied Microbiology and Biotechnology (Q4); Bioengineering (Q4); Biotechnology (Q4); Food Science (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
704;19978;Ars Pharmaceutica (discontinued);journal;00042927;0.107;Q4;20;23;103;609;18;99;0.25;26.48;Spain;Western Europe;Universidad de Granada;1980-1981, 1983-1984, 1986-2001, 2003-2017, 2021;"History and Philosophy of Science (Q4); Pharmaceutical Science (Q4)"
705;19700174811;European Journal of Parenteral and Pharmaceutical Sciences;journal;17406277, 09644679;0.107;Q4;6;2;41;38;8;30;0.25;19;United Kingdom;Western Europe;Pharmaceutical and Healthcare Sciences Society;2010-2016, 2018-2021;"Pharmaceutical Science (Q4); Pharmacy (Q4)"
706;21100205709;International Journal of Toxicological and Pharmacological Research (discontinued);journal;09755160;0.107;Q4;10;0;142;0;43;142;0.32;0;India;Asiatic Region;Dr. Yashwant Research Labs Pvt. Ltd.;2011-2016;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)
707;50105;Japanese Journal of Neuropsychopharmacology;journal;03887588, 13434144;0.107;Q4;11;26;44;487;8;44;0.24;18.73;Japan;Asiatic Region;Japanese Society of Neuropsychopharmacology;1982-1997, 2002-2017;"Clinical Psychology (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4); Psychiatry and Mental Health (Q4)"
708;15323;Journal of Jilin University Medicine Edition;journal;1671587X;0.107;Q4;7;250;520;3310;45;520;0.09;13.24;China;Asiatic Region;Jilin University Press;2005-2021;Pharmacology (Q4)
709;21083;Pharmaceutical Care Espana (discontinued);journal;11396202;0.107;Q4;9;1;105;5;5;84;0.07;5;Spain;Western Europe;Fundacion Pharamaceutical Care Espana;2001-2017;"Pharmaceutical Science (Q4); Pharmacology (Q4); Pharmacy (Q4)"
710;18098;Japanese Journal of Psychopharmacology;journal;13402544;0.106;Q4;0;0;0;0;0;0;0;0;Japan;Asiatic Region;Japanese Society of Neuropsychopharmacology;1981-2016;"Clinical Psychology (Q4); Medicine (miscellaneous) (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4); Psychiatry and Mental Health (Q4)"
711;15842;Journal of Applied Research;journal;1537064X;0.106;Q4;22;0;4;0;0;4;0;0;United States;Northern America;The Journal of Applied Research;2001-2014;"Medicine (miscellaneous) (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4)"
712;24097;Journal of the Indian Chemical Society;journal;00194522;0.105;Q4;33;145;753;5174;131;753;0.18;35.68;India;Asiatic Region;Elsevier BV;1973-1985, 1987-1991, 1996-2021;"Drug Discovery (Q4); Electrochemistry (Q4); Inorganic Chemistry (Q4); Organic Chemistry (Q4); Physical and Theoretical Chemistry (Q4)"
713;21100398550;Orphan Drugs: Research and Reviews;journal;22306161;0.105;Q4;3;4;12;323;4;12;0.4;80.75;New Zealand;Pacific Region;Dove Medical Press Ltd.;2014-2015, 2017;"Drug Discovery (Q4); Pharmaceutical Science (Q4)"
714;19700174966;Pharmakeftiki;journal;22413081, 11054999;0.105;Q4;5;4;28;150;1;28;0.06;37.5;Greece;Western Europe;Zita Medical Managent;2008-2010, 2012-2021;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
715;5200152602;Acta Pharmaceutica Sciencia;journal;13072080;0.104;Q4;20;31;7;1000;1;7;0.14;32.26;Turkey;Middle East;Istanbul Medipol University;2006-2011, 2016-2021;Pharmaceutical Science (Q4)
716;19459;Ankara Universitesi Eczacilik Fakultesi Dergisi;journal;10153918;0.104;Q4;11;7;21;222;0;21;0;31.71;Turkey;Middle East;University of Ankara;1997-2001, 2003-2010, 2014, 2016-2021;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
717;19700171709;Arhiv za Farmaciju;journal;00041963;0.104;Q4;4;20;82;645;6;76;0.04;32.25;Serbia;Eastern Europe;Farmaceutsko Drustvo Srbije;1954-1955, 2009-2021;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
718;19700175108;Drug Delivery System;journal;18812732, 09135006;0.104;Q4;8;62;186;822;4;124;0.02;13.26;Japan;Asiatic Region;Japan Society of Drug Delivery System;1986, 1988-2021;Pharmaceutical Science (Q4)
719;21100853528;International Journal of Advances in Pharmaceutical Research;journal;22497226;0.104;Q4;0;0;6;0;0;6;0;0;India;Asiatic Region;;;"Drug Discovery (Q4); Pharmaceutical Science (Q4)"
720;19700200708;Journal of Global Pharma Technology (discontinued);journal;09758542;0.104;Q4;17;217;100;6266;31;100;0.33;28.88;India;Asiatic Region;Journal of Global Pharma Technology;2010-2020;Pharmaceutical Science (Q4)
721;11200153306;Journal of Pharmacology and Toxicology (discontinued);journal;1816496X, 2152100X;0.104;Q4;18;6;24;261;5;24;0.08;43.5;United States;Northern America;Academic Journals Inc.;2008-2017;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)
722;21100456849;4th International Conference on Accelerating Biopharmaceutical Development 2015;conference and proceedings;-;0.103;-;0;0;8;0;0;7;0;0;United States;Northern America;;;"Chemistry (miscellaneous); Management of Technology and Innovation; Process Chemistry and Technology"
723;19700174892;Chinese Journal of Cancer Biotherapy;journal;1007385X;0.103;Q4;5;0;314;0;11;296;0.03;0;China;Asiatic Region;Editorial office of Chinese Journal of Cancer Biotherapy;2008-2011, 2013-2016, 2018-2022;"Cancer Research (Q4); Molecular Medicine (Q4); Pharmacology (Q4)"
724;21100829255;Chinese Journal of Pharmaceutical Biotechnology;journal;10058915;0.103;Q4;5;119;386;2045;11;386;0.02;17.18;China;Asiatic Region;China Pharmaceutical University;2007-2021;"Applied Microbiology and Biotechnology (Q4); Pharmaceutical Science (Q4)"
725;21238;Drug Topics;journal;19378157, 00126616;0.103;Q4;8;159;835;50;10;126;0.01;0.31;United States;Northern America;Advanstar Communications Inc.;1991, 1997-2021;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
726;19700174992;European Journal of Oncology Pharmacy;journal;17833914;0.103;Q4;4;9;50;102;2;28;0.05;11.33;Belgium;Western Europe;Pharma Publishing and Media Europe;2008-2015, 2017-2019;"Oncology (Q4); Pharmacology (Q4)"
727;21100853529;International Journal of Pharmaceutical and Phytopharmacological Research;journal;22501029;0.103;Q4;2;0;7;0;0;7;0;0;India;Asiatic Region;;;"Drug Discovery (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
728;86349;Oral Therapeutics and Pharmacology;journal;02881012;0.103;Q4;5;13;27;223;1;27;0.05;17.15;Japan;Asiatic Region;Japanese Society of Oral Therapeutics and Pharmacology;1982-2021;"Dentistry (miscellaneous) (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4)"
729;21102;Pharmaceutical Journal;journal;00316873;0.103;Q4;28;72;1003;317;28;273;0.03;4.4;United Kingdom;Western Europe;Pharmaceutical Press;1945-1949, 1994-2012, 2014-2017;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
730;21243;Pharmacy Times;trade journal;00030627;0.103;Q4;8;238;790;1231;9;247;0.01;5.17;United States;Northern America;Intellisphere LLC;1977-1987, 2007-2021;"Pharmaceutical Science (Q4); Pharmacology (Q4); Pharmacy (Q4)"
731;5200152604;Pharma Times;journal;00316849;0.103;Q4;12;81;247;651;12;119;0.02;8.04;India;Asiatic Region;Indian Pharmaceutical Association;2006-2021;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)
732;21100446017;Proceedings of the 16th International Association for Mathematical Geosciences - Geostatistical and Geospatial Approaches for the Characterization of Natural Resources in the Environment: Challenges, Processes and Strategies, IAMG 2014;conference and proceedings;-;0.103;-;2;0;148;0;9;146;0;0;India;Asiatic Region;;;"Organic Chemistry; Pharmaceutical Science"
733;5800207507;Side Effects of Drugs Annual;book series;03786080;0.103;Q4;6;49;206;3005;11;0;0.1;61.33;Netherlands;Western Europe;Elsevier;1977-1995, 1997-2005, 2007-2012, 2014-2020;"Drug Guides (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4)"
734;21100818733;Archives of Pharmacy Practice;journal;2045080X;0.102;Q4;2;0;6;0;0;6;0;0;India;Asiatic Region;Wolters Kluwer Medknow Publications;2014, 2016;Pharmaceutical Science (Q4)
735;21100204921;Bulletin of Pharmaceutical Sciences;journal;11100052;0.102;Q4;8;0;9;0;0;9;0;0;Egypt;Africa/Middle East;Faculty of Pharmacy, Assiut University;2008-2014, 2018-2021;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
736;22887;Chinese Journal of Antibiotics;journal;10018689;0.102;Q4;11;0;297;0;12;297;0.04;0;China;Asiatic Region;Editorial Office of Chinese Journal of Antibiotics;1983-2015;Pharmacology (Q4)
737;21100202747;GMP Review;trade journal;14764547;0.102;Q4;2;9;11;37;0;11;0;4.11;United Kingdom;Western Europe;Euromed Communications Ltd;2011-2015, 2017-2021;Pharmaceutical Science (Q4)
738;11100153311;Iranian Journal of Pharmacology and Therapeutics;journal;17352657;0.102;Q4;21;0;11;0;0;11;0;0;Iran;Middle East;Academy of Medical Sciences of I.R. Iran;2006-2015;Pharmacology (Q4)
739;21100853545;Journal of Global Trends in Pharmaceutical Sciences;journal;22307346;0.102;Q4;1;0;9;0;0;9;0;0;India;Asiatic Region;Annamacharya College of Pharmacy;2015-2016;"Molecular Medicine (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
740;19700201410;Milestones in Drug Therapy;book series;22966056;0.102;Q4;5;8;29;621;1;14;0;77.63;United States;Northern America;Springer Science + Business Media;2010-2017;"Drug Discovery (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
741;21100446069;Pharmaceutical Discovery, Development and Manufacturing Forum 2014 - Core Programming Area at the 2014 AIChE Annual Meeting;conference and proceedings;-;0.102;-;1;0;53;0;1;52;0;0;United States;Northern America;;;Engineering (miscellaneous)
742;21100812582;Pharmaceutical Discovery, Development and Manufacturing Forum 2016 - Core Programming Area at the 2016 AIChE Annual Meeting;conference and proceedings;-;0.102;-;1;0;13;0;0;12;0;0;United States;Northern America;;;"Chemical Engineering (miscellaneous); Engineering (miscellaneous); Environmental Engineering; Materials Chemistry"
743;19700182122;Pharmaceuticals Policy and Law;journal;2210495X, 13892827;0.102;Q4;10;11;69;202;4;62;0.04;18.36;Netherlands;Western Europe;IOS Press BV;1999, 2001-2002, 2005, 2007-2018;"Health Policy (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
744;17744;Anales de la Real Academia Nacional de Medicina;journal;00340634;0.101;Q4;6;0;34;0;0;34;0;0;Spain;Western Europe;Real Academia de Farmacia;1949-2012, 2014;"Cell Biology (Q4); Medicine (miscellaneous) (Q4); Molecular Biology (Q4); Pharmaceutical Science (Q4); Pharmacology (medical) (Q4)"
745;27715;Anil Aggrawal's Internet Journal of Forensic Medicine and Toxicology;journal;09728074, 09728066;0.101;Q4;11;3;29;79;0;26;0;26.33;India;Asiatic Region;Anil Aggrawal;2000-2020;"Pathology and Forensic Medicine (Q4); Toxicology (Q4)"
746;9800153152;Archivos Venezolanos de Farmacologia y Terapeutica;journal;07980264;0.101;Q4;8;41;21;1631;0;21;0;39.78;Venezuela;Latin America;Sociedad Latinoamericana de Hipertension;2007-2013, 2015-2021;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
747;21100781407;EMC Seattle 2016 - 34th Annual West Coast Energy Management Congress;conference and proceedings;-;0.101;-;0;0;29;0;0;28;0;0;Hong Kong;Asiatic Region;;;"Health, Toxicology and Mutagenesis; Pollution; Toxicology"
748;21800;Farmacevtski Vestnik (discontinued);journal;00148229;0.101;Q4;4;0;179;0;1;167;0.01;0;Slovenia;Eastern Europe;Slovenian Pharmaceutical Society;1961, 1989-2016;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
749;21100435458;Food, Pharmaceutical and Bioengineering Division 2015 - Core Programming Area at the 2015 AIChE Meeting;conference and proceedings;-;0.101;-;1;0;255;0;1;251;0.02;0;United States;Northern America;;;"Computer Networks and Communications; Computer Science Applications"
750;21100204506;International Journal of Pharmaceutical Quality Assurance;journal;09759506;0.101;Q4;7;33;37;786;2;37;0.06;23.82;India;Asiatic Region;Dr. Yashwant Research Labs Pvt. Ltd.;2011, 2013-2021;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)
751;21100463844;Pharmaceutical Discovery, Development and Manufacturing Forum 2015 - Core Programming Area at the 2015 AIChE Annual Meeting;conference and proceedings;-;0.101;-;0;0;21;0;0;20;0;0;United States;Northern America;;;"Energy (miscellaneous); Materials Science (miscellaneous); Pollution"
752;19700175034;Pharmaceutical Processing;trade journal;10499156;0.101;Q4;3;37;98;16;0;25;0;0.43;United States;Northern America;Advantage Business Media;2009-2018;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)
753;19700175580;PharmacoVigilance Review;journal;17526752;0.101;Q4;2;8;31;10;1;24;0.04;1.25;United Kingdom;Western Europe;Euromed Communications;2010-2019;"Health Policy (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
754;21100812575;Process Development Division 2016 - Core Programming Area at the 2016 AIChE Meeting;conference and proceedings;-;0.101;-;0;0;20;0;0;19;0;0;United States;Northern America;;;"Bioengineering; Food Science; Pharmaceutical Science"
755;21828;Revista Cubana de Farmacia;journal;00347515, 15612988;0.101;Q4;9;61;183;1443;30;172;0.12;23.66;Cuba;Latin America;Editorial Ciencias Medicas;1980-1991, 1996-2000, 2002, 2004-2021;"Pharmaceutical Science (Q4); Pharmacology (Q4); Pharmacy (Q4)"
756;16800154712;Sp2;trade journal;1476184X;0.101;Q4;2;0;37;0;0;34;0;0;United Kingdom;Western Europe;Avakado Ltd;2009-2014;"Drug Discovery (Q4); Molecular Medicine (Q4)"
757;4800154015;S.T.P. Pharma Pratiques;journal;11571497;0.101;Q4;10;5;37;62;0;37;0;12.4;France;Western Europe;Editions de Sante;1991-2014, 2017-2018;Pharmaceutical Science (Q4)
758;19900195040;Therapeutics, Pharmacology and Clinical Toxicology;journal;20660170, 15830012;0.101;Q4;3;0;63;0;1;62;0.03;0;Romania;Eastern Europe;Rp Publishing House;2011-2012, 2014-2016;"Pharmacology (medical) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
759;21100463816;39th International Precious Metals Conference: Charting Precious Metals through the Changing Currents of Compliance, Finance, Consumer Trends, Risk and New Technology, IPMI 2015;conference and proceedings;-;0.1;-;1;0;55;0;0;54;0;0;United States;Northern America;;;"Organic Chemistry; Pharmaceutical Science"
760;19700174886;Arzneimitteltherapie;journal;07236913;0.1;Q4;6;153;528;994;4;227;0.01;6.5;Germany;Western Europe;Wissenschaftliche Verlagsgesellschaft Stuttgart;2008-2021;"Pharmacology (medical) (Q4); Pharmacology (nursing) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
761;19700175121;Azerbaijan Pharmaceutical and Pharmacotherapy Journal;journal;19941951;0.1;Q4;3;17;52;62;1;52;0;3.65;Azerbaijan;Eastern Europe;Azerbaijan Medical University;2009-2020;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)
762;50087;EBR - European Biopharmaceutical Review;journal;13690663;0.1;Q4;5;29;122;191;0;106;0;6.59;United Kingdom;Western Europe;Samedan Ltd;2004-2019;Pharmaceutical Science (Q4)
763;21334;EPC - European Pharmaceutical Contractor;journal;1364369X;0.1;Q4;3;0;104;0;0;97;0;0;United Kingdom;Western Europe;Samedan Ltd;2002-2016;Pharmaceutical Science (Q4)
764;21292;Epitheorese Klinikes Farmakologias kai Farmakokinetikes;journal;10116575;0.1;Q4;5;15;62;406;0;58;0;27.07;Bulgaria;Eastern Europe;PHARMAKON-Press;1989-2021;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
765;21795;Farmaceuticky Obzor (discontinued);journal;00148172;0.1;Q4;7;0;54;0;0;50;0;0;Slovakia;Eastern Europe;Postgraduate Medical and Pharmaceutical School;1961-1963, 1974, 1976-2016;Pharmaceutical Science (Q4)
766;21100812573;Food, Pharmaceutical and Bioengineering Division 2016 - Core Programming Area at the 2016 AIChE Annual Meeting;conference and proceedings;-;0.1;-;1;0;45;0;0;43;0;0;United States;Northern America;;;"Chemical Engineering (miscellaneous); Education; Engineering (miscellaneous)"
767;21867;Geneesmiddelenbulletin;journal;03044629;0.1;Q4;7;33;137;442;0;103;0;13.39;Netherlands;Western Europe;Stichting Geneesmiddelenbulletin;1973-2021;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
768;21100829925;HiSTOReLo;journal;2145132X;0.1;-;3;29;68;1315;3;58;0.05;45.34;Colombia;Latin America;Universidad Nacional de Colombia;2013-2021;History (Q4)
769;10600153336;Innovations in Pharmaceutical Technology;trade journal;14717204;0.1;Q4;9;29;127;119;0;126;0;4.1;United Kingdom;Western Europe;Samedan Ltd;2007-2010, 2012-2019;Pharmaceutical Science (Q4)
770;13637;Manufacturing Chemist;trade journal;02624230;0.1;Q4;6;46;134;112;0;124;0;2.43;United Kingdom;Western Europe;Wilmington Publishing;1981-1984, 1986, 1989, 1996-2001, 2006-2021;Pharmaceutical Science (Q4)
771;21100407623;Multimedia Technology IV - Proceedings of the 4th International Conference on Multimedia Technology;conference and proceedings;-;0.1;-;1;0;28;0;0;27;0;0;Netherlands;Western Europe;;;"Health, Toxicology and Mutagenesis; Toxicology"
772;19700181430;Pharmaceutical Manufacturing and Packing Sourcer;trade journal;14631245;0.1;Q4;3;0;148;0;1;147;0.01;0;United Kingdom;Western Europe;Samedan Ltd;2009-2016, 2018-2019;"Pharmaceutical Science (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
773;19700181403;Pharmaceutical Outsourcing;journal;19453337, 19453345;0.1;Q4;6;97;152;297;1;125;0.01;3.06;United States;Northern America;Russell Publishing LLC;2010-2018, 2021;"Health Policy (Q4); Pharmaceutical Science (Q4)"
774;12100156730;Pharmaceutische Weekblad Wetenschappelijk Platform;journal;18738982;0.1;Q4;2;0;132;0;0;115;0;0;Netherlands;Western Europe;Kon. Ned. Mij. ter Bevordering der Pharmacie (KNMP);2008, 2013-2015;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
775;21142;Pharmaceutisch Weekblad;journal;00316911;0.1;Q4;9;441;1162;416;2;699;0;0.94;Netherlands;Western Europe;Kon. Ned. Mij. ter Bevordering der Pharmacie (KNMP);1948-2021;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
776;20572;PZ Prisma;journal;09455566;0.1;Q4;5;35;98;912;0;85;0;26.06;Germany;Western Europe;Govi-Verlag Pharmazeutischer Verlag GmbH;1994-2021;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
777;21100841779;ADMET and DMPK;journal;18487718;;-;15;22;80;1135;51;75;0.62;51.59;Croatia;Eastern Europe;International Association of Physical Chemists;2013-2021;"Health (social science); Pharmacology (medical)"
778;21100854647;Applied In Vitro Toxicology;journal;23321512, 23321539;;-;12;5;2;408;7;2;3.5;81.6;United States;Northern America;Mary Ann Liebert Inc.;2015-2021;"Health, Toxicology and Mutagenesis; Medical Laboratory Technology; Toxicology"
779;21100811517;Birth Defects Research;journal;24721727;;-;25;135;0;8444;0;0;0;62.55;United Kingdom;Western Europe;John Wiley and Sons Ltd;2017-2021;"Developmental Biology; Embryology; Health, Toxicology and Mutagenesis; Pediatrics, Perinatology and Child Health; Toxicology"
780;21100986051;Cancer Drug Discovery and Development;book series;21969906, 21969914;;-;5;34;65;4708;11;51;0.21;138.47;United States;Northern America;Springer New York;2014-2015, 2017-2020;"Cancer Research; Drug Discovery; Oncology"
781;21100892509;Cannabis and Cannabinoid Research;journal;23788763;;-;29;32;35;220;77;29;2.2;6.88;United States;Northern America;Mary Ann Liebert Inc.;2016-2021;"Complementary and Alternative Medicine; Pharmacology; Pharmacology (medical)"
782;21100829975;Clinical and Experimental Vaccine Research;journal;2287366X, 22873651;;-;13;21;0;763;0;0;0;36.33;South Korea;Asiatic Region;Korean Vaccine Society;2017-2021;"Immunology and Allergy; Infectious Diseases; Pharmacology; Public Health, Environmental and Occupational Health"
783;21100824046;Computational Toxicology;journal;24681113;;-;15;20;0;1040;0;0;0;52;Netherlands;Western Europe;Elsevier BV;2017-2021;"Computer Science Applications; Health, Toxicology and Mutagenesis; Toxicology"
784;21100873055;Cosmetics;journal;20799284;;-;27;57;94;2491;135;89;1.45;43.7;Switzerland;Western Europe;MDPI AG;2014-2021;"Aging; Chemical Engineering (miscellaneous); Dermatology; Pharmaceutical Science; Surgery"
785;21100857212;Current Opinion in Systems Biology;journal;24523100;;-;26;119;0;6835;0;0;0;57.44;United Kingdom;Western Europe;Elsevier Ltd.;2017-2021;"Applied Mathematics; Biochemistry, Genetics and Molecular Biology (miscellaneous); Computer Science Applications; Drug Discovery; Modeling and Simulation"
786;21101055116;Current Reviews in Clinical and Experimental Pharmacology;journal;27724328, 27724336;;-;43;38;113;1897;193;102;1.58;49.92;United Arab Emirates;Middle East;Bentham Science Publishers;2021;"Pharmacology (medical); Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
787;21100854828;Current Traditional Medicine;journal;22150846, 22150838;;-;4;2;4;92;1;3;0.25;46;Netherlands;Western Europe;Bentham Science Publishers B.V.;2015-2017, 2020-2021;"Complementary and Alternative Medicine; Drug Discovery"
788;21101039763;EJNMMI Radiopharmacy and Chemistry;journal;2365421X;;-;6;6;0;73;0;0;0;12.17;Switzerland;Western Europe;Springer Science and Business Media Deutschland GmbH;2017-2021;"Analytical Chemistry; Pharmacology; Pharmacology (medical); Radiology, Nuclear Medicine and Imaging"
789;21100938253;Environmental Pollutants and Bioavailability;journal;26395940, 26395932;;-;33;23;84;939;131;83;1.14;40.83;United Kingdom;Western Europe;Taylor and Francis Ltd.;2019-2021;"Chemical Health and Safety; Health, Toxicology and Mutagenesis; Toxicology"
790;21100860941;Expert Review of Precision Medicine and Drug Development;journal;23808993;;-;12;40;52;3195;56;41;1.08;79.88;United Kingdom;Western Europe;Taylor and Francis Ltd.;2016-2021;"Drug Discovery; Genetics; Molecular Medicine; Pharmacology"
791;19700174970;Hacettepe University Journal of the Faculty of Pharmacy;journal;13000608;;-;7;10;29;701;0;29;0;70.1;Turkey;Middle East;Hacettepe University, Faculty of Pharmacy;2008-2021;Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
792;21100867470;Indonesian Journal of Pharmacy;journal;23389486, 23389427;;-;7;29;31;725;5;31;0.16;25;Indonesia;Asiatic Region;Universitas Gadjah Mada - Faculty of Pharmacy;2016-2021;"Pharmaceutical Science; Pharmacology (medical); Pharmacy"
793;25110;International Journal of Medical Toxicology and Legal Medicine;journal;09720448;;-;9;29;0;450;0;0;0;15.52;India;Asiatic Region;All India Institute of Medical Sciences;1999-2003, 2005-2011, 2017-2021;"Pathology and Forensic Medicine; Toxicology"
794;21101041727;International Journal of Pharmaceutical Sciences and Research;journal;23205148, 09758232;;-;1;1;0;30;0;0;0;30;India;Asiatic Region;Pharmaceutical Education and Research Society;2017, 2019-2021;Pharmaceutical Science
795;21100820896;Journal of Advanced Pharmacy Education and Research;journal;22493379;;-;8;107;1;2465;0;1;0;23.04;India;Asiatic Region;"Society of Pharmaceutical Education &amp; Research [SPER]";2015, 2017-2021;"Education; Pharmaceutical Science; Pharmacy"
796;21100902935;Journal of Biologically Active Products from Nature;journal;22311874, 22311866;;-;13;40;119;1561;55;119;0.39;39.03;United Kingdom;Western Europe;Taylor and Francis Ltd.;2011-2021;"Agricultural and Biological Sciences (miscellaneous); Complementary and Alternative Medicine; Drug Discovery; Pharmacology; Plant Science; Toxicology"
797;21101022494;Journal of Cardiovascular Development and Disease;journal;23083425;;-;21;23;70;1998;104;65;1.69;86.87;Switzerland;Western Europe;MDPI AG;2014-2021;"Pharmacology (medical); Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
798;27767;Journal of Forensic Medicine and Toxicology;journal;09711929;;-;18;12;89;306;9;88;0.14;25.5;India;Asiatic Region;;1997-2020;"Pathology and Forensic Medicine; Toxicology"
799;21100881509;Journal of International Pharmaceutical Research;journal;16740440;;-;7;77;435;1941;33;435;0.07;25.21;China;Asiatic Region;Editorial office of Journal of International Pharmaceutical Research;2010-2011, 2013-2020;Pharmaceutical Science
800;21100928216;Journal of Research in Pharmacy;journal;26306344;;-;16;95;114;3178;43;114;0.39;33.45;Turkey;Middle East;Marmara University;2019-2021;"Pharmacology (medical); Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
801;21100874234;Latin American Journal of Pharmacy;journal;23623853, 03262383;;-;26;382;916;9132;402;908;0.44;23.91;Argentina;Latin America;Colegio de Farmaceuticos de la Provincia de Buenos Aires;2007-2021;"Drug Discovery; Pharmaceutical Science"
802;21100904379;Nanotheranostics;journal;22067418;;-;20;32;0;2831;0;0;0;88.47;Australia;Pacific Region;Ivyspring International Publishers;2017-2021;"Biomedical Engineering; Biotechnology; Medicine (miscellaneous); Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
803;21100924771;Natural Products and Bioprospecting;journal;21922209, 21922195;;-;26;30;109;1848;152;109;1.18;61.6;Singapore;Asiatic Region;Springer Singapore;2011-2021;"Analytical Chemistry; Biochemistry; Food Science; Organic Chemistry; Pharmacology; Plant Science; Toxicology"
804;21100875801;npj Systems Biology and Applications;journal;20567189;;-;25;36;28;2203;93;27;3.32;61.19;United Kingdom;Western Europe;Nature Publishing Group;2015-2021;"Applied Mathematics; Biochemistry, Genetics and Molecular Biology (miscellaneous); Computer Science Applications; Drug Discovery; Modeling and Simulation"
805;21100858119;Pharmaceutical Sciences Asia;journal;25868195, 25868470;;-;4;21;0;639;0;0;0;30.43;Thailand;Asiatic Region;Mahidol University - Faculty of Pharmacy;2017-2021;"Pharmacology (medical); Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
806;21100932732;PharmacoEconomics - Open;journal;25094262, 25094254;;-;13;29;0;942;0;0;0;32.48;Switzerland;Western Europe;Springer Nature Switzerland AG;2017-2021;"Health Policy; Pharmacology; Pharmacology (medical)"
807;21101055117;Recent Advances in Anti-Infective Drug Discovery;journal;27724352, 27724344;;-;33;14;63;610;72;52;1.24;43.57;United Arab Emirates;Middle East;Bentham Science Publishers;2021;"Drug Discovery; Infectious Diseases; Pharmacology (medical)"
808;21100977423;RSC Medicinal Chemistry;journal;26328682;;-;62;230;719;10297;1793;711;2.39;44.77;United Kingdom;Western Europe;Royal Society of Chemistry;2020-2021;"Biochemistry; Drug Discovery; Molecular Medicine; Organic Chemistry; Pharmaceutical Science; Pharmacology"
809;21100830708;Toxics;journal;23056304;;-;32;37;82;1799;133;78;1.57;48.62;Switzerland;Western Europe;MDPI AG;2013-2021;"Chemical Health and Safety; Health, Toxicology and Mutagenesis; Toxicology"
810;21100933230;Tropical Journal of Natural Product Research;journal;26160692, 26160684;;-;5;52;0;1891;0;0;0;36.37;Nigeria;Africa;Faculty of Pharmacy, University of Benin;2017-2021;"Analytical Chemistry; Biochemistry; Complementary and Alternative Medicine; Drug Discovery; Molecular Medicine; Pharmaceutical Science; Pharmacology"
